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Abstract 
 
Tendon and ligament are prone to age- and injury-related degeneration. 
Tendon and ligament are unable to heal effectively after injury and current 
treatment strategies have variable success rates. The identification of stem cell 
populations in tendon and ligament holds potential for new therapeutic strategies 
to treat tendon and ligament injuries. The stem cell niche has been shown to be 
vital for survival and function of a number of stem cell populations, including 
tendon. Modulation of the stem cell niche can induce changes in stem cell 
phenotype and function and holds therapeutic potential. 
The aim of this study was to characterise stem cell populations in equine 
superficial digital flexor tendon (SDFT) and canine cranial cruciate ligament (CCL), as 
well as characterise the stem cell niche of these cell populations. Tendon- and 
ligament-derived stem cells (TDSCs and LDSCs respectively) and tenocytes and 
ligamentocytes (tendon and ligament fibroblasts respectively) were isolated from 
tendon and ligament tissue and assessed for clonogenicity, proliferation, stem cell 
and tenogenic marker expression and multipotency. The extracellular matrix niche 
of the different ligament cell populations was also investigated using metabolic 
labelling and proteomic analysis.  
Cell populations isolated from equine SDFT demonstrated many properties of 
stem cells however differentiation potential was restricted. There were very few 
differences in stemness and niche composition between TDSCs and tenocytes 
suggesting a heterogeneous mixture of cells within equine SDFT at different stages 
of differentiation. LDSCs isolated from canine CCL demonstrated all of the hallmarks 
of a stem cell and differed in phenotype and gene expression to ligamentocytes 
which showed reduced stemness. The proteomic composition of the LDSC and 
ligamentocyte niche was similar with differential expression and turnover of some 
extracellular matrix proteins between cell types. These results indicate the presence 
of two cell populations and niches within canine CCL. Stem cell populations present 
in equine tendon and canine ligament may hold therapeutic potential and 
modulation of the stem cell niche in these tissues may provide a less invasive 
alternative treatment strategy than current therapies. 
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Chapter 1 
 
General Introduction 
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1.1 Introduction 
 
Tendon and ligament are prone to injury and degeneration, and this is most 
often seen in occupational and sporting environments (Cimino et al., 2010; Maffulli 
et al., 2003). The healing process for tendon and ligament is poorly understood, 
however it is well documented that tendon and ligament tissue is unable to heal 
effectively resulting in painful and debilitating scar tissue, unable to perform its 
normal physiological function (Frank, 2004; Maffulli et al., 2003). 
The current treatment for damaged or degenerated tendon varies 
depending on the severity and location of the tendinopathy (Goldin and Malanga, 
2013; Lempainen et al., 2015; Mayor, 2012; Schwartz et al., 2015). Physiotherapy is 
often prescribed for less severe injuries such as tendinitis, as well as other physical 
therapies including ultrasound and cryotherapy, however these strategies are 
largely ineffective and/or lack any real clinical evidence as to their efficacy (Mayor, 
2012). Pharmacotherapies, such as anti-inflammatories, are used as an alternative 
or in combination with physiotherapy with limited effect (Mayor, 2012; Schwartz et 
al., 2015). For more severe tendinopathies peritendinous steroid injections can be 
given or surgical intervention is performed, with these procedures being invasive 
with poor success rates (Coleman et al., 2000; Mayor, 2012). Therefore, an 
alternative approach for the management and treatment of tendinopathies is 
currently being sought. One such alternative is stem cell therapies which hold great 
potential particularly since the identification of a stem cell population within tendon 
tissue (Bi et al., 2007). 
The current treatment strategies are also limited for ligament injuries; as 
with tendinopathies, rest, immobilisation and physiotherapy are often prescribed 
(Temponi et al., 2015). Where conservative therapies have failed, surgery is often 
performed, however there appears to be little difference in success outcome 
between surgical and conservative treatment options (Dawson et al., 2016). Most 
cases requiring surgery for anterior cruciate ligament (ACL) injuries, one of the most 
commonly injured ligaments (Gianotti et al., 2009; Woo et al., 2000), undergo 
reconstruction of the ACL using a section of the patients’ hamstring or patellar 
tendon, or less commonly, cadaveric tissue (Murawski et al., 2014). There are 
3 
 
variable success rates associated with ACL reconstruction, dependent upon the 
patients’ lifestyle, age and health (Dawson et al., 2016; Murawski et al., 2014), 
however recent advances in the field of stem cell research may provide a treatment 
option with improved success rates. For example, the injection of mesenchymal 
stromal cells (MSCs) alone (Kanaya et al., 2007) or with the use of a biosynthetic 
scaffold (Figueroa et al., 2014) to treat ACL rupture shows promising results at the 
preclinical research stage. It is clear that stem cell therapies hold potential for 
treatment of ligament injuries. 
 
1.2 Function and structure of tendon and ligament  
 
1.2.1 Function 
 
Tendons are dense, regularly arranged, connective tissues which transfer 
forces from muscle to bone, and tendons vary in composition and location 
dependent upon their function (Sharma and Maffulli, 2006; Thorpe et al., 2014). 
The main function of tendon is to transmit loads from muscle to bone as well as to 
resist tension, however tendon is also compliant to enable easier physiological and 
mechanical movement (Shepherd and Screen, 2013). These conflicting functions are 
achieved through stiff collagen fibres, preventing excessive strain and loss of 
contractile energy during movement, and a viscous matrix which allows for sliding 
of fibres within tendon and an increased range of movement (Shepherd and Screen, 
2013). Tendon also plays a role in proprioception and maintaining posture 
(Nourissat et al., 2015) as well as acting as an energy store (Thorpe et al., 2014). 
These final two functions of tendon are dependent on the type of tendon. Positional 
tendons such as the human digital flexor tendon and equine common digital 
extensor tendon are stiff and help to position limbs, whereas energy-storing 
tendons such as the human Achilles tendon and equine superficial digital flexor 
tendon act as a spring to aid motion (Thorpe et al., 2014). 
 Ligaments provide a similar function to tendon, however there are notable 
differences between the two tissue types. Ligaments are also dense, regularly 
arranged connective tissues, however they connect bone to bone in the case of 
4 
 
skeletal ligaments. Ligaments can also vary in composition, positioning and location 
which has an impact on their function, for example, skeletal ligaments span joints 
and insert into bones (known as insertion points), providing multiple functions such 
as stabilisation of the joint, as well as allowing movement during locomotion (Frank, 
2004; Tozer and Duprez, 2005). Similar to tendon, ligaments are compliant due to 
their viscoelastic properties which aid joint mobility, as well as being able to adapt 
to repetitive strain or loads by “creeping” which involves deformation of the 
ligament. In addition, skeletal ligaments are involved in proprioception of joints, 
allowing coordinated joint movement (Birch et al., 2013; Frank, 2004). 
 
1.2.2 Structure 
 
Tendon is surrounded by a sheath known as the paratenon which is 
composed of loose connective tissue and is quite distinct from the tendon itself 
(Benjamin and Ralphs, 1998). Immediately surrounding the tendon is the epitenon 
which is a layer of connective tissue continuous with the interfascicular matrix 
(IFM), also known as the endotenon (Benjamin and Ralphs, 1998). The paratenon 
and epitenon contain blood vessels and nerves (Franchi et al., 2007), whereas the 
tendon body varies in the extent of vasculature and innervation between species, 
tendon types and location in the tendon. For example, the human Achilles tendon is 
well vascularised at the insertion and origin points, however the mid-region is 
largely avascular (Theobald et al., 2005). Murine flexor tendons show poor 
vascularisation (Wong et al., 2006) whereas the equine superficial digital flexor 
tendon has a strong vascular network (Kraus-Hansen et al., 1992). 
Tendon is largely acellular and is mainly composed of extracellular matrix 
(ECM) in the form of collagen fibrils which are held together by ECM components 
such as decorin and aggrecan (Kannus, 2000; Thorpe et al., 2013). Collagen type I is 
predominant, accounting for 95% of the total collagen within tendon, with the 
remainder being made up of types II, III, V, XI, XII and XIV (Franchi et al., 2007; 
Thorpe et al., 2013). Collagen type I is a heterotrimer composed of two alpha 1 
chains (encoded by the COL1A1 gene) and one alpha 2 chain (encoded by the 
COL1A2 gene) (Nourissat et al., 2015). Collectively the collagen fibrils form collagen 
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fibres and fascicles (Fig.1.1), which are inter-related and the movement or sliding of 
fascicles and fibres aids tendon movement and function. In addition, a helical 
formation of some fascicles provides elasticity to aid extension and recoil of tendon 
(Franchi et al., 2007; Sharma and Maffulli, 2006; Thorpe et al., 2014).  
Between each fascicle is the IFM which acts to maintain the structure of the 
tendon. This matrix contains many different glycoproteins including proteoglycans 
(PGs) which are the predominant class of glycoprotein found in tendon. PGs consist 
of varying numbers of glycosaminoglycan (GAG) chains which branch from a core 
protein; sulphation of these chains is common (Yoon and Halper, 2005). There are 
various different GAGs which alter the structure and function of PGs, these include 
dermatan sulphate, chondroitin sulphate, heparin sulphate, keratin sulphate and 
hyaluronan (Kannus, 2000). PGs enable resistance to high tensile and compressive 
forces which are present during mobilisation. In addition, they are involved in 
collagen fibrillogenesis, aiding collagen fibril formation and maturation (Franchi et 
al., 2007). There are two types of PG in tendon, small leucine-rich PGs (SLRPs) and 
large aggregating PGs. SLRPs are the most common PGs in tendon, and these 
include decorin (accounting for approximately 80% of total PG content), biglycan, 
fibromodulin and lumican (Thorpe et al., 2013). Aggrecan and versican are larger 
PGs and are only found in small quantities in tendon, approximately 10% (Yoon and 
Halper, 2005). Other proteins found within tendon include tenomodulin, tenascin-C, 
COMP, lubricin (Thorpe et al., 2013), thrombospondin, fibronectin and undulin 
(Kannus, 2000). These non-collagenous proteins found within the IFM and between 
fascicles, often termed the non-collagenous matrix (NCM), are found in a greater 
abundance in areas under compression, such as the enthesis. This is possibly due to 
the increased water content associated with PGs which hydrates the tendon and 
resists compression (Kjaer, 2004; Thorpe et al., 2013). There are also variations in 
the NCM composition between hierarchical levels of tendon, with the NCM 
increasing in complexity as the subunits increase in size (Thorpe et al., 2013). 
The IFM also contains elastic fibres, blood vessels and cells (Franchi et al., 
2007). Tenocytes are tendon-specific fibroblasts and traditionally were thought to 
be the only cell type present in tendon, however it is now thought that tenocytes 
account for approximately 95% of the cellular content of tendon, with progenitor  
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Figure 1.1. Tendon structure. The role of tendon in connecting muscle and bone (a). 
The hierarchical structure of tendon (b). Adapted from (Nourissat et al, 2015). 
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cells, endothelial cells and chondrocytes comprising the remaining 5% 
(Franchi et al., 2007). Tenocytes are located between collagen fibrils and in the IFM 
and they are responsible for the production of the ECM as well as the repair and 
maintenance of tendon tissue (Franchi et al., 2007; Kannus, 2000). 
Ligament structure is similar to that of tendon, therefore only a brief 
description is provided, including any differences in nomenclature. The outer layer 
of ligament tissue, known as the epiligament, is normally very vascular and highly 
innervated, with nerves running parallel to blood vessels, however the ligament 
itself has a limited blood supply and innervation. The epiligament is continuous with 
the interfascicular matrix (IFM), also known as the endoligament (Frank, 2004). 
Ligaments are composed of dense bands made up of collagenous fibres. 
These fibres are inter-related and can tighten or loosen independently of one 
another suggesting a complex structure (Benjamin and Ralphs, 1998). As described 
previously for tendon tissue these fibres form fibrils and fascicles. The collagen 
fibres are connected by IFM, which is composed of a variety of proteins, blood 
vessels, elastic fibres and cells (Birch et al., 2013; Clark and Sidles, 1990). The 
predominant cell type within ligament are fibroblasts known as ligamentocytes, 
which are present within the IFM as well as between fascicles, and are responsible 
for the production of ECM (Frank, 2004; Lo et al., 2002). 
Ligaments are predominantly composed of water, approximately two thirds, 
with the remaining third comprising ECM mainly in the form of collagen, 
proteoglycans and other proteins. Collagen type I accounts for 85% of the total 
collagen within ligament, with the remainder made up of types III, V, VI, XI and XIV 
(Frank, 2004). The majority of water found within ligament is associated with PGs 
and GAGs, which play a similar role in ligament as they do in tendon (Frank, 2004; 
Kjaer, 2004). In addition, the complement of PGs and GAGs seen in ligament is 
similar to that of tendon (Birch et al., 2013; Frank, 2004), although differences 
between the two tissue types have recently been demonstrated (Kharaz et al., 
2016). 
 
 
8 
 
1.3 Mesenchymal stem/stromal cells (MSCs) 
 
Mesenchymal stem cells (MSCs) are a population of tissue-specific cells which 
have the ability to form skeletal tissues. MSCs have been shown to self-renew, 
express pluripotency markers and differentiate into a number of different cell types, 
including adipogenic, osteogenic and chondrogenic lineages in vitro (Baddoo et al., 
2003; Bianco et al., 2013; Caplan, 1991; Colter et al., 2001; Dominici et al., 2006). 
However, more recently these properties of MSCs have been called into question, 
as well as the classification of these cells as stem cells. For example, other cells 
besides stem cells demonstrate clonogenicity, such as fibroblasts (Williamson et al., 
2015). The expression of some pluripotency markers has been shown to be 
restricted to embryonic stem cells, not somatic cells (Lengner et al., 2008); studies 
demonstrating expression of Oct4 in MSCs may be identifying non-functional 
pseudogenes or non-specific staining of Oct4 (Lengner et al., 2008). Traditional MSC 
markers are also found on other cell types such as fibroblasts (Cadby et al., 2014; 
Lupatov et al., 2015; Williamson et al., 2015). In addition, despite the ability of 
MSCs to differentiate down multiple lineages in vitro, this ability seems to be 
restricted in vivo (Caplan, 2017). Despite this, many studies have shown the efficacy 
of MSCs as a cell transplantation therapy for a number of conditions (Caplan and 
Correa, 2011). Traditionally the mechanism of action was thought to be 
differentiation of the cells into tissue-specific cells to aid repair, however it is now 
thought that the beneficial effects of these cells is actually due to the release of 
paracrine factors which stimulate local tissue repair (Caplan and Correa, 2011; de 
Windt et al., 2017). For the reasons described above, there is now a call for MSCs to 
be renamed “mesenchymal stromal cells” or “medicinal signalling cells”, rather than 
“mesenchymal stem cells” (Caplan, 2017). Despite the reduced stemness of these 
cells they still hold potential for the treatment of a range of conditions. The majority 
of research into MSCs has isolated cells from bone marrow, however MSC-like sub-
populations have been isolated from a number of tissues, including tendon and 
ligament, which may hold therapeutic potential. 
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1.4 Tendon-derived stem cells 
 
1.4.1 Tendon-derived stem cell characteristics 
 
Bi and others (2007) discovered a population of cells within tendon that 
possessed stem cell-like properties including self-renewal, clonogenicity and the 
ability to differentiate into a variety of cell types (Bi et al., 2007). Since this 
publication a considerable amount of research has been conducted (Lee et al., 
2012; Lovati et al., 2011; Mienaltowski et al., 2013; Rui et al., 2010; Rui et al., 
2013b; Zhang and Wang, 2010b; Zhang and Wang, 2013a) in an attempt to 
characterise tendon-derived stem cells (TDSCs) as they may hold potential for 
future treatment of tendinopathies.  
 
1.4.1.1 Stem cell markers 
Many markers have been identified for TDSCs in a range of species 
(Table.1.1), however the majority of these markers are present in other cell types. 
TDSCs have been shown to possess many markers which are also expressed by 
MSCs indicating that TDSCs are a form of MSC. The majority of identified MSC 
markers are surface cluster of differentiation (CD) antigens which are expressed by 
a number of different cell types. There are many CD antigens, and the presence or 
absence of particular markers is indicative of MSCs (De Schauwer et al., 2011; 
Dominici et al., 2006). In order to distinguish between TDSCs and MSCs it is possible 
to use tendon specific markers however such markers are usually expressed by 
tenocytes also, making isolation of pure TDSC cultures difficult, therefore a panel of 
MSC and tenogenic markers needs to be used. 
TDSCs have been found to express the pluripotency markers Oct-4, SSEA-4 
and nucleostemin (Zhang and Wang, 2010b; Zhang and Wang, 2015) indicating that 
they possess stem cell-like characteristics and these markers can be used to 
distinguish TDSCs from tenocytes.  However, Oct4 has been shown to be expressed 
in embryonic stem cells only, not in somatic stem cell populations (Lengner et al., 
2008). The apparent expression of Oct4 in TDSCs and MSCs is most likely due to the 
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Table 1.1. The expression of stem cell and tenogenic markers in TDSCs in various species. + = positive expression, - = no expression, NA = not 
applicable in this species, blank = expression unknown. Information gathered from: aAlberton et al., 2014; bChen et al., 2015; cAsai et al., 2014; 
dBi et al., 2007; eChen et al., 2012a; fChen et al., 2016; gLee et al., 2012; hLovati et al., 2011; iMienaltowski et al., 2013; jNagura et al., 2016; kRui 
et al., 2010; lRui et al., 2013a; mTan et al., 2013; nTao et al., 2015; oWilliamson et al., 2015; pYang et al., 2016; qZhang and Wang, 2010a; rZhang 
and Wang, 2010b; sZhang and Wang, 2013a; tZhang and Wang, 2013b. 
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presence of non-functional Oct4 pseudogenes in these cell types or non-specific 
staining (Lengner et al., 2008), indicating that Oct4 is not a useful marker for TDSCs. 
TDSCs have also been shown to express MSC markers, as TDSCs derived 
from human patellar tendon were subjected to flow cytometry in order to analyse 
surface antigens on the cells and were found to express CD29, CD73, CD44, CD90 
and CD105. These TDSCs were negative for CD34 and CD45, markers which are 
absent on MSCs, but present on haematopoietic stem cells (HSCs) (Lee et al., 2012; 
Nagura et al., 2016). Bi and others (2007) attempted to identify markers to 
distinguish between TDSCs and MSCs, they found that murine TDSCs expressed 
stem cell antigen-1, CD90.2 and CD44 (Bi et al., 2007). The cells were negative for 
CD34, CD117, CD45 and CD18. Similar results were found for human TDSCs with the 
cells expressing CD90 and CD44 but not CD18 (Bi et al., 2007). Bi and others (2007) 
found no expression of CD90.2 in MSCs but high expression in TDSCs, however the 
use of CD90.2 as a marker to distinguish between TDSCs and MSCs is not possible as 
CD90.2 expression has since been demonstrated in murine MSCs (Li et al., 2014). A 
more promising marker is the MSC marker CD18, with Bi and others (2007) 
demonstrating no expression of CD18 in murine and human TDSCs (Bi et al., 2007), 
which is consistent with a more recent study (Mienaltowski et al., 2013). Therefore 
it is clear that many of the markers present on TDSCs are also present on MSCs with 
few exceptions. 
Other studies have investigated tenogenic markers as a means of isolating 
TDSCs (Bi et al., 2007; Rui et al., 2010). Several studies have demonstrated 
expression of tenascin C in TDSCs which is a component of tendon ECM (Lee et al., 
2012; Rui et al., 2010). Similarly, TDSCs have been shown to express scleraxis, a 
transcription factor specific to tendon tissue and tenomodulin, a component of 
tendon ECM (Bi et al., 2007; Mienaltowski et al., 2013). Tenogenic markers may be 
useful candidates to distinguish between TDSCs and MSCs as expression of scleraxis 
and tenomodulin has been shown to be increased in TDSCs when compared with 
MSCs (Bi et al., 2007). It is therefore necessary to use a range of markers to identify 
TDSCs as at present there is not one single marker which can be used for their 
identification.  
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1.4.1.2 Stem cell culture 
TDSCs have been cultured successfully in vitro for several species including 
human, mouse (Bi et al., 2007), rat (Rui et al., 2010), rabbit (Zhang and Wang, 
2010a) and cow (Yang et al., 2016). Initially the tendon tissue must be digested 
which is routinely performed using collagenase type I or II overnight. The cells are 
then counted and seeded at low seeding densities for selection of clonal cell 
populations (Asai et al., 2014; Lee et al., 2012; Lui and Wong, 2013; Mienaltowski et 
al., 2014; Ni et al., 2012; Rui et al., 2010). TDSCs adhere to the culture flask and 
produce distinct colonies after several days (Rui et al., 2013a). There are various 
methods for isolation of TDSCs; individual colonies can be scraped off or detached 
by local application of trypsin (Zhang and Wang, 2010a) or by trypsinising the whole 
culture vessel (Rui et al., 2013a). However, the latter method of complete vessel 
trypsinisation does not distinguish between TDSC colonies and tenocyte colonies. 
TDSCs are then transferred to a culture vessel and allowed to proliferate. 
Certain conditions are conducive to proliferation with hypoxia causing an 
increase in proliferation when compared with a normoxic environment (Zhang and 
Wang, 2013b). In addition, TDSCs obtained from younger animals have increased 
proliferation rates when compared with aged tendon (Zhang and Wang, 2015; Zhou 
et al., 2010). Tendon derived from younger animals also possesses higher numbers 
of TDSCs than older tissue, indicating that younger tendon tissue may have greater 
regenerative potential (Zhou et al., 2010). The passage number has also been 
shown to have a significant effect on stem cell characteristics with one study finding 
that cell proliferation rates increased with passage number as well as clonogenicity 
(Tan et al., 2012a). However other studies have found that cell proliferation 
decreases with passage number (Zhang and Wang, 2010b) suggesting that the 
discrepancy may be due to species and methodological variations as the two studies 
used differing methods. However, Tan and others (2012a) did note an increase in β-
galactosidase activity in higher passages (Tan et al., 2012a) which is indicative of cell 
senescence and consistent with the study by Zhang and others (2010b), although it 
should be noted that Zhang and others (2010b) did not provide the data or figures 
relating to this experiment. In addition, mechanical factors can also affect 
proliferation, with cyclic tensile strain causing an increase in proliferation of rat 
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TDSCs at moderate frequencies and amplitudes such as 4%, but a decrease at 
extreme strain, such as 8% (Xu et al., 2015). 
 
1.4.1.3 Stem cell differentiation capacity 
TDSCs have been found to differentiate into tenocytes in vitro (Guo et al., 
2016; Zhang and Wang, 2010a) as well as adipocytes, osteocytes and chondrocytes 
(Bi et al., 2007; Rui et al., 2010). TDSCs have also been shown to differentiate into 
tenocytes, chondrocytes and osteocytes in vivo in a rabbit model (Zhang and Wang, 
2010b). 
The culture conditions of the TDSCs determine their differentiation capacity 
as certain factors are conducive to tenogenic or non-tenogenic differentiation. For 
example transforming growth factor-β1 (TGF-β1) promoted tenogenic 
differentiation of rat TDSCs (Guo et al., 2016). Similarly, platelet-rich plasma (PRP) 
promoted differentiation of TDSCs into tenocytes when added in cell culture, as well 
as increasing TDSC proliferation (Zhang and Wang, 2010a). In contrast, PRP has 
been found to inhibit non-tenogenic differentiation with the addition of PRP to 
TDSCs in culture preventing adipogenic, osteogenic and chondrogenic 
differentiation (Chen et al., 2012b). Similarly hypoxia has also been found to exhibit 
an inhibitory effect on adipogenic, osteogenic and chondrogenic differentiation of 
human TDSCs (Lee et al., 2012). However a more recent study has found the 
opposite with hypoxia producing an increase in non-tenogenic differentiation of 
human TDSCs (Zhang and Wang, 2013b). This discrepancy may be due to the 
different oxygen tensions used with Lee and others (2012) using 2% oxygen (Lee et 
al., 2012) and Zhang and others (2013b) using 5% (Zhang and Wang, 2013b), or the 
induction periods, as Lee and others (2012) induced differentiation for 14 days, 
whereas Zhang and others (2013b) induced differentiation for 21 days. The 
additional seven days incubation may have been sufficient to induce non-tenogenic 
differentiation. In addition, the glucocorticoid drug dexamethasone, which is often 
included in non-tenogenic differentiation induction media, has been shown to 
inhibit tenogenic differentiation of rat TDSCs in vitro, with a reduction in type I 
collagen and tenomodulin gene expression seen with prolonged exposure. The 
inhibitory effect of dexamethasone on tenogenic differentiation is due to inhibition 
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of the scleraxis gene highlighting the key role this gene plays in the normal function 
of TDSCs (Chen et al., 2015c). 
The location of the TDSCs within the tendon does not have an impact on 
their differentiation capacity as TDSCs isolated from two sites within the murine 
Achilles tendon (tendon body and peritenon) were both found to exhibit 
multipotency (Mienaltowski et al., 2013). Similarly, there were no differences in 
multipotency between tenocytes isolated from the peritenon and tendon body 
(Cadby et al., 2014). However the type and location of the tendon may have an 
impact on the function of TDSCs in certain species such as humans. TDSCs isolated 
from the human patellar tendon (Lee et al., 2012) demonstrated differentiation 
down osteogenic, adipogenic and chondrogenic lineages, whereas TDSCs isolated 
from human semitendinosus and gracilis tendons only showed osteogenic and 
chondrogenic differentiation (Stanco et al., 2014). This would suggest that these cell 
populations are not true stem cells but a form of tendon progenitor cell. However it 
should be noted that the chondrogenic induction media used differed between the 
two studies mentioned above. Lee and others (2012) also added L-proline and bone 
morphogenetic protein 2 (BMP-2) to their induction media which may account for 
their observation of chondrogenic differentiation of TDSCs when compared with the 
study conducted by Stanco and others (2014). The difference in multipotency seen 
between TDSCs isolated from these two tendon types may therefore be due to the 
culture conditions and the artificial nature of differentiation assays, rather than 
inherent differences in the cell populations. Similarly, TDSCs isolated from equine 
superficial digital flexor tendon (SDFT) also showed osteogenic and adipogenic 
differentiation, but limited chondrogenic differentiation (Lovati et al., 2011), 
highlighting the variability in differentiation potential of TDSCs isolated from certain 
tendon types. In addition, TDSCs from rat Achilles (Chen et al., 2012b) and flexor 
tendons (Chen et al., 2015c) were able to differentiate down osteogenic, adipogenic 
and chondrogenic lineages. However tendon cells isolated from the rat patellar 
tendon did not show differentiation towards any of the three lineages, except when 
CD146+ cells were enriched from the population, with these cells exhibiting 
differentiation down all three lineages (Lee et al., 2015a). The CD146+ cell 
population was located in the perivascular region, however the study did not 
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analyse expression of haematopoietic markers, so it is unknown whether these cells 
are true TDSCs or whether they are contaminated with HSCs. In contrast, in some 
species there appears to be little difference between TDSCs isolated from different 
tendon types. For example, in mice, TDSCs isolated from the tail (Alberton et al., 
2014) and Achilles tendon (Asai et al., 2014) demonstrated differentiation down all 
three lineages, and in rabbits, TDSCs isolated from the patellar and Achilles tendon 
also demonstrated differentiation down all three lineages (Zhang and Wang, 
2010b). 
Certain growth factors promote non-tenogenic differentiation, such as BMP-
2 which promotes adipogenic, osteogenic and chondrogenic differentiation of 
TDSCs (Rui et al., 2013b). However other growth factors such as early growth 
response-1 (EGR1) and fibroblast growth factor-2 (FGF-2) can promote tenogenic 
differentiation of TDSCs. In lapine patellar tendons EGR-1 induced tenogenic 
differentiation and promoted tendon repair, whilst inhibiting non-tenogenic 
differentiation (Tao et al., 2015). FGF-2 also promoted tenogenic differentiation of 
TDSCs, with an increase in tenomodulin and scleraxis seen in rat TDSCs subjected to 
FGF-2 in cell culture. In addition, FGF-2 promoted tendon repair with an increase in 
cells expressing stem cell markers as well as increases in tenomodulin and scleraxis 
expression seen in injury sites when compared with healing tendon in the absence 
of FGF-2 (Tokunaga et al., 2015). 
Mechanical stretching of TDSCs also affects their differentiation capacity, as 
4% stretching has been shown to increase tenogenic differentiation, whereas 8% 
stretching increased both tenogenic and non-tenogenic differentiation when 
compared with controls (Zhang and Wang, 2010d). Another study also found that 
4% and 8% stretching of TDSCs seeded on collagen scaffolds caused an increase in 
tenogenic differentiation (Xu et al., 2015). 
The passage number also affects the multipotency of TDSCs with those at a 
lower passage being able to differentiate into tenocytes, adipocytes, osteocytes and 
chondrocytes, whereas cells at higher passage numbers tended to differentiate into 
osteocytes only, and lost the ability to differentiate into tenocytes, adipocytes and 
chondrocytes (Tan et al., 2012a). 
 
16 
 
1.4.2 The role of TDSCs in failed healing of tendon 
 
As TDSCs have been shown to differentiate into tenocytes, and tenocytes 
are responsible for maintaining and repairing tendon, then it is reasonable to 
hypothesise that TDSCs play a crucial role in tendon maintenance and repair, which 
may be the case for acute injury (Kajikawa et al., 2007; Lui, 2013; Rui et al., 2011a). 
However evidence has shown that TDSCs can contribute to poor healing in chronic 
tendinopathy due to their erroneous differentiation (Rui et al., 2011a) (Fig.1.2). 
Chronic tendinopathy is characterised by increased cellularity, vascularity, 
proteoglycan deposition, ECM degradation, ossification, lipid deposition, and the 
presence of chondrogenic and osteogenic cell types (Omachi et al., 2014; Rui et al., 
2013a). Rui and others (2013a) have recently shown that TDSCs differentiate into 
chondrocytes and osteocytes after collagenase-induced injury in a rat model of 
chronic tendinopathy (Rui et al., 2013a). TDSCs taken from the patellar tendon of 
injured rats had an increased proliferation rate, increased numbers of cells which 
differentiated into osteocytes and an increase in calcium nodule formation and ALP 
activity. Similarly, there was an increase in the number of TDSCs which 
differentiated into chondrocytes with an increase in collagen type II and Sox9 gene 
expression in the injured rat tendons compared with the healthy controls. Finally 
there was a decrease in tenogenic markers in the injured rat tendons compared 
with the controls (Rui et al., 2013a).  
Previously, Bi and others (2007) produced an Fmod and Bgn double 
knockout mouse to investigate the role of these proteins in the TDSC niche (Bi et al., 
2007). Fmod (fibromodulin) and Bgn (biglycan) are ECM proteins found in tendon 
tissue. They found that in the knockout mouse there was significant ossification, 
indicating differentiation of TDSCs into osteocytes as well as the expression of 
chondrogenic markers, indicating the presence of chondrocytes. They also found an 
increase in the activity of the BMP/Smad pathway which may be a cause of the 
increase in non-tenogenic differentiation of TDSCs. Bi and others (2007) 
hypothesised that tendinopathy causes changes in the ECM which in turn causes an 
imbalance in growth factors and cytokines within the niche. This imbalance may 
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Figure 1.2. The possible route by which TDSCs can lead to failed healing and calcification and ossification of tendon, and treatment 
strategies by which this process can be attenuated. Adapted from (Rui et al., 2011a). 
18 
 
change the fate of TDSCs from a tenogenic lineage to an osteogenic and 
chondrogenic lineage and therefore cause ossification of the tendon and lead to 
further damage and pain (Bi et al., 2007). There also seems to be changes in the 
phenotype of TDSCs after tendon injury (Runesson et al., 2015). After a tendon 
injury was induced in rat Achilles tendons, different populations of TDSCs were 
noted throughout the length of the tendon. TDSCs expressing high levels of 
nucleostemin were dispersed throughout the length of the tissue, however at the 
site of injury and also in the connective tissue surrounding the tendon there were 
distinct populations of cells with different marker expression, principally increased 
OCT4 expression (Runesson et al., 2015). It is unknown whether these OCT4+ cells 
contribute towards tendon healing after injury or whether they in fact contribute 
towards poor tendon healing, however it is possible that these cells are derived 
from the peritenon. In addition, areas of increased proteoglycan deposition with 
resident chondrocyte-like cells were also found in the injury and mid-proximal 
regions with high levels of nucleostemin+ cells. It is unknown why these areas have 
developed, but it is possible that such proteoglycan-rich areas lead to inferior 
tendon regeneration (Runesson et al., 2015). 
There is currently no evidence to confirm why the fate of TDSCs is altered 
during chronic tendinopathy however there are many possible causes in addition to 
changes to ECM components. Excessive mechanical loading causes non-tenogenic 
differentiation of TDSCs as discussed previously, and overloading of tendon, often 
due to exercise or sport, is a common cause of tendinopathy (Zhang and Wang, 
2010d). Certain biological mediators have been implicated in tendinopathy, 
including BMPs and prostaglandin E2 (PGE2) (Liu et al., 2014a; Zhang and Wang, 
2010c). PGE2 is an inflammatory mediator and its expression is increased in tendon 
during and after prolonged mechanical loading. After an intensive treadmill run 
TDSCs isolated from murine Achilles and patellar tendons had increased levels of 
PGE2 and differentiated into adipocytes and chondrocytes in vitro upon PGE2 
stimulation (Zhang and Wang, 2010c). A recent study has identified the signalling 
pathway linking PGE2 and adipogenic differentiation of TDSCs; PGE2 activates BMP-2 
and IGF-1 signalling leading to PPARγ2 activation and adipogenic differentiation (Liu 
et al., 2014a). Tenocytes may also play a role in chronic tendinopathy as when 
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tendon is damaged the native cells release inflammatory mediators and other 
growth factors (Wang et al., 2003) which have a detrimental effect on the tissue 
and disturb the balance of cytokines within the TDSC niche. This may then result in 
erroneous differentiation and further chronic damage. Another possible cause of 
the altered fate of TDSCs during tendinopathy may be due to treatments, for 
example the use of glucocorticoids is common for chronic tendinopathies. One such 
glucocorticoid, dexamethasone, has been shown to inhibit tenogenic differentiation 
of TDSCs (Chen et al., 2015c) and thereby prevent the ability of TDSCs to aid tendon 
healing, exacerbating the problem by inducing osteogenic and chondrogenic 
differentiation of TDSCs. 
It is clear that, although TDSCs may play a key role in tendon repair for acute 
injury, they have a detrimental effect on the capacity of tendon tissue to repair 
itself after chronic injury or mechanical overloading (Bi et al., 2007; Rui et al., 
2013a; Zhang and Wang, 2010d).  
 
1.4.3 TDSCs and ageing 
 
As tendon ages there is a loss of regenerative capability, demonstrated by 
foetal tendon which showed healing properties after injury as opposed to scar 
tissue formation in adult tendon (Barboni et al., 2012). Barboni and others (2012) 
isolated ovine amniotic epithelial cells and indirectly co-cultured them using 
transwell chambers with fresh tendon explants from both foetal and adult calcaneal 
tendon. The cells co-cultured with foetal tendon were able to differentiate down 
the tenogenic lineage and formed tendon-like structures. These cells also expressed 
stem cell markers whereas cells co-cultured with adult tendon did not display this 
expression. These findings indicate that in foetal tendon inducive tenogenic soluble 
factors may play a vital role in promoting tenogenesis, which was not observed in 
adult tendon (Barboni et al., 2012). In addition to this Russo and others (2014) 
observed distinct differences between foetal and adult ovine tendon. During 
development they observed a decrease in cellularity and vascularity as well as 
morphological changes to cells and nuclei, with adult tendon displaying elongated, 
spindle-shaped cells and nuclei and foetal tendon showing heterogeneous cell and 
20 
 
nuclei morphology. Cells expressing stem cell markers were seen in foetal tendon 
but not in adult tendon, and the proliferative capacity of cells was reduced with age 
(Russo et al., 2014). 
Such changes with ageing have also been observed in other species, with 
aged human (Kohler et al., 2013; Ruzzini et al., 2013) and rat (Zhou et al., 2010) 
TDSCs also showing decreased cellularity and self-renewal potential as well as a 
reduced ability to differentiate into tendon cells. However their ability to 
differentiate down other cell lineages was retained. Aged rat TDSCs have also been 
shown to change in size and morphology compared with young TDSCs, with aged 
cells being large and flat and younger cells smaller and elongated. In addition, aged 
TDSCs also showed increased stiffness and viscosity (Wu et al., 2015a) contributing 
to overall stiffness of the tendon which is commonly seen with age. The ability of 
young tendon to rescue the phenotype of aged tendon has also been demonstrated 
in rats. In one study media was collected from young rat patellar TDSCs grown in 
culture under hypoxic conditions and added to aged TDSCs for ten days. The aged 
TDSCs grown in the conditioned media exhibited increased proliferation, reduced 
senescence and increased expression of tenogenic genes when compared with aged 
TDSCs grown in regular media (Jiang et al., 2014). Again, these findings suggest that 
young tendon produces soluble factors which promote tenogenesis which are not 
present in aged tendon. 
Rat TDSCs from older patellar tendon show earlier entry into senescence, 
which is possibly caused by a decrease in microRNA-135a (miR-135a). miR-135a 
binds to ROCK-1 and normally inhibits entry into senescence in young tendon, a 
decrease in miR-135a in aged tendon may be the cause of early entry into 
senescence and reduced stem cell proliferation, self-renewal and tenogenic 
differentiation (Chen et al., 2015b). Another study has shown that miR-140-5p may 
also play a role in tendon ageing (Chen et al., 2015a). Pin1, a peptidyl-prolyl 
isomerase, has been found to regulate senescence in human TDSCs with increased 
levels delaying entry into senescence. Aged TDSCs were found to express decreased 
levels of Pin1 and therefore entry into senescence occurred more rapidly. In 
addition, miR-140-5p was found to regulate the expression of Pin1 and therefore 
control TDSC senescence (Chen et al., 2015a). Alternatively, a loss of tenomodulin, a 
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marker for the tenogenic linage, may be the cause of TDSC senescence in older 
tendon with a tenomodulin mouse knock-out model showing reduced cellular self-
renewal and early entry into senescence (Alberton et al., 2014). 
It is clear that tendon ageing has a large impact on function and the ability of 
tendon to heal after injury or degeneration (Alberton et al., 2014; Barboni et al., 
2012; Russo et al., 2014). However a recent study demonstrated the ability of 
moderate exercise to rescue aged tendon with a reversal of age-related TDSC 
characteristics (Zhang and Wang, 2015). TDSCs cultured in vitro from aged mice 
showed reduced proliferation and stem cell marker expression and showed non-
tenogenic differentiation. After 4% stretching of the TDSCs, stem cell marker 
expression was increased and the expression of non-tenogenic markers remained 
the same, however after 8% stretching stem cell marker expression was decreased 
and non-tenogenic marker expression was increased (Zhang and Wang, 2015). The 
study also described an in vivo experiment that used treadmill running to assess the 
effects of exercise on TDSC characteristics (Zhang and Wang, 2015). Moderate 
treadmill running caused an increase in TDSC proliferation as well as stem cell 
marker expression. In addition, there was a decrease in the osteogenic, adipogenic 
and chondrogenic differentiation of TDSCs. The study indicated that moderate 
exercise may be able to prevent or reverse the age-related degeneration of tendon, 
however intense exercise can have detrimental effects (Zhang and Wang, 2015). 
The aforementioned studies have all investigated the effects of ageing on 
TDSCs, with a comparison of tendon isolated from young and older adults. Chen and 
others (2016) investigated the changes in TDSCs during early postnatal 
development comparing seven day old rats with 56 day old rats. They found many 
differences between the two groups with colony forming ability, stem cell marker 
expression, proliferation and multipotency all decreasing with age. Adipogenic 
differentiation was the only parameter maintained across both groups (Chen et al., 
2016). In combination with the studies outlined previously, the study conducted by 
Chen and others (2016) suggests that the stem cell properties of TDSCs increase 
during early postnatal development and then progressively decline during tendon 
ageing. 
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1.4.4 The use of TDSCs in tendon repair 
 
TDSCs have been used successfully in tissue engineering for the repair of 
tendon and other tissues such as ligament in a number of different species. When 
compared with BMSCs, TDSCs exhibit many advantages including increased 
clonogenicity, proliferation, differentiation potential and stem cell marker 
expression (Tan et al., 2012b), making TDSCs an ideal cell source for tendon tissue 
engineering strategies. 
The application of TDSCs to an injury site usually requires the use of a 
synthetic scaffold or construct to allow integration of the cells. Ni and others (2012) 
used fibrin glue constructs to introduce TDSCs into patellar tendon defects in rats. 
The application of TDSCs promoted earlier and more effective tendon repair than 
controls, measured by increased collagen production and improved cell and 
collagen fibre alignment, as well as increased ultimate stress and Young’s modulus 
(Ni et al., 2012). Other studies have used decellularised tendon matrices to enhance 
TDSC-mediated tendon repair. The use of decellularised matrices prepared from 
rabbit patellar tendon and seeded with autologous TDSCs led to the formation of 
tendon-like tissues and increased collagen production, which was not seen in 
controls. These matrices also increased the proliferation and maintained the 
stemness of TDSCs, however no mechanical testing was performed to analyse the 
strength of the newly formed tissue (Zhang et al., 2011a). Similarly, decellularised 
matrices were also prepared from rat tendon, and along with TDSCs were implanted 
into rat patellar defects. There was formation of tendon-like tissue and an increase 
in collagen fibre diameter which was not witnessed when TDSCs alone were 
implanted (Yin et al., 2013). These findings were mirrored in another study, in which 
rat TDSCs were seeded on to canine decellularised tendon slices (DTSs) (Ning et al., 
2015). The combination of DTSs and TDSCs produced aligned tendon tissue, with 
the TDSCs showing an increase in tenogenic markers, compared with TDSCs alone 
(Ning et al., 2015). Alternatively, matrices derived from fibroblast ECM can also be 
used, with positive results seen in a rat patellar tendon defect model (Jiang et al., 
2013). In the study by Jiang and others (2013), fibroblasts were stimulated to 
produce ECM and subsequently decellularised before the addition of TDSCs and 
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implantation into the injury site. Tendon-like structures were observed with 
increased collagen production and mechanical strength when compared with 
controls (Jiang et al., 2013). Bioimprinting of bovine tendon tissue, mimicking the 
natural tendon tissue microenvironment, provided a scaffold for a successful tissue 
engineering approach using MSCs. This involved using tendon tissue sections as a 
template for imprinting using polydimethylsiloxane to produce a synthetic tendon 
mimic. MSCs were then seeded on to the synthetic scaffolds and the cells 
underwent tenogenesis and expressed tenomodulin, suggestive of a new approach 
for tendon tissue engineering (Tong et al., 2012). 
Certain factors, such as cellular and matrix alignment, are conducive to 
successful tissue engineering in tendon. Human TDSCs grown on aligned poly (L-
lactic acid) nanofibres highly expressed tendon-specific genes, whereas cells grown 
on randomly-orientated nanofibres expressed only low levels of these genes (Yin et 
al., 2010). In addition, cells grown on randomly-orientated nanofibres differentiated 
into osteoblasts, whereas aligned nanofibres prevented this process. The use of 
aligned nanofibres also induced tendon tissue formation whereas randomly-
orientated fibres did not, however the mechanical integrity of the tissue was not 
tested (Yin et al., 2010). The study by Yin and others (2010) emphasises the 
importance of the structural environment on TDSC survival and function. 
Mechanical stimulation also has a positive impact on the ability of TDSCs to 
form tendon tissue. Rabbit TDSCs subjected to a mechanical stretch of 4% at 0.5 Hz 
expressed tendon-specific ECM proteins and when seeded on to poly(L-lactide-co-ε-
caprolactone)/collagen scaffolds followed by implantation into rabbit patellar 
tendon injuries caused tendon regeneration (Xu et al., 2014). 
Successful tendon engineering has also been achieved without the use of a 
scaffold (Lui et al., 2016; Ni et al., 2013). Rat TDSCs were used to form a scaffold-
free tendon tissue with the use of connective tissue growth factor (CTGF) and 
ascorbic acid. When implanted into nude mice they formed neo-tendon and also 
assisted with tendon repair in a rabbit patellar tendon defect model (Ni et al., 
2013). These results have been mirrored in a rat patellar tendon injury model (Lui et 
al., 2016) indicating that scaffolds may not be necessary for successful tissue 
engineering in tendon. Further to this, the combined use of TDSCs and platelet-rich 
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plasma (PRP) without the use of a scaffold showed positive tendon healing in a 
collagenase-induced rat injury model when compared with an injured control, 
however the use of PRP and TDSCs produced tendon tissue mechanically inferior to 
healthy tendon (Chen et al., 2014). 
TDSCs have been used for repair of non-tendon tissue including anterior 
cruciate ligament (ACL) (Lui et al., 2014). A cell sheet was produced from rat TDSCs, 
CTGF and ascorbic acid, which was wrapped around rat patellar tendon grafts 
before insertion during ACL reconstructive surgery. Rats which received the cell 
sheet and graft had a higher tunnel bone mineral density, better cell alignment, 
graft osteointegration and intra-articular graft integrity, and higher collagen 
birefringence. In addition, the ultimate load and stiffness of the joint were higher 
when compared with graft only rats (Lui et al., 2014). The study suggested that the 
use of TDSCs for tissue engineering may have wide applications, with the potential 
to repair and regenerate a number of tissues besides tendon. 
 
1.4.5 Equine TDSCs 
 
The majority of current research into TDSCs has been conducted in rodents 
and small animals, with a small amount in humans, however there is very little data 
available regarding TDSCs in larger animals. Large animal models can be invaluable 
as they are able to provide a comparative representation of disease and injury in 
humans, including musculoskeletal disorders (Innes and Clegg, 2010). 
Horses provide a useful model for tendon research as equine tendon has 
many similarities with that of humans. For example, the equine superficial digital 
flexor tendon (SDFT) (Fig.1.3) is functionally and clinically equivalent to the human 
Achilles tendon, with both tendons being energy-storing and aiding with locomotion 
(Lichtwark and Wilson, 2005; Lui et al., 2011; Patterson-Kane and Rich, 2014; Wilson 
et al., 2001). In addition, tendon injury and degeneration manifest in a similar 
manner in both humans and horses, with matrix alterations, increased cellularity 
and increased metalloproteinases present in both species (Birch et al., 1998; Clegg 
et al., 2007; Innes and Clegg, 2010; Ireland et al., 2001; Jones et al., 2006; Riley et 
al., 1994). 
25 
 
  
Figure 1.3. Schematic diagram of an equine forelimb showing the location of the 
superficial digital flexor tendon (SDFT). AL, accessory ligament; DDF, deep digital 
flexor; SDF, superficial digital flexor. Adapted from (Wilson et al., 2001). 
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The study of equine tendon is important, not only to inform on tendon 
function and tendinopathy in humans, but also because equine tendon injuries are 
extremely common, particularly within the horse racing industry. One study found 
that 15% of racehorses will suffer a tendon or ligament injury during one racing 
season (Kasashima et al., 2004). SDFT injury is common in athletic horses, resulting 
in increased lameness and reduced performance. One study identified SDFT injuries 
as accounting for 98% of all tendon and ligament injuries in the horse (Ely et al., 
2009). SDF tendinopathies are also more prevalent with age, indicating that this 
tendon is prone to both injury and age related degeneration (Kasashima et al., 
2004). 
As with humans, the treatment options are limited and rarely successful for 
equine tendon injuries, therefore alternative therapies, including stem cell research, 
are being investigated. The majority of current research on equine tendon repair is 
focused on MSCs and their potential use in tissue engineering approaches. For 
example, Lovati et al (2012) isolated bone marrow derived MSCs and indirectly co-
cultured the cells with native equine tendon tissue. The cells expressed tenogenic 
markers, including tenomodulin and tenascin-C, indicating tenogenic differentiation 
of the MSCs (Lovati et al., 2012). In addition, research has also focused on the use of 
foetal-derived embryonic stem cells (fdESCs), with the cells being introduced into 
collagenase-induced tendon injuries (Watts et al., 2011). The study revealed the 
tendon lesions to be reduced and the overall tendon size to be increased after fdESC 
treatment. Tissue architecture was also improved with more aligned tendon fibres 
(Watts et al., 2011). However to date, there is little research available on the 
characterisation of equine TDSCs. Lovati and others (2011) isolated and 
characterised TDSCs from equine SDFT and found that TDSCs were able to form 
colonies and proliferated for an extensive period in vitro. Reverse transcription-
polymerase chain reaction (RT-PCR) showed expression of MSC markers by TDSCs 
and tri-lineage differentiation assays resulted in osteogenic and adipogenic 
differentiation but not chondrogenic (Lovati et al., 2011). Similarly, Durgam and 
others (2016a) isolated TDSCs from equine lateral digital extensor tendon which 
demonstrated similar properties: MSC marker expression and tri-lineage 
differentiation, although clonogenicity was not assessed (Durgam et al., 2016a). 
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Durgam and others (2016b) have also introduced TDSC populations into a 
collagenase-induced injury model in equine SDFT with limited beneficial effects. 
Collagen and ECM gene expression was similar between TDSC and saline controls, as 
was the elastic modulus. However yield and maximal stresses were significantly 
higher in the TDSC group compared with controls and collagen alignment was 
significantly improved in the TDSC group (Durgam et al., 2016b). The progenitor cell 
populations identified within equine tendon in these studies highlight a potential 
cell population for use in equine tendon tissue engineering strategies. 
 
1.5 Ligament-derived stem cells 
 
1.5.1 Ligament-derived stem cell characteristics 
 
In 2004 Seo and others identified a population of cells within periodontal 
ligament which expressed certain stem cell markers and were able to differentiate 
down a number of different cell lineages (Seo et al., 2004). Following this discovery, 
a large amount of research has been conducted into periodontal ligament stem cells 
(PDLSCs); both into the characterisation of these cells and their use in tissue 
engineering strategies. Therefore, the majority of published research on stem cells 
in ligament has focussed on PDLSCs. The promising results seen in these cells may 
also be applicable for other ligaments in other areas of the body and in recent years 
research has turned to the anterior cruciate ligament (ACL) and the potential for 
ligament-derived stem cells (LDSCs) to provide therapies for other types of ligament 
injury.  
 
1.5.1.1 Stem cell markers 
Many of the markers used to identify LDSCs (Table 1.2) are found in other 
cell types including MSCs and TDSCs. For example, stem cells derived from human 
periodontal ligament have been found to express Stro-1, CD146 (Seo et al., 2004), 
CD44, CD105 (Gay et al., 2007), CD29 (Kim et al., 2012), Oct-3/4, SSEA-4, Sox2, 
CD13, CD73, CD90 (Eleuterio et al., 2013), Nanog (Navabazam et al., 2013) and also 
scleraxis, a tendon specific marker (Fujii et al., 2008). However a study focussing on 
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Table 1.2. The expression of stem cell and tenogenic markers in LDSCs in various species. + = positive expression, - = no expression, blank = 
expression unknown. Information gathered from: aCheng et al., 2009; bCheng et al., 2010; cEleuterio et al., 2013; dFujii et al., 2008; eHakki et al., 
2014; fJiang et al., 2015; gKowalski et al., 2015; hLee et al., 2014; iShikh Alsook et al., 2015; jSteinert et al., 2011; kWang et al., 2012; lZhang et 
al., 2011. 
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the use of PDLSCs from a single human patient has shown expression of CD44, 
CD105, CD90 and Nestin, although there was no expression of CD146 or Stro-1 
(Prateeptongkum et al., 2015) indicating that there may be significant individual 
variation in stem cell marker expression. This individual variation may be a feature 
of age as one study has demonstrated a significant decline in the expression of Oct-
4, Nanog, Sox-2 and CD146 with age (Wu et al., 2015b). LDSCs isolated from non-
dental ligaments appear to express similar markers to PDLSCs, with LDSCs isolated 
from human interspinous ligaments expressing CD29, CD44, CD73, CD90 and 
CD105, but not CD34 and CD45 (Kristjánsson et al., 2016). Stem cells derived from 
human ACL tissue (ACLDSCs) have been shown to express the MSC markers 
CD13,CD29, CD49c, CD73, CD90, CD97, CD105, CD146, CD166, SSEA-4, STRO-1 and 
HLA A, B, C, as well as the pluripotency markers Oct4, Nanog and Sox2, and negative 
expression of CD34 and CD45 (Cheng et al., 2009; Steinert et al., 2011; Zhang et al., 
2011b). Stem cells derived from ruptured ACL remnants and healthy tissue show a 
similar marker expression profile (Cheng et al., 2009; Zhang et al., 2011b). Stem 
cells derived from rabbit medial collateral ligament (MCL) have been shown to 
express CD44 and CD90, however not CD34, CD106 or CD11b (Jiang et al., 2015). 
The cells isolated in the above studies have all been negative for haematopoietic 
and endothelial markers, however one group has identified a cell population within 
the ACL which is positive for CD34 (Matsumoto et al., 2012; Uefuji et al., 2014), 
suggesting an alternative vascular source for stem cells located within the ACL. 
However the CD34+ cells isolated in these studies are located in ruptured regions so 
these cells may be a feature of ligament injury. In addition, the cells lost expression 
of CD34 after two weeks expansion, with a phenotype similar to that reported for 
ACLDSCs in other studies (Matsumoto et al., 2012). It is possible that CD34+ cells 
infiltrate ligament tissue during times of injury and undergo ligamentogenic 
differentiation to aid tissue repair. Alternatively, it is possible that CD34+ cells are 
an entirely separate cell population to LDSCs resident in ligament tissue and their 
phenotype changes during prolonged periods in culture, which is a common 
phenomenon for in vitro experiments. An additional explanation may be that all 
LDSCs initially express CD34, however this expression is lost by the time cell 
phenotype is normally analysed. Other studies investigating ACLDSCs from ruptured 
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ACL tissue found negative expression of CD34 for cells at passage three (Fu et al., 
2015; Nohmi et al., 2012), it is possible that these cells had already lost expression 
of CD34 by this passage, or that they never expressed this marker at all. Further 
investigation into the effects of passaging on LDSC phenotype is warranted. 
 
1.5.1.2 Stem cell culture 
As the majority of research on LDSCs has focussed on cells extracted from 
periodontal ligament, most of the published studies have used human tissue, due to 
the ease of dental tissue access (Fujii et al., 2008; Hakki et al., 2014; Seo et al., 
2004). The majority of studies investigating ACLDSCs have also used human tissue 
(Cheng et al., 2009; Steinert et al., 2011). However, there are a number of other 
studies which have isolated and cultured dental and non-dental LDSCs from other 
species, including dogs (Chang et al., 2009; Wang et al., 2012), pigs (Liu et al., 2008), 
horses (Shikh Alsook et al., 2015) and rabbits (Jiang et al., 2015). 
As with TDSCs the isolation of LDSCs involves tissue extraction, digestion in 
collagenase and low-density seeding of cells (Seo et al., 2004; Zhang et al., 2011b). 
After several days in culture the LDSCs start to form colonies (Gay et al., 2007; Seo 
et al., 2004) and can be passaged and further cultured. Unlike TDSCs there is little 
research on the optimum culture conditions for LDSC survival and expansion. The 
rate of proliferation of cells is normally dependent upon the culture conditions, 
however oxygen tension appears to have a variable effect on LDSC proliferation 
with one study observing similar proliferation rates at 21% and 2% oxygen, although 
stem cell marker expression was increased in hypoxia (Zhou et al., 2014) and 
another showing a significant increase in cell proliferation and clonogenicity after 
pre-treatment at 2% oxygen (Yu et al., 2016). In addition, pre-treatment at lower 
oxygen tensions has been shown to enhance LDSC populations and increase stem 
cell marker expression (Kawasaki et al., 2015). The reason for the discrepancy is 
most likely due to differences in culture systems. Zhou and others (2014) cultured 
PDLSCs in hypoxia immediately after digestion and seeding, whereas Yu and others 
(2016), and Kawasaki and others (2015) cultured cells in normoxia until 24 hours 
prior to analysis when cells were transferred to a hypoxic environment. Although 
this approach is useful to analyse the effects of hypoxia on PDLSCs, it is not 
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physiologically relevant and the duration of the effects of the hypoxic pre-treatment 
are unknown and may be transient. 
The age of the donor seems to have an impact on the morphology and 
proliferation of PDLSCs as cells from younger donors exhibited a spindle-shaped 
morphology, however cells from older donors appeared larger (Wu et al., 2015b). In 
addition, cells from younger donors formed increased numbers of colonies and 
these colonies contained increased numbers of cells. Finally, PDLSCs from younger 
donors had decreased proliferation times compared with cells from older donors 
(Wu et al., 2015b). Stem cells isolated from ruptured human ACL remnants 
demonstrated similar characteristics to cells from healthy tissue. Cells had a similar 
morphology to healthy cells and were also able to form colonies (Fu et al., 2015). 
This indicates that age rather than injury has an impact on human LDSC function. 
 
1.5.1.3 Stem cell differentiation capacity 
As a subpopulation of MSCs, LDSCs should be multipotent and have the 
potential to differentiate into various cell lineages, including osteogenic, adipogenic 
and chondrogenic lineages (Dominici et al., 2006). Many studies have shown the 
ability of human PDLSCs to form osteogenic, adipogenic and chondrogenic cells in 
vitro (Gay et al., 2007; Kim et al., 2012; Prateeptongkum et al., 2015; Seo et al., 
2004). The multipotency of the cells was confirmed by staining with alizarin red and 
for alkaline phosphatase for osteogenic differentiation assays, oil red O for 
adipogenic differentiation assays and alcian blue and toluidine blue for 
chondrogenic differentiation assays, as well as western blotting and PCR for analysis 
of lineage specific proteins and genes respectively. The multipotency of PDLSCs has 
also been shown in canine PDL, with the PDLSCs able to differentiate into 
osteogenic, adipogenic and chondrogenic cells (Sedigh et al., 2010; Wang et al., 
2012). LDSCs isolated from human interspinous ligaments demonstrated 
differentiation down all three lineages (Kristjánsson et al., 2016). Similarly, human 
ACLDSCs have been shown to differentiate into osteogenic, adipogenic and 
chondrogenic cells (Cheng et al., 2009; Steinert et al., 2011), as have LDSCs isolated 
from equine suspensory ligaments (Shikh Alsook et al., 2015). PDLSCs isolated from 
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rabbit ligament however, have only been shown to differentiate into osteogenic 
and adipogenic cells as chondrogenesis was not assessed (Su et al., 2015). 
The environment of the LDSCs has a significant impact on their 
multipotency, for example hypoxia increases the differentiation potential of human 
PDLSCs (Zhou et al., 2014). Transient exposure to 5% oxygen has been shown to 
increase osteogenic differentiation of PDLSCs after reoxygenation at 21% oxygen 
(Kawasaki et al., 2015; Yu et al., 2016), whereas anoxic conditions enhanced 
tenogenic/ligamentogenic differentiation when compared with cells cultured at 
21% oxygen (Kawasaki et al., 2015). No differences in adipogenic (Yu et al., 2016) 
and chondrogenic potential were observed between groups (Kawasaki et al., 2015). 
Growth factors also play a role as bone morphogenetic protein-7 and -9 both 
increase osteogenic differentiation of human PDLSCs (Torii et al., 2014; Ye et al., 
2014). 
Age seems to have a variable effect on LDSC multipotency, which is most 
likely dependent on ligament type. Age has been shown to impact the ability of 
PDLSCs to differentiate down different lineages, with cells from older donors 
exhibiting decreased calcium nodule and lipid droplet formation when compared 
with cells from younger donors (Wu et al., 2015b), whereas LDSCs isolated from 
aged ACL demonstrated similar multipotency to those from younger donors (Lee et 
al., 2015b). Ligament injury appears to have less of an effect on LDSCs than age as 
cells derived from ruptured human ACL remnants were able to differentiate down 
all three lineages (Fu et al., 2015). 
Besides the cell lineages originally derived from the mesenchyme, PDLSCs 
have been shown to transdifferentiate into cell lineages derived from the 
endoderm. Lee and others (2014a) induced human PDLSCs to differentiate into 
pancreatic cells by culturing the cells in defined conditions with specific growth 
factors and substrates (Lee et al., 2014a). In addition, two studies have induced 
canine PDLSCs to differentiate into neural cells, again with the use of specific 
conditions and growth factors (Dapeng et al., 2014; Li et al., 2010). These studies 
emphasise the plasticity of LDSCs with implications for potential treatments for a 
range of conditions. 
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1.5.2 The use of LDSCs in ligament repair 
 
Recent studies have investigated the use of PDLSCs in tissue engineering 
approaches for the repair of periodontal cementum/bone and ligament (Fujii et al., 
2008; Lee et al., 2014c; Su et al., 2015), however little research has been conducted 
into the use of LDSCs for other forms of ligament repair.  
Human PDLSC pellets in combination with fibrinogen and thrombin were 
transplanted subcutaneously into the dorsal surfaces of SCID mice, where they 
formed cementum/bone-like structures. Gene expression and histological analysis 
revealed cementum/bone formation and the development of PDL-like structures 
(Fujii et al., 2008). A similar study transplanted a 3D complex of human PDLSCs 
embedded in their ECM into SCID mice which formed a cementum-PDL complex-like 
structure. Further analysis confirmed the presence of cementum and ligament 
tissue formation in the mice (Yang et al., 2009). PDLSCs implanted into pigs also 
produced periodontal structures. Periodontal lesions were created in pigs, and after 
one month autologous PDLSCs were transplanted into the defect along with gelatin 
membranes. The resultant tissue growth resembled cementum and imaging and 
histological staining revealed osteogenic differentiation (Liu et al., 2008).  
Scaffolds have been found to aid tissue regeneration of periodontal tissues 
(Lee et al., 2014b; Lee et al., 2014c; Rodríguez-Lozano et al., 2014). For example, 
fibronectin and calcium phosphate scaffolds promoted in vitro attachment of canine 
PDLSCs to the scaffold and to canine dental roots. When the canine teeth were 
replanted in vivo with the constructs, functional new periodontal attachments were 
seen (Lee et al., 2014b). Similarly, human PDLSCs grown on polydopamine film 
showed increased osteogenic activity compared with controls, indicating 
polydopamine may be a potential substrate for tissue engineering strategies (Lee et 
al., 2014c). Scaffolds containing silk fibroin and graphene oxide have been shown to 
have a beneficial effect on PDLSCs with an increase seen in cell proliferation and 
viability, although no changes in stem cell phenotype were noted (Rodríguez-Lozano 
et al., 2014). The use of nanotubes has been shown to benefit tissue engineering 
strategies (Gao et al., 2015). Nanotubes (25-90 nm) with PDLSC sheets, BMSCs, 
titanium sheets and hydroxyapatite all in combination together, promoted PDLSC 
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adhesion and spread as well as increasing collagen production. Dense collagen 
fibres were well aligned and there was formation of blood vessels and cementum-
like tissue with the regenerated tissue mimicking that of natural PDL (Gao et al., 
2015). These studies suggest that PDLSCs hold potential for treating periodontal 
trauma, therefore it is possible that LDSCs from other sites may also be used for 
ligament repair strategies. 
A recent study has used rabbit stem cells derived from the medial collateral 
ligament (MCL) in order to repair an experimentally induced MCL injury (Jiang et al., 
2015). When introduced to the injury site MCLSCs alone induced repair and 
remodelling with expression of collagen type I and the formation of aligned collagen 
fibres as well as vascularisation. Functional recovery was also assessed with the use 
of MCLSCs aiding the formation of ligament that was better able to withstand 
mechanical strain and failure loads (Jiang et al., 2015). However, the addition of 
CD34+ cells derived from human umbilical cord blood in combination with MCLSCs 
produced an even greater effect than MCLSCs or CD34+ cells alone. Collagen 
expression was increased, the fibre alignment scores were higher, vascularisation 
was increased and also increased loads were tolerated before failure (Jiang et al., 
2015). The study highlights the potential use of LDSCs for repair of ligament injuries 
outside of the field of dentistry. In addition, this research demonstrates that 
although LDSCs can promote repair of ligament injury, this healing effect can be 
increased by the addition of other cell types (Jiang et al., 2015). 
As mentioned previously, LDSCs positive for CD34 have also been isolated 
from ACL tissue and one study has used these cells to investigate the effects of 
angiogenesis on ACL repair strategies (Takayama et al., 2015). CD34+ ACLDSCs were 
transfected with vascular endothelial growth factor (VEGF) and grown into cell 
sheets that were wrapped around tendon grafts. These grafts were then implanted 
into rat knee joints in place of previously excised ACLs. The grafts in combination 
with the cell sheets exhibited increased tensile strength and load to failure when 
compared with tendon grafts alone (Takayama et al., 2015). In addition, the tendon-
bone healing was increased with the use of the LDSC sheets with improved collagen 
fibre alignment and increased collagen production. The main focus of the study was 
to assess vascularisation of healing tissue and with the use of LDSC sheets 
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angiogenesis was significantly increased compared with tendon graft only controls. 
A VEGF antagonist was used to show the expected decrease in angiogenesis in the 
absence of VEGF and in addition there was a decrease in tendon-bone healing 
(Takayama et al., 2015). The study demonstrates the potential of vascular-derived 
LDSCs in treatment strategies for ligament repair but also the importance of 
angiogenesis during ligament healing. 
LDSCs have also been used in tissue engineering strategies for the formation 
of periodontal bone/cementum (Manescu et al., 2015; Su et al., 2015). One study 
isolated PDLSCs from human patients and seeded the cells onto collagenated 
porcine bone scaffolds. The LDSCs differentiated into osteogenic cells with clear 
formation of newly synthesised mineralised bone (Manescu et al., 2015). A second 
study transfected rabbit PDLSCs with human osteoprotegerin (hOPG) and seeded 
these cells on to a scaffold composed of beta-tricalcium phosphate (β-TCP) (Su et 
al., 2015). PDLSCs with and without hOPG transfection adhered and proliferated on 
the β-TCP scaffold, however hOPG-transfected PDLSCs demonstrated earlier and 
increased mineralisation and bone formation and these cells contributed to the 
synthesis of new bone (Su et al., 2015). This highlights the potential of LDSCs for 
treatment of not only ligament injuries but also bone defects and possibly other 
tissue pathologies. 
 
1.5.3 Canine LDSCs 
 
The majority of non-human LDSC studies have utilised a canine model, 
however, as with humans, many of the canine studies also focus on periodontal 
ligament (Lee et al., 2014b; Wang et al., 2012). The reason for the use of dogs in 
many LDSC studies is that they provide a useful and translatable model for human 
work due to the similarities in structure and function of the ACL between the two 
species (Cook et al., 2010). In addition, there are over 300 different dog breeds with 
significant physical differences between breeds. The strict breeding strategies have 
led to specific populations with stable phenotypes and predispositions for certain 
disorders, which produce animals with interesting genetic and phenotypic traits 
(Innes and Clegg, 2010). Some dog breeds are particularly prone to ACL (or cranial 
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cruciate ligament (CCL) (Fig.1.4)) damage and rupture, which is normally a non-
contact injury in the dog. Although ACL injury is commonly associated with acute 
trauma, often during sporting activity, there is a growing trend of non-contact 
related ACL injuries in humans, with 70% of all ACL injuries being caused by non-
contact events (Cimino et al., 2010). For example, OA patients with no previous 
knee injuries have been found to have absent ACLs after MRI scans (Hill et al., 2005) 
and patients undergoing total knee replacements have also shown signs of ACL 
degeneration (Trompeter et al., 2009). This research suggests that with the current 
ageing population, non-contact ACL injuries are becoming more common. Therefore 
the dog could provide a useful model for studying such non-contact ligament 
injuries. In addition, CCL/ACL non-contact injury induced degeneration occurs in a 
similar manner in both dogs and humans (Comerford et al., 2011; Hasegawa et al., 
2013). Matrix metalloproteinase-2 (MMP-2) has been found to be upregulated in 
dog breeds prone to CCL rupture (Comerford et al., 2005), suggesting a role for this 
proteolytic enzyme in CCL degeneration. Similarly in humans MMP-2, as well as a 
range of other MMPs, have also been shown to be upregulated in injured ACL tissue 
(Tang et al., 2009). 
As well as providing a useful model for translation of research into humans, 
investigating canine CCL injuries and degeneration is an important area of research 
in itself due to the prevalence of CCL injuries in the canine population. CCL rupture 
is the predominant cause of canine lameness (Wilke et al., 2006), and since 1970 
the number of reported CCL injuries has tripled (Witsberger et al., 2008). This may 
be due to a number of factors, including improvements in veterinary medicine 
leading to an increased lifespan in dogs. Advancing age can lead to CCL disease as 
CCL degeneration has been found in some studies to increase with age (Witsberger 
et al., 2008). In addition, neutering female dogs has been suggested as a factor in 
the number of CCL injuries, and the number of these procedures performed has 
increased over the years (Whitehair et al., 1993; Witsberger et al., 2008). Obesity is 
a growing trend in the canine population and increased body weight applies more 
pressure to the stifle joint leading to CCL degeneration and rupture (Adams et al., 
2011) which again may account for the increase in the prevalence of CCL disease. 
Finally, the genetic predisposition of certain dog breeds to CCL rupture may be  
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Figure 1.4. Schematic diagram of a canine stifle joint, showing the 
location of the cranial cruciate ligament (CCL). Adapted from (Canapp Jr, 
2007). 
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exacerbated by inbreeding (Baird et al., 2014a; Baird et al., 2014b). For example the 
Rottweiler, Newfoundland, Labrador and Staffordshire terrier are all particularly 
high risk breeds, with CCL rupture rates being as high as 22% (Wilke et al., 2006).  
As with humans, the treatment options for canine CCL injury can be 
unrewarding and they include rest, rehabilitation, anti-inflammatories, glucosamine 
supplements, ultrasound therapy, shockwave therapy as well as surgical options 
which are often associated with short and long term side effects such as 
osteoarthritis (Bergh et al., 2014; Duerr et al., 2014; Moles et al., 2009; Mölsä et al., 
2014; Wolf et al., 2012). Therefore, alternative therapies are currently being sought. 
Amongst other things, stem cell therapies are under investigation. MSCs have been 
shown to successfully engraft on to injured CCL tissue with no adverse side effects 
(Linon et al., 2014), however to date only safety studies have been conducted and 
no studies investigating efficacy have yet been published. With the identification of 
stem cells in canine periodontal ligament (Chang et al., 2009), it is possible that 
future research and treatment strategies could utilise LDSCs, rather than MSCs, as 
LDSCs derived from canine periodontal ligament have been used successfully to 
treat periodontal ligament damage (Lee et al., 2014b) and are a readily accessible 
source of cells. 
 
 
1.6 The stem cell niche 
 
The stem cell environment or ‘niche’ has been found to be integral for stem 
cell survival and viability in a range of stem cell populations and sites (Calvi et al., 
2003; Garcion et al., 2004). The stem cell niche consists of a number of different 
factors, including ECM composition, cellular interactions as well as secreted and 
mechanical factors (Lane et al., 2014) (Fig.1.5). For example, neural stem cells are 
regulated by several ECM proteins including tenascin C, which orchestrates neural 
stem cell development (Garcion et al., 2004). The structure of the ECM has also 
been shown to contribute to neural stem cell development, with the presence of 
fractones, branched ECM structures, being necessary for stem cell function (Kerever 
et al., 2007) (Fig.1.6.A). These findings indicate that both the composition and the  
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Figure 1.5. The various factors affecting the stem cell niche. Adapted from (Lane et 
al, 2014). 
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structure of the ECM are crucial for stem cell fate. In addition to the ECM, resident 
cells within the niche can influence stem cell survival and behaviour. For example, in 
the haematopoietic stem cell niche osteoblasts release biological mediators, 
including angiopoietin, which have an impact on stem cell number and quiescence 
(Calvi et al., 2003). Other mediators and growth factors may be transported to the 
niche via the vasculature, as seen in the haematopoietic stem cell niche where the 
presence of blood vessels is vital (Nakamura-Ishizu and Suda, 2013) (Fig.1.6.B). 
These studies emphasise the importance of the stem cell niche for stem cell 
survival and function, which suggests that the tendon and ligament stem cell niche 
may also play a vital role in tendon and ligament stem cell survival and 
development. 
 
1.6.1 Tendon stem cell niche 
 
The importance of the stem cell niche in tendon tissue has been highlighted 
by several studies that have used tendon extracts to induce tenogenic 
differentiation of MSCs derived from non-tenogenic tissue (Voss et al., 2016; Yang 
et al., 2013). Bovine tendon ECM was extracted and added to human MSCs which 
displayed increased tenogenic differentiation and also increased the mechanical 
strength of the tendon ECM/MSC constructs when compared with controls (Yang et 
al., 2013). Similarly, MSCs were extracted from human bone marrow and grown on 
human rotator cuff tendon which promoted tenogenic differentiation of the cells 
(Voss et al., 2016). These studies emphasise the importance of the tendon 
environment and ECM in tenogenic differentiation, suggesting a positive role of the 
tendon stem cell niche in TDSC viability (Fig.1.7).  
 
1.6.1.1 Extracellular matrix 
As previously discussed the tendon ECM has been shown to promote 
tenogenic differentiation in non-tenogenic cell lines. Bi and others (2007) have 
shown that the tendon ECM also promotes the tenogenic differentiation of TDSCs  
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Figure 1.6. Schematic diagrams of the neural (A) and haematopoietic (B) stem cell niche. 
Adapted from (Gattazzo et al., 2014). 
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Figure 1.7. The potential factors comprising the tendon stem cell niche. 
Adapted from (Lee et al., 2017). 
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(Bi et al., 2007). The study analysed certain components of the TDSC niche and the 
effects of removing those components on TDSC characteristics, in particular they 
investigated two components of the tendon ECM; fibromodulin (Fmod) and biglycan 
(Bgn). Bi and others (2007) noted that the TDSCs were located between the collagen 
fibrils and surrounded by ECM suggesting that the ECM was involved in TDSC 
development and survival. They hypothesised that alterations in the TDSC niche 
could lead to dysregulation of TDSCs. Genetic inactivation of Fmod and Bgn resulted 
in abnormal tendon development with the tendon being thinner and more cellular 
than wild-type mice (Bi et al., 2007). The number of TDSC colonies and the 
proliferation rate increased, however their capacity to differentiate into tenocytes 
was decreased with reduced expression of tenogenic markers such as scleraxis. This 
was also evidenced by the reduction in collagen production and the disorganisation 
of the small amount of collagen produced. The lack of Fmod and Bgn also led to 
ossification of tendon tissue and markers of osteogenic and chondrogenic cell 
lineages were also identified (Bi et al., 2007). Bi and others (2007) have 
demonstrated that the absence of fibromodulin and biglycan from the TDSC niche 
increased stemness and non-tenogenic differentiation, however tenogenic 
differentiation was reduced, highlighting the role of these two ECM components in 
promoting tenogenic differentiation. 
Two recent studies have also shown similarly that the TDSC ECM is beneficial 
for TDSC function (Yin et al., 2013; Zhang et al., 2011a). The use of decellularised 
tendon matrices increased both the stemness of TDSCs and the proliferation rate 
when compared with control cells grown on plastic culture surfaces, as well as 
increasing expression of stem cell markers and multipotency (Zhang et al., 2011a). 
TDSCs grown on porcine decellularised tendon matrices also had the capacity to 
repair a rat Achilles tendon injury with the quality of the repaired tendon tissue 
being greater with the use of TDSCs grown on the matrix, as determined by 
increased collagen deposition, improved fibre structure and arrangement, fewer 
inflammatory cells as well as increased stiffness and maximum force (Yin et al., 
2013). 
The structure of the ECM also affects the function of TDSCs, as one study 
found that aligned nanofibres encouraged the growth of spindle-shaped cells which 
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were able to produce tendon tissue in vivo (Yin et al., 2010). In addition, TDSCs 
grown on nanofibres were able to differentiate into tenocytes and had a higher 
expression of tenogenic markers than cells grown on randomly orientated 
nanofibres. TDSCs grown on randomly orientated nanofibres differentiated into 
osteocytes, however the aligned nanofibres prevented this, indicating that the 
correct ECM structure is vital for TDSC function (Yin et al., 2010). 
 
1.6.1.2 Oxygen tension 
As discussed previously, hypoxia has been shown to promote TDSC 
proliferation, however its effects on multipotency are varied (Lee et al., 2012; Zhang 
and Wang, 2013b). It is likely that tendon has a low oxygen tension in vivo as it is 
poorly vascularised (Franchi et al., 2007), therefore it would be expected that a 
hypoxic environment would promote TDSC viability in vitro. Despite some 
discrepancies within the literature it seems clear that TDSCs cultured in a hypoxic 
environment show increased stem cell characteristics. 
 
1.6.1.3 Biological mediators 
There are certain biological mediators that have an impact on TDSCs and 
their survival and function, for example BMP-2 (Lui and Wong, 2013; Rui et al., 
2013b). BMP-2 stimulated adipogenic, osteogenic and chondrogenic differentiation 
and inhibited tenogenic differentiation of rat TDSCs. BMP-2 also promoted 
glycosaminoglycan (GAG) deposition and aggrecan expression however the 
expression of other ECM components, such as fibromodulin, decorin and biglycan, 
were inhibited by BMP-2 (Rui et al., 2013b). BMPs bind to cell surface receptors 
which trigger a signalling pathway involving a Smad complex, an intracellular 
signalling protein complex (Lui and Wong, 2013). A recent study found that in 
tendon injury the sensitivity of the BMP/Smad pathway was increased and there 
was increased expression of several BMPs, including BMP-2 (Lui and Wong, 2013). 
Insulin-like growth factor-1 (IGF-1) has been found to induce adipogenic 
differentiation of TDSCs through PI3K/Akt pathway signalling and PPARγ2 activation 
(Liu et al., 2014a), however this effect of IGF-1 only occurs in the presence of BMP-
2. Similarly, the study also noted that BMP-2 mediated adipogenic differentiation 
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only occurs in the presence of IGF-1 (Liu et al., 2014a). Therefore, it appears that 
expression of both BMP-2 and IGF-1 is required for adipogenic differentiation of 
TDSCs and the overexpression of these proteins may be a cause of tendinopathy. 
Connective tissue growth factor (CTGF) has been shown to select for CD146+ TDSCs 
and enrich this cell population (Lee et al., 2015a). The selected cells exhibited 
normal TDSC characteristics and successfully contributed to tendon regeneration in 
rats with increased alignment of collagen fibres and tensile stiffness seen with the 
use of CTGF, compared with controls. In addition, CTGF stimulated TDSC 
proliferation and tenogenic differentiation causing such effects via FAK and ERK1/2 
signalling (Lee et al., 2015a). Another study has shown a link between CTGF and 
BMP-12 signalling where CTGF has been found to promote tenogenic differentiation 
of TDSCs and BMP-12 has also been shown to promote tenogenesis, with both 
proteins increasing TDSC expression of scleraxis, tenomodulin and type I collagen. 
The study also demonstrated the interaction between BMP-12 and CTGF in causing 
these effects (Liu et al., 2015a). As discussed previously both EGR-1 (Tao et al., 
2015) and FGF-2 (Tokunaga et al., 2015) also promote tenogenic differentiation of 
TDSCs. 
 
1.6.1.4 Tenocytes 
The predominant cell type within tendon is the tenocyte (tendon fibroblast) 
and tenocytes are responsible for producing and maintaining the ECM (Birch et al., 
2013). They therefore have an important role in the survival and function of TDSCs, 
however it is possible that tenocytes have a direct effect on TDSCs through cell-cell 
contact or through the secretion of growth factors and other soluble mediators. 
Although no studies have shown such a link, the use of tenocytes to promote 
tenogenic differentiation of other stem cell types has been extensively studied. 
Tenocytes have stimulated tenogenic differentiation of human MSCs (Kraus et al., 
2013), canine MSCs (Schneider et al., 2011), rat MSCs (Luo et al., 2009) and ovine 
amniotic epithelial cells (Barboni et al., 2012). These studies utilised a range of 
techniques involving both direct and indirect contact of the stem cells and 
tenocytes indicating that tenocytes may release biological factors that promote 
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tenogenic differentiation. The importance of cell-cell contact between TDSCs and 
tenocytes has yet to be determined. 
 
1.6.1.5 Mechanical loading 
Physical factors also play an important role in tendon development and 
TDSC function. The application of mechanical load to rabbit tendon tissue increased 
TDSC proliferation with higher proliferation rates seen with increased load. 
Mechanical stretching of 4% promoted tenogenic differentiation of TDSCs, however 
mechanical stretching of 8% also induced adipogenic, osteogenic and chondrogenic 
differentiation (Zhang and Wang, 2010d) indicating that extreme mechanical loads 
can be detrimental to TDSC function. Two studies have investigated the role of 
exercise on TDSC function with the use of a treadmill model in mice (Zhang et al., 
2010; Zhang and Wang, 2013a). The first study found that TDSC proliferation was 
increased in mice that had been subjected to exercise compared with control caged 
mice. In addition, they found that collagen production by TDSCs was increased after 
exercise compared with control mice (Zhang et al., 2010). The second study used 
varying levels of exercise, with moderate exercise promoting tenogenic 
differentiation, and intensive exercise promoting both tenogenic and non-tenogenic 
differentiation (Zhang and Wang, 2013a). The study by Zhang and Wang (2013a) 
supports the theory that moderate exercise and mechanical loading is beneficial to 
tendon whereas intensive exercise and loading can be harmful. A possible cause for 
non-tenogenic differentiation of TDSCs at high mechanical loads may be due to the 
increased expression of BMP-2 seen during mechanical stimulation (Rui et al., 
2011c). Other signalling pathways have also been implicated in non-tenogenic 
differentiation of TDSCs after mechanical loading. Wnt5a-RhoA signalling (Shi et al., 
2012b) as well as Wnt5a/Wnt5b/JNK signalling (Liu et al., 2015b) have been shown 
to be involved in osteogenic differentiation of TDSCs after uniaxial mechanical 
tension which may be the cause of tendon ossification in athletes. In addition, the 
upregulation of tendon matrix proteins seen in human tendon after 8% mechanical 
stimulation of TDSCs is regulated by ERK1/2 kinases and p38 (Popov et al., 2015). It 
is clear that mechanical loading has a significant impact on TDSC function and this is 
mediated via a complex array of signalling pathways. 
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1.6.1.6 Vasculature and innervation 
As discussed previously the vascularisation and innervation of tendon varies 
considerably between species, tendon types and location in the tendon. However, it 
is likely that these factors play a role in the tendon stem cell niche, particularly the 
vasculature, as blood vessels provide a steady flow of oxygen and biological 
mediators to the peritenon. It has also been proposed that the vasculature may 
actually be a source of TDSCs, as perivascular cells from the supraspinatus tendon 
expressed stem cell, haematopoietic and tenogenic markers (Tempfer et al., 2009). 
In contrast, other studies have shown null expression of haematopoietic and 
endothelial markers in TDSCs (Bi et al., 2007; Rui et al., 2010) and one group has 
shown that TDSCs isolated from poorly vascularised tendon show enhanced stem 
cell properties compared with cells from the highly vascularised paratenon 
(Mienaltowski et al., 2013). Therefore, it is possible that there are two sources of 
TDSCs within tendon suggestive of an important role of the vasculature within the 
stem cell niche. 
 
1.6.2 Ligament stem cell niche 
 
There is currently very little known about the ligament stem cell niche, 
however as ligament is structurally and functionally similar to tendon (Benjamin and 
Ralphs, 1998; Birch et al., 2013; Rumian et al., 2007) it is likely that those niche 
factors which are essential for TDSC viability are also necessary in the ligament stem 
cell niche. As with the majority of research focussing on LDSCs, studies investigating 
the ligament stem cell niche have mainly focussed on periodontal ligament. 
 
1.6.2.1 Extracellular matrix 
The composition and structure of the ECM have been found to have 
significant effects on various stem cells and some studies also indicate that the ECM 
has a large impact on LDSC viability and function (Chockalingam et al., 2013; Lee et 
al., 2014b; Yang et al., 2009). When human PDLSCs embedded in endogenous ECM 
were implanted into SCID mice they formed a cementum-PDL like structure, 
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indicative of new tooth growth (Yang et al., 2009). PDLSC tissue engineering 
approaches have also used a number of different ECM-based scaffolds such as 
fibronectin which have proven successful in repairing periodontal ligament tissue in 
vivo (Lee et al., 2014b). Tenascin-C, an ECM protein found in various stem cell 
niches, has been shown to be increased in human and canine synovial fluid after 
injury to the joint (Chockalingam et al., 2013). It is possible that this ECM protein 
has a role in stem cell viability but also in tissue degeneration. As seen in tendon (Ni 
et al., 2012; Rui et al., 2013a), stem cells in ligament may promote healing of acute 
injury, however they may contribute towards further degradation through 
erroneous differentiation in chronic injuries. Tenascin-C may be a cause or an effect 
of such tissue degeneration.  
 
1.6.2.2 Oxygen tension 
As discussed previously, hypoxia has been shown to promote cell 
proliferation and the expression of stem cell markers as well as promoting 
differentiation of human PDLSCs into osteogenic, adipogenic and chondrogenic cell 
lines (Yu et al., 2016; Zhou et al., 2014). 
 
1.6.2.3 Biological mediators 
The presence and quantity of certain biological mediators also has an impact 
on LDSC properties (Cheng et al., 2014b; Li et al., 2010; Yu and Wang, 2014). For 
example, the presence of platelet-derived growth factor (PDGF), nerve growth 
factor and all-trans retinoic acid cause the differentiation of PDLSCs into Schwann 
cells (Li et al., 2010), which is mediated by Erk1/2 signalling (Dapeng et al., 2014). 
These studies indicate that the presence of these growth factors in the ligament 
stem cell niche could cause erroneous differentiation. In contrast, a study 
investigating the effects of growth factors on the viability of canine PDLSCs found 
that the cocktail of endogenous growth factors isolated from whole blood 
promoted proliferation and osteogenic differentiation of PDLSCs. The cocktail 
included PDGF, transforming growth factor-beta (TGF-β) and BMP, however the 
exact composition was not stated (Yu and Wang, 2014). More specifically BMP-7 
(Torii et al., 2014) and -9 (Ye et al., 2014) have been found to induce 
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cementogenesis/osteogenesis of human PDLSCs in other studies. For stem cells 
derived from ACL certain media formulations and the presence of specific growth 
factors, for example FGF and TGF-β1, influence various stem cell properties 
including proliferation and multipotency (Cheng et al., 2014b). ACLDSCs transfected 
with BMP-12 and -13 demonstrate increased ECM production (Haddad-Weber et 
al., 2010) indicating the importance of these mediators in tissue homeostasis. 
 
1.6.2.4 Neighbouring cells 
Ligamentocytes (ligament fibroblasts) are the predominant cell type within 
ligament and they are responsible for maintenance of ECM homeostasis (Frank, 
2004). As discussed previously, components of the ECM are vital for the survival and 
function of LDSCs, therefore ligamentocytes are an integral part of the LDSC niche. 
It is possible that ligamentocytes have a direct effect on LDSCs and although no 
studies have shown such a link, the use of ligamentocytes to promote 
ligamentogenic differentiation of MSCs has been studied. Bone marrow-derived 
MSCs have been shown to differentiate into ACL cells when indirectly co-cultured 
with ACL fibroblasts in combination with mechanical stimulation (Lee et al., 2007). 
This influence of ACL fibroblasts on MSC differentiation may indicate their role in 
LDSC differentiation. Other cell types have been shown to influence LDSC survival 
and function, for example in inflammatory environments PDLSC function may be 
impaired and this loss of function appears to be rescued by the addition of dental 
follicular cells (Liu et al., 2014b). These findings suggest that certain cell types may 
play important roles within specific ligament stem cell niche environments.  
 
1.6.2.5 Vasculature and innervation 
As with tendon, ligament is poorly vascularised and innervated, however it is 
likely that these two factors still play a role within the stem cell niche. As mentioned 
above, one study found CD34+ stem cells within human ACL tissue, which possess 
all the properties found in other LDSCs (Matsumoto et al., 2012). The study 
suggested that LDSCs may be derived from pericytes and the vasculature. 
Therefore, as a possible source of LDSCs, the vasculature may be a vital part of the 
ligament stem cell niche. However other studies have shown no expression of 
50 
 
haematopoietic and endothelial markers in LDSCs (Cheng et al., 2009; 
Singhatanadgit et al., 2009). Similar to tendon it is possible that there are two 
sources of LDSCs. 
 
1.6.3 Therapeutic manipulation of the stem cell niche 
 
Manipulation of stem cells in vivo via modulation of the stem cell niche 
holds therapeutic potential for the treatment of a number of conditions. Although 
stem cell therapies show promising results and successful outcomes, there are a 
number of issues associated with cell transplantation therapies (Lane et al., 2014). 
The use of autologous stem cells and the associated isolation, culture and 
implantation of cells can be time consuming and expensive often involving invasive 
and painful techniques in order to extract cells from the patient (Corso et al., 2013). 
Allogeneic stem cells can be used to avoid some of these issues, however 
immunosuppression is then required which can result in problematic long-term side 
effects (Correa et al., 2016; Luo et al., 2016). In addition, whether autologous or 
allogeneic cells are used, the survival of these cells when introduced into wounds or 
diseased tissue is low (Farrar et al., 2013; Lane et al., 2014). There are also problems 
associated with the culture of these cells, as phenotypic changes occur when cells 
are cultured in vitro (Mueller et al., 2016). 
An alternative to stem cell transplantation therapies is modulation of stem 
cells in vivo, which can be achieved via manipulation of the stem cell niche. This 
manipulation can promote survival, proliferation and differentiation of stem cells. 
Costly and time consuming laboratory processes could be avoided as well as 
invasive surgical techniques and the requirement for immunosuppressants. Several 
clinical trials are currently underway or have recently been completed investigating 
the safety and efficacy of stem cell niche modulation therapies (Cianfarani et al., 
2006; Olnes et al., 2012). For example, the administration of a thrombopoietin 
mimetic to patients with severe aplastic anaemia has been shown to increase HSC 
numbers as well as differentiation of these cells (Olnes et al., 2012; Qian et al., 
2007), demonstrating the benefit of targeting secreted factors for stem cell niche  
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Figure 1.8. Potential targets for the manipulation of the haematopoietic stem cell 
niche. Adapted from (Lane et al 2014). 
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modulation. Other potential targets for the manipulation of the HSC niche are of 
shown in Fig.1.8. Granulocyte/macrophage colony stimulating factor (GM-CSF) has 
been shown to regulate survival, proliferation and differentiation of a number of 
stem cell types. When injected into chronic skin ulcers GM-CSF causes modulation 
the stem cell niche by increasing vascularisation (Cianfarani et al., 2006), indicating 
the potential advantages of targeting other cell types within the stem cell niche. 
Therefore it is possible that modulation of the tendon and ligament stem 
cell niche could also influence the behaviour of tendon and ligament stem cells in  
vivo and provide potential therapeutic benefits. As the quantity of research 
surrounding TDSCs, and to a lesser extent LDSCs, increases, it may be possible to 
identify specific factors within their stem cell niche which can be targeted to 
produce a desired change in phenotype and/or function. This approach could 
provide a new treatment strategy to treat tendon and ligament injury and 
degeneration. 
  
1.7 Summary 
 
Tendon- and ligament-derived stem cells have been well characterised in 
certain species for certain tendon/ligament types, however there are still large gaps 
in the knowledge base. Previous studies have highlighted differences in 
TDSCs/LDSCs between species and tendon/ligament types, therefore further 
research into different species and tendon/ligament types is necessary. In addition, 
clarification of tendon/ligament markers is vital to enable consistency in cell 
isolation and identification as well as to aid the use of stem cells in tendon and 
ligament repair. The stem cell niche is essential for maintenance and function of 
TDSCs/LDSCs and holds potential for treatment of tendon/ligament injuries and 
degeneration, however further characterisation of the niche is needed.  
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1.8 Hypothesis 
 
This study will address the hypothesis that stem cells reside within equine 
superficial digital flexor tendon and canine cranial cruciate ligament and such cells 
possess traditional MSC properties, however they differ in phenotype to native 
tissue fibroblasts. It is further hypothesised that the ECM composition of the niche 
differs between stem cells and native tissue fibroblasts. 
 
1.9 Aims 
 
1. To characterise equine TDSCs and tenocytes isolated from the SDFT; 
including analysis of stem cell and tenogenic marker expression, colony-
forming ability, cell proliferation and multipotency. Further, to compare the 
differences in phenotype between TDSCs and tenocytes.  
2. To characterise canine LDSCs and ligamentocytes isolated from the CCL; 
including analysis of stem cell and tenogenic marker expression, colony-
forming ability, cell proliferation and multipotency. Further, to compare the 
differences in phenotype between LDSCs and ligamentocytes. 
3. To characterise the TDSC/LDSC and tenocyte/ligamentocyte niche; including 
analysis of gene and protein expression of ECM components. Further, to 
compare the differences in niche composition between TDSCs/LDSCs and 
tenocytes/ligamentocytes. 
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Chapter 2 
 
Materials and Methods 
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2.1 Materials 
 
Materials are listed below and grouped by supplier: 
 
Thermo Fisher (Massachusetts, USA): DMEM, trypsin, amphotericin B, L-glutamine, 
penicillin/streptomycin, glycoblue, TE buffer, DNase I, 10 x DNase I reaction buffer, 
phenol:chloroform:IAA, ammonium acetate, Novex SDS sample buffer, Novex MES 
running buffer, Novex transfer buffer, NuPage Bis-Tris (4-12%) precast gels 
Sigma: foetal calf serum, phosphate-buffered saline, goat serum, donkey serum, 
dexamethasone, β-glycerophosphate, ascorbic acid, indomethacin, human insulin, 
IBMX, ITS+3, alizarin red, oil-red-O, alcian blue, safranin-O, SigmaFast BCIP/NBT 
tablets, tween 20, isopropanol, acetic acid, ethanol, papain, sodium acetate, EDTA, 
L-cysteine, chondroitin sulphate C, 1-9 dimethyl methylene blue, sodium formate, 
formic acid, xylene, tri-reagent, BCP, sodium chloride, tris-HCl, β-apn, β-
mercaptoethanol, methanol, paraformaldehyde, sodium hydroxide, hexane, 
hydrogen peroxide, trizma base, DAB 3,3’-diaminobenzidine tablets, haematoxylin, 
DPX mounting medium, HRP-conjugated goat anti-mouse secondary antibody, 
crystal violet solution, gluteraldehyde, SILAC media, ammonium bicarbonate, 
[¹2C]lysine, [¹2C]arginine, [¹2C]proline, [¹3C]lysine, [¹3C]arginine, [¹3C]proline, BCA 
protein assay, 660nm protein assay, GelCode stain, Silver Stain kit 
Worthington Biochemicals (New Jersey, USA): collagenase type 1 and 2 
PeproTech (New Jersey, USA): FGF-2, TGF-β 
Millipore (Darmstadt, Germany): human fibronectin, Accutase 
Abcam (Cambridge, UK): anti-CD90 antibody, anti-fibronectin antibody, anti-collagen 
I antibody, anti-collagen II antibody, anti-collagen VI antibody, HRP-conjugated goat 
anti-rabbit secondary antibody 
AbD Serotec (California, USA): anti-CD105 antibody 
BD Pharmingen (New Jersey, USA): anti-CD73 antibody 
Santa Cruz (Texas, USA): anti-tenascin C antibody 
Jackson ImmunoResearch (Pennsylvania, USA): FITC-conjugated donkey anti-mouse 
secondary antibody 
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Promega (Wisconsin, USA): random primers, M-MLV reverse transcriptase, M-MLV 
reverse transcriptase 5x buffer, RNAsin plus, GoTaq qPCR master mix, dNTP mix 
Eurogentec (Liège, Belgium): qPCR primers 
PerkinElmer (Massachusetts, USA): [¹⁴C]lysine, [¹⁴C]arginine, [¹⁴C]proline, 
[¹⁴C]molecular weight marker, nitrocellulose membrane, Western Lightnening-Plus 
ECL chemoluminescence solution 
Roche (Basel, Switzerland): mini protease inhibitor cocktail with EDTA 
GE Healthcare (Illinois, USA): Ficoll-Paque Plus 
Cell Path (Newtown, Wales): OCT embedding matrix 
Waters (Massachusetts, USA): Rapigest SF Surfactant 
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2.2 Methods 
 
2.2.1 Cell isolation 
 
2.2.1.1 Isolation of equine tendon-derived stem cells (TDSCs) and tenocytes 
 
Equine superficial digital flexor tendon (SDFT) (Fig.2.1) was harvested from 
equine cadavers obtained from the abattoir. Tendon tissue was grossly normal upon 
post-mortem examination. The mid-substance tendon tissue (Fig.2.2) was dissected 
into chunks and digested overnight at 37°C in 125 U/ml collagenase type II. The 
resulting cell suspension was strained and then centrifuged at 1200 g for 10 minutes 
and the supernatant discarded. The cells were resuspended in complete DMEM 
(DMEM supplemented with 10% foetal calf serum, 100 U/ml penicillin, 100 µg/ml 
streptomycin and 2 µg/ml amphotericin B) and counted using a haemocytometer. 
The same batch of foetal calf serum was used for all experiments (113M 3395, 
Sigma). For tenocyte isolation the cells were seeded at 1x106 cells in T75 culture 
flasks (1.3x104 cells/cm2) and for TDSC isolation the cells were seeded at 100 cells 
per well of a 6-well plate (10 cells/cm2). The cells were cultured at 37°C, 5% CO2 and 
either 21% or 5% O2 for 10-12 days until they formed colonies. The colonies were 
isolated using cloning cylinders and local application of trypsin and transferred to 
T25 culture flasks. Alternatively TDSCs were isolated using differential adhesion to 
fibronectin substrates. For differential adhesion cells were seeded after digestion at 
12,000 cells per well of a 6-well plate (1200 cells/cm2), previously coated with 20 
µg/ml human fibronectin, and the media (complete DMEM + 5 ng/ml FGF-2) 
replaced after 20 minutes. After 6-8 days the cells were confluent and transferred to 
a T25 culture flask. Cells were used at passage 2-3 for all experiments. 
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Figure 2.1. Schematic diagram of an equine forelimb indicating the location of the 
SDFT. Adapted from (Wilson et al., 2001). 
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Figure 2.2. Equine SDFT indicating the different regions: proximal, middle and distal. 
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2.2.1.2 Isolation of murine tendon-derived stem cells (TDSCs), tenocytes and 
MSCs 
 
Murine tails (C57BL/6; genotype: G4 CTGF x HuRfl, HuRErt2luc, 
HuRPchu94lacZ; HuRErt2luc, Fl+/+, Cre +/-) were donated by Dr. Simon Tew and 
Kirsty Johnson (University of Liverpool) as spare tissue from other projects. The 
tendon tissue was extracted from the tail and digested for 3 hours at 37°C in 20 ml 
375 U/ml collagenase type I and 1 x trypsin. The resulting cell suspension was 
strained and then centrifuged at 1200 g for 10 minutes and the supernatant 
discarded. The cells were resuspended in complete DMEM (DMEM supplemented 
with 10% foetal calf serum, 100 U/ml penicillin, 100 µg/ml streptomycin and 2 
µg/ml amphotericin B) and counted using a haemocytometer. The same batch of 
foetal calf serum was used for all experiments (113M 3395, Sigma). For tenocyte 
isolation the cells were seeded at 1x105 cells in T25 culture flasks (4x103 cells/cm2) 
and for TDSC isolation the cells were seeded at 100 cells per well of a 6-well plate 
(10 cells/cm2). The cells were cultured in complete DMEM + 20% FBS at 37°C, 5% 
CO2 and 21% O2 for 10-12 days until they formed colonies. The colonies were 
isolated using cloning cylinders and local application of trypsin and transferred to 
T25 culture flasks. Cells were used at passage 2-3 for all experiments. Murine MSCs 
were purchased from Cyagen, cells were isolated from bone marrow of C57BL/6 
mice and used at passage 8-9. 
 
2.2.1.3 Isolation of canine ligament-derived stem cells (LDSCs) and 
ligamentocytes 
 
Canine cranial cruciate ligament (CCL) was harvested from the stifle joint 
(Fig.2.3-2.6) of canine cadavers which were euthanased for purposes not related to 
this study and were clinical waste material donated to the University of Liverpool. 
Ethical approval for use of this material in this project was granted by the local 
ethics committee (VREC159). The tissue was dissected into chunks and digested 
overnight at 37°C in 125 U/ml collagenase type II. The resulting cell suspension was  
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Figure 2.3. Schematic diagram of a canine stifle joint indicating the location of the 
CCL. Adapted from (Canapp Jr, 2007).   
Cranial cruciate 
ligament 
Medial meniscus 
Lateral meniscus 
Caudal cruciate 
ligament 
Long digital 
extensor tendon 
Figure 2.4. Enlarged image of a canine stifle joint highlighting the location of the major 
ligaments and tendons. 
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Caudolateral bundle of 
the CCL 
Craniomedial bundle of 
the CCL 
Middle 
Proximal origin 
Distal insertion 
Figure 2.5. Canine stifle joint indicating the location of the caudolateral and 
craniomedial bundles of the CCL. 
Figure 2.6. Canine CCL indicating the different regions: origin, 
middle and insertion. 
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strained and then centrifuged at 1200 g for 10 minutes and the supernatant 
discarded. The cells were resuspended in complete DMEM (DMEM supplemented 
with 10% foetal calf serum, 100 U/ml penicillin, 100 µg/ml streptomycin and 2 
µg/ml amphotericin B) and counted using a haemocytometer. The same batch of 
foetal calf serum was used for all experiments (113M 3395, Sigma). For 
ligamentocyte isolation the cells were seeded at 1x106 cells in T75 culture flasks 
(1.3x104 cells/cm2) and for LDSC isolation the cells were seeded at 100 cells per well 
of a 6-well plate (10 cells/cm2). The cells were cultured at 37°C, 5% CO2 and 5% O2 
for 10-12 days until they formed colonies. The colonies were isolated using cloning 
cylinders and local application of trypsin and transferred to T25 culture flasks. 
Alternatively LDSCs were isolated using differential fibronectin adhesion. For 
differential adhesion cells were seeded after digestion at 12,000 cells per well of a 6-
well plate (1200 cells/cm2), previously coated with 20 µg/ml human fibronectin, and 
the media (complete DMEM + 5 ng/ml FGF-2) replaced after 20 minutes. After 6-8 
days the cells were confluent and transferred to a T25 culture flask. Cells were used 
at passage 2-3 for all experiments. 
 
2.2.1.4 Isolation of canine mesenchymal stromal cells (MSCs) 
 
To obtain MSCs, bone marrow was harvested from canine subjects 
undergoing total hip arthroplasty at the Small Animal Teaching Hospital, University 
of Liverpool. Ethical approval for use of this material in this project was granted by 
the local ethics committee (VREC63ab). A Jamshidi needle was inserted into the 
femur and used to extract the bone marrow. The bone marrow aspirate was layered 
on to Ficoll-Paque Plus and centrifuged for 1500 rpm for 30 minutes. The straw-
coloured buffy layer was removed and added to complete DMEM before being 
centrifuged again at 1200 rpm for 10 minutes. The cell pellet was resuspended in 
complete DMEM and transferred to T25 culture flasks. Cells were used at passage 2-
3 for all experiments. 
 
 
 
63 
 
2.2.2 Stem cell characterisation 
 
2.2.2.1 Cell proliferation assay 
 
Cells were seeded at 10,000 cells in T25 culture flasks at day 0. At 80% 
confluency the cells were counted and the doubling time calculated using the 
formula below. 
 
(LOG10(cell number after proliferation)-LOG10(initial seeding density))/LOG10(2) 
 
2.2.2.2 Colony formation assay 
 
Cells were seeded at 100 cells/cm2 in 6-well cell culture plates. After 7 days 
in culture the cells were washed and then fixed with 6% gluteraldehyde and stained 
with 0.5% crystal violet solution. The cells were washed again and imaged using a 
biomolecular imager (Typhoon FLA 7000, GE Healthcare) and analysed using 
ImageQuant software (GE Healthcare) for colony number and size (Fig 2.7). 
 
2.2.2.3 Flow cytometric analysis of stem cell marker expression 
 
TDSCs were detached using Accutase, a sensitive solution for removal of 
cells, and counted. Aliquots containing 1x106 cells were blocked with 10% normal 
donkey serum in FACS buffer (2.5% FBS in PBS) for 20 minutes before washing. Cells 
were resuspended in either fluorescently conjugated or unconjugated primary 
antibodies for 45 minutes at 4°C. Cells were washed and either analysed by flow 
cytometry (BD Acurri C6 flow cytometer, BD Biosciences) or if required incubated 
with a secondary antibody (donkey anti-mouse IgG FITC-conjugated antibody) for a 
further 45 minutes at 4°C before washing and analysis. Cells in the absence of 
antibody and in the presence of the secondary antibody only were used as negative 
controls (Radcliffe et al., 2010). Anti-CD90 (ab225, Abcam), anti-CD105  
 
64 
 
 
  
Colony number 
Colony size 
Figure 2.7. Illustration of colony formation analysis using ImageQuant software (GE 
Healthcare) in order to determine colony number and size. 
65 
 
(MCA1557A488T, AbD Serotec) and anti-CD73 (550256, BD Pharmingen) antibodies 
were used in this study. Average fluorescence values were recorded and a threshold 
gating out 99.5% of control cells was used. For samples including primary antibody 
the percentage of positive cells was calculated as that exceeding this threshold. 
 
2.2.2.4 Tri-lineage differentiation assays 
 
Cell monolayers were cultured for 21 days in osteogenic (complete DMEM 
containing 100 nM dexamethasone, 10 mM β-glycerophosphate and 50 mM 
ascorbic acid) (Jaiswal et al., 1997) and adipogenic (complete DMEM containing 1 
µM dexamethasone, 100 µM indomethacin, 10 µg/ml insulin and 500 µM IBMX) 
induction media (Cheng et al., 2009). Cell pellets (containing 5x105 cells) were 
cultured for 21 days in chondrogenic (complete DMEM containing 100 nM 
dexamethasone, 25 µg/ml ascorbic acid, 10 ng/ml TGF-β and ITS+3 supplement) 
induction media (Murdoch et al., 2007). Control cells for all treatments were 
cultured in complete DMEM (phenol red-free). After culturing the cells were stained 
with alizarin red and BCIP/NBT (5-Bromo-4-chloro-3-indolyl phosphate/Nitro blue 
tetrazolium) to assess osteogenic differentiation, Oil Red O to assess adipogenic 
differentiation, or alcian blue for chondrogenic differentiation, as described in the 
PromoCell MSC application notes 
(http://www.promocell.com/downloads/application-notes/). Briefly, for alizarin red 
staining: cell monolayers were washed with PBS before fixing in 10% formalin for 30 
minutes. Cells were washed in distilled water, followed by addition of 2% alizarin red 
S solution (pH 4.1-4.3) for 45 minutes in the dark. Cells were then washed 4 times in 
distilled water before imaging. For BCIP/NBT staining: cell monolayers were washed 
with PBS before fixing in 10% formalin for 60 seconds. Cells were washed in 0.05% 
Tween 20 in PBS, followed by addition of BCIP/NBT substrate solution for 5-10 
minutes in the dark. Cells were then washed in 0.05% Tween 20 in PBS before 
imaging. For oil red O staining: cell monolayers were washed with PBS before fixing 
in 10% formalin for 30 minutes. Cells were washed in distilled water, followed by 
addition of 60% isopropanol for 5 minutes. 0.18% oil red O solution was then added 
to cells for 15 minutes. Cells were then washed 2 times in distilled water before the 
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addition of haematoxylin for 1 minute. Cells were then washed 4 times with distilled 
water before imaging. For alcian blue staining: cell monolayers were washed with 
PBS before fixing in 10% formalin for 60 minutes. Cells were washed twice in 
distilled water, followed by addition of 0.01% alcian blue solution overnight in the 
dark. Cells were then washed 3 times in destaining solution (60% ethanol, 40% 
acetic acid) before imaging. Chondrogenic pellets were also paraffin embedded and 
4 µm sections taken (processed by the Department of Veterinary Pathology, 
Institute of Veterinary Science, University of Liverpool) which were rehydrated and 
further stained with either 1% Alcian blue solution for 30 minutes or 0.1% Safranin 
O solution for 5 minutes. Cell pellets were also digested in 10 U/ml papain solution 
for 3 hours at 60°C before the total sulphated glycosaminoglycan (GAG) content was 
quantified. Dimethylmethylene blue (DMMB) dye was added to each sample and 
the absorbance read immediately at 570 nm. The GAG content was calculated from 
a standard curve produced using chondroitin sulphate standards (Fig.2.8) (Farndale 
et al., 1986). RNA was extracted from all assays to analyse lineage-specific gene 
expression (see Section 2.2.2.5). 
 
2.2.2.5 RNA extraction and quantitative real time-polymerase chain reaction 
(qRT-PCR) 
 
RNA was extracted from all cell types by firstly applying Trizol to cell 
monolayers and using a cell scraper to aid cell detachment. 100 µl BCP was added 
to samples before vortexing and incubation at room temperature for 3 minutes. 
Samples were then centrifuged at 14,000 g for 15 minutes at 4°C. The upper 
aqueous phase was transferred to a new tube and 2 µl of 50 µg/ml glycoblue and 
250 µl of 100% isopropanol were added to precipitate the RNA by incubation on ice 
for 30 minutes. Next the samples were centrifuged at 14,000 g for 20 minutes at 
4°C, and the supernatant removed and discarded. 1 ml of 75% ethanol was added to 
wash the pellet by centrifugation at 14,000 g for 5 minutes at 4°C. The ethanol was 
removed and discarded and the pellets dried before resuspension in 21.2 µl  of Tris-
EDTA (TE) buffer. The quantity and quality of RNA was assessed using a NanoDrop 
spectrophotometer (Thermo Fisher), 260/280 values between 1.8-2.1 were deemed  
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Figure 2.8. Representative standard curve produced using chondroitin sulphate 
standards, ranging in concentration from 10-70 ug/ml, to enable quantification of 
sulphated GAG content from the linear equation. 
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of a sufficient RNA quality. 2 µl  of 4 U DNase was then added to the samples for 30 
minutes at 37°C to remove DNA, after which time 50 µl of phenol:chloroform:IAA 
was added to each sample and centrifuged at 14,000 g for 5 minutes at 4°C. 1 µl of 
50 µg/ml glycoblue, 10 µl of 5 M ammonium acetate and 330 µl of 100% ethanol 
were then added to precipitate the RNA by incubation on ice for 30 minutes. The 
samples were then centrifuged, washed in ethanol and the RNA assessed as 
described above. This method was adapted from previous studies (McDermott et 
al., 2016; Reynolds et al., 2016). 
cDNA was synthesised in a 25 µl reaction from 1-2 µg of total RNA. The 
conditions for cDNA synthesis were: incubation at 5 minutes at 70°C, 60 minutes at 
37°C and 5 minutes at 93°C with 0.6 µl of 1 U/µl RNasin ribonuclease inhibitor, 5 µl 
of 2 mM PCR nucleotide mix, 1 µl of 8 U/µl M-MLV reverse transcriptase and 1 µl of 
0.02 µg/µl random-hexamer oligonucleotides per reaction. qRT-PCR was conducted 
using a GoTaq(R) qPCR Master Mix which included SYBR Green DNA intercalating 
dye, and in a 25 µl reaction 10 ng of cDNA was amplified in an AB 7300 Real Time 
PCR System (Applied Biosystems). After an initial denaturation for 10 minutes at 
95°C, 40 PCR cycles were performed consisting of 15 seconds at 95°C and 1 minute 
at 60°C. Relative gene expression was calculated according to the comparative Ct 
method. These methods were adapted from previous studies (Livak and Schmittgen, 
2001; McDermott et al., 2016; Peffers et al., 2015a; Reynolds et al., 2016). 
Equine, murine and canine specific primers were used (Table 2.1) and 
GAPDH was used as an internal control. Primers were designed using Primer-BLAST 
(NCBI) and the quality of each primer was tested using NetPrimer (Premier Biosoft). 
In addition, each primer was subjected to a BLAST (NCBI) search to ensure 
specificity. The best housekeeping genes were determined and all primers were 
tested for efficiency (see Appendix B). 
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Species Gene Forward Reverse 
Equine GAPDH GCATCGTGGAGGGACTCA GCCACATCTTCCCAGAGG 
  CD90 TGCTCCGAGACAAACTGGT CCGAGGTGTGTGAGGGATTG 
  CD73 CCAGGAAGTGGGGAGAACAC CCAAGGTAATGGTGCCGTTG 
  TNC GTTTCAGATGCCACCCCAGA AGCCCATAGCTGTTGTTGCT 
  SCX TCTGCCTCAGCAACCAGAGA TCCGAATCGCCGTCTTTC 
  MKX GATGACGCTAGTGCAGGTGT CCCCCTTCGTTCATGTGGTT 
  EGR-1 CCACCATGGACAACTACCCT ATGTCAGGAAAAGACTCTGAGG 
  OCT-4 GAGAAGGACGTGGTACGAGTG GTGCCAGGGGAAAGGATACC 
  NANOG CAGGGGATCTTCACCAGTGC GGAAGGCAGAGGAGAGACAGT 
  TNMD ACGTGACCATGTATTGGATCAATC   CACCATCCTCCTCAAAGTCTTGT   
  THBS4 AATCCTGACAGACCCCACCC GGTAGCGGAGGATGGCTTTGTT 
  CD34 CACTAAACCCTCTACATCATTTTCTCCTA GGCAGATACCTTGAGTCAATTTCA 
  CD144 ACTATGAACGCATCCGGCAA GGAGTATCCAATGCTCCGCC 
  RUNX2 GTGGACGAGGCAAGAGTTTC TGAGGCGGTCAGAGAACAAA 
  OMD CAAATTCATCAACCCCTGAAA CTTCATCTGGCTCTTGGTCA 
  ALP GGGTAGCAGCCAGTTCAGTT GGGATCTTTCTCTTTCTCTGGCA 
  COL1A1 CATGTTCAGCTTTGTGGACCT TGACTGCTGGGATGTCTTCTT 
  DCN GTCACAGAGCAGCACCTACC TCACAACCAAGGAACCTTTTAATCC 
  Osteocalcin  GAGGTGCAGCCTTCGTGTC  AGCCAATGATCCAGGTAGCG 
  Osterix CCAGATCCCCCAGGAGGAAG TTTGCCCAGTGTCGTTGAGT 
  Osteopontin CGCCTATGCCCTTCCAGTTA TGGTCATGGCTTTCGTTGGA 
  FABP4 CAGAGGGTCAGAGCACCTTC GCCCACTCCCACTTCTTTCA 
  PPARγ ATGGGTGAAACTCTGGAAGATT GGTAATTTCTTGTGAAGTGCTTGC 
  LEP CATTGAAGCTGTGCCCATCC AGACTGACTGCGTGTGTGAAA 
  SOX9 AGCAGACACACATCTCCCCC GCGAGGAATGAGCCTACAAGGT 
  COL2A1 TGAGCCATGATACGCCTCG CTCCTTTCTGTCCCTTCGGT 
  ACAN GCGGTACGAGATCAACTCCC CTTGTAGCTGGCGGGGTC 
  COL1A2 GCACATGCCGTGACTTGAGA CATCCATAGTGCATCCTTGATTAGG 
  COMP GGTGCGGCTGCTATGGAA CCAGCTCAGGGCCCTCAT 
  BIGLYCAN TCACCTTCCAGCCCCTAGAGT AGAAGCAGCCCCTCCTCAA 
Murine GAPDH GAGAGGCCCTATCCCAACTC GTGGGTGCAGCGAACTTTAT 
  CD90 GGATGAGGGCGACTACTTTTGT TTGGAGCTCATGGGATTCG 
  CD73 TGGTTCACCGTTTACAAAGG CGCTCAGAATTGGAAATTTAAC 
  TNC AGGCGATCCCAGCCAGTCAGT ATGGACGGGGCACCTCCTGTC 
  SCX AAGTTGAGCAAAGACCGTGACA TGTGGACCCTCCTCCTTCTAAC 
  MKX AGTAAAGACAGTCAAGCTGCCACTG TCCTGGCCACTCTAGAAGCG 
  Sca-1 GTTTGCTGATTCTTCTTGTGGCCC ACTGCTGCCTCCTGAGTAACAC 
  NANOG AGGGTCTGCTACTGAGATGCTCTG CAACCACTGGTTTTTCTGCCACCG 
  TNMD AACTCCACCTCAGCAGTAGTCC TTTCTTGGATACCTCGGGCCAGAA 
  THBS4 TCCTCCGCTACCTGAAGAATGATGG TTCAATGGACTCTGGGTTCTGGGTG 
70 
 
  CD34 AGGCTGATGCTGGTGCTAG AGTCTTTCGGGAATAGCTCTG 
  CD45 AGTTAGTGAATGGAGACCAGGAA TCCATAAGTCTGCTTTCCTTCG 
  RUNX2 ATGCGTATTCCTGTAGATCCG TTGGGGAGGATTTGTGAAGAC 
  ALP CCAACTCTTTTGTGCCAGAGA GGCTACATTGGTGTTGAGCTTTT 
  COL1A1 TTCTCCTGGCAAAGACGGACTCAA AGGAAGCTGAAGTCATAACCGCCA 
  DCN TGAGCTTCAACAGCATCACC AAGTCATTTTGCCCAACTGC 
  Osteocalcin  CTCTGTCTCTCTGACCTCACA CAGGTCCTAAA AGTGATACC 
  Osterix GAAAGGAGGCACAAAGAAG CACCAAGGAGTAGGTGTGTT 
  Osteopontin CATGAGATTGGCAGTGATTTGC TGCAGGCTGTAAAGCTTCTCCT 
  FABP4 GAAGCTTGTCTCCAGTCAAAA AGTCACGCCTTTCATAACACAT 
  PPARγ CTCCGTGATGGAAGACCACTC AGACTCGGAACTCAATGGC 
  LEP CTTCACCCCATTCTGAGTTTGT TTCTCCAGGTCATTGGCTATCT 
  SOX9 TGGCAGACCAGTACCCGCATCT TCTTTCTTGTGCTGCACGCGC 
  COL2A1 GGTTTGGAGAGACCATGAAC TGGGTTCGCAATGGATTGTG 
  ACAN TTGCCAGGGGGAGTTGTATTC GACAGTTCTCACGCCAGGTTTG 
Canine GAPDH CTGGGGCTCACTTGAAAGG CAAACATGGGGGCATCAG 
  CD90 TGTGCTCAGAGACAAACTGGT CAGCCAGTCACAGGGAGATG 
  CD73 ATGGCTCCACTCAATCCTGC TCCCAGGTAATTGTGCCGTT 
  CD105 GACGCCGAGGTGACATACAT GCTCTGACAGCTCCCTTGAG 
  CD44 ACCTTCCAACTGCATACCCG TCGTGGTCTTTGGTAATGGGG 
  SCX GTCCAGCTACATCTCGCACC GTCCAGCTACATCTCGCACC 
  MKX GCGACCCCGGAGTTCTTC CGCGGTCCTCAAAAAGCAC 
  OCT-4 GAGGCTCTGCAGCTCAGTTT AGCCCAGAGTGGTGACAGAC 
  TNMD CCCACTCTAATAGCAGTTTCAGA TCCTCACTTGCTTGTCTGGT 
  RUNX2 GAACCCAGAAGGCACAGACA ACTTGGTGCAGAGTTCAGGG 
  Osteocalcin  AGGGCACGACCCAGAGTAT GCTTGGACACGAAGGTTGC 
  Osteopontin CTCTGAGGAAAAGCAGAATGC GTTGCTGGAATGTCAGTGGG 
  FABP4 ATCAGTGTAAACGGGGATGTG GACTTTTCTGTCATCCGCAGTA 
  PPARγ TTCTTTTAATGGATTGGTCTTTTGC TGGTAGTTTCTTGTGAAGTGCT 
  LEP TATCTGTCCTGTGTTGAAGCTG GTGTGAAAATGTCATTGATCCTG 
  SOX9 CTCTGGAGGCTGCTGAACG AAGATGGCGTTGGGGGAAAT 
  COL2A1 AGCTAAAGGATCTGCTGGCG CTTGTTCGCCTTTGAAGCCA 
  ACAN ACAATGCCCAAGACTACCAGTGGA TTCTCGTGCCAGATCATCACCACA 
 
Table 2.1. Primer sequences for equine, murine and canine genes.  
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2.2.3 Stem cell niche characterisation 
 
2.2.3.1 Histology 
 
SDFT tissue was fixed overnight in 4% paraformaldehyde at 4°C before 
paraffin embedding. 4 µm thick sections were cut, dried and washed before the 
following stains were performed: Haematoxylin and Eosin (H&E) and Masson’s 
trichrome (processed by the Department of Veterinary Pathology, Institute of 
Veterinary Science, University of Liverpool). 
 
2.2.3.2 Immunohistochemistry 
 
 Whole SDFT tissue sections were frozen in OCT cryo-embedding compound 
using hexane and dry ice. Hexane was cooled on dry ice before the dry ice was 
added to the hexane. The tissue samples were fixed to cork disks and covered in 
OCT before being added to the hexane. Once samples were completely frozen they 
were removed and stored at -80°C. 4 µm sections were cut from the blocks using a 
cryostat, after which the sections were fixed in methanol for 20 minutes. 3% 
hydrogen peroxide was then added to all sections for 10 minutes to block 
endogenous peroxidase activity. After washing 3 times each in distilled water and 
Tris-buffered saline (TBS) (20 mM Trizma Base and 0.14 M NaCl in water) for 5 
minutes the sections were blocked for one hour in 10% goat serum and then for a 
further hour in primary antibody at room temperature. After washing, the 
secondary antibody (goat anti-mouse IgG horseradish peroxidase-conjugated 
antibody) was added to the sections for one hour at room temperature, followed by 
further washing steps. Next, 3,3’-Diaminobenzidine (DAB) substrate was added to 
the sections for 30 seconds and then another washing step. The sections were then 
counterstained with haematoxylin for 10 seconds before washing. Finally the 
sections were dehydrated using ethanol and xylene before mounting with DPX 
mountant and imaging. This method was adapted from the Abcam 
Immunohistochemistry (IHC-Fr) – Frozen sections protocol 
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(http://www.abcam.com/ps/pdf/protocols/ihc_fr.pdf) and the Abcam  IHC-Paraffin 
protocol (IHC-P) (http://www.abcam.com/ps/pdf/protocols/ihc_p.pdf). Anti-
tenascin C (sc-59884, Santa Cruz) and anti-decorin (kindly donated by Professor 
Bruce Caterson, Cardiff University) antibodies were used in this study, as well as 
anti-CD90 (ab225, Abcam) and anti-CD73 (550256, BD Pharmingen) antibodies. 
 
2.2.3.3 Extracellular matrix (ECM) extraction  
 
For equine SDFT stem cell niche characterisation experiments, the ECM was 
extracted from cultured cells in a monolayer by initially extracting the cells using 
trypsin. The ECM was then extracted using a guanidine extraction buffer (4 M 
guanidine HCl, 50 mM sodium acetate, 65 mM DTT, containing Roche mini protease 
inhibitor cocktail tablets), for 48 hours at 4°C. The resultant protein suspension was 
then centrifuged at 14,000 g for 15 minutes at 4°C and the soluble fraction removed 
and stored at -80°C until required (Kharaz et al., 2016).  
For canine CCL proteomics validation experiments, the ECM was extracted 
from cultured cells in a monolayer using a number of different methods. Cells were 
initially extracted using either 4.8 mM EDTA; 1x trypsin or 20 mM NH4OH in 0.5% 
(w/v) Triton X-100 (detergent) (Choi et al., 2011; Soteriou et al., 2013). The ECM was 
then extracted using a urea extraction buffer (7 M urea, 0.15 M NaCl, 50 mM Tris-
HCl, pH 6.5, EDTA containing Roche mini protease inhibitor cocktail tablets) and 
incubated at 4°C for 48 hours. Alternatively, the ECM was extracted using a 2x 
reducing sample buffer (50 mM Tris-HCl, pH 6.8, 10% (w/v) glycerol, 4% (w/v) SDS, 
0.004% (w/v) bromphenol blue, 8% (v/v) β-mercaptoethanol) which was added to 
the plates and the ECM removed immediately using a cell scraper (Soteriou et al., 
2013). The final method of ECM extraction was the use of a Rapigest buffer (0.06% 
(w/v) Rapigest diluted in 25 mM ammonium bicarbonate) where the plates were 
incubated at room temperature for 30 minutes and 80°C for 10 minutes (Peffers et 
al., 2015b). Rapigest is a solution used to promote enzymatic digestion of proteins, 
which is often used prior to mass spectrometry proteomic analysis (Little et al., 
2014; Peffers et al., 2015b). 
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All experiments were performed in 6-well plates and 1 ml of cell/ECM 
extraction buffer was added to each well, except for the Rapigest method where 
only 180 µl of buffer was added to 35 mm petri dishes (to maintain consistency with 
the methodology used by the Centre for Proteome Research, University of 
Liverpool). The protein extractions from all experiments were stored at -80°C until 
required. 
 
2.2.3.4 Electrophoresis 
 
The quantity of protein in ECM samples was analysed using a 660 protein 
assay as per manufacturer’s instructions. The protein quantity was calculated from a 
standard curve produced from albumin standards (Fig.2.9). Samples were then 
diluted to the same concentration as the sample containing the lowest protein 
concentration to ensure equal loading, before the addition of 2 x SDS sample buffer 
containing β-mercaptoethanol to each sample. After boiling for 5 minutes the 
samples were loaded on to 4-12% precast Bis-Tris gels and run at 200 V for 35 
minutes. After running the gels were fixed and stained with GelCode or a Silver Stain 
kit as per the manufacturer’s instructions. 
 
2.2.3.5 14C metabolic labelling of ECM proteins 
 
SDFT cells were subjected to 14C metabolic labelling in 24 well plates. Cells 
were incubated in SILAC (stable isotope labelling with amino acids in cell culture) 
media supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin and 2 µg/ml 
amphotericin B, 0.2 mM ascorbate and 0.4 mM β-APN (complete SILAC media), as 
well as 0.8 mM [12C]L-lysine 2HCl, 0.4 mM [12C]L-arginine HCl and 0.4 mM [12C]L-
proline, for 1 hour at 37°C. The media was replaced with complete SILAC media 
supplemented with 2.5 µCi/ml [¹⁴C]L-lysine and [¹⁴C]L-arginine or 2.5 µCi/ml [¹⁴C]L-
proline, for 24 hours at 37°C. After which the cells and ECM were extracted and 
analysed using electrophoresis as described previously (Section 2.2.3.3 and 2.2.3.4).  
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Figure 2.9. Representative standard curve produced using albumin standards, 
ranging in concentration from 50-2000 ug/ml to enable protein quantification from 
the linear equation. 
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Following this the gels were stained with GelCode, dried under vacuum for 90 
minutes at 80°C and exposed to a phosphorimaging plate. After 24 hour exposure 
the plate was processed using a phosphorimager (Typhoon FLA 7000, GE 
Healthcare) and the images analysed using ImageJ (NIH). 
 
2.2.3.6 13C metabolic labelling of ECM proteins for proteomic analysis 
 
LDSCs and ligamentocytes were subjected to 13C lysine metabolic labelling. 
Cells were incubated in complete SILAC media (Section 2.2.3.5) supplemented with 
0.8 mM [12C]L-lysine 2HCl, 0.4 mM [12C]L-arginine HCl and 0.4 mM [12C]L-proline 
(unlabelled media) for 1 hour. The media was then exchanged for labelled media 
(complete SILAC media supplemented with 0.8 mM [13C]L-lysine 2HCl, 0.4 mM 
[12C]L-arginine HCl and 0.4 mM [12C]L-proline) for 4, 24 and 48 hours. After which 
the cells were removed using trypsin and the plates washed with PBS, before 
transfer to the Centre for Proteome Research, University of Liverpool for protein 
extraction and proteomic analysis. 
 
2.2.3.7 Proteomic analysis 
 
The experiments and methods described in Sections 2.2.3.7.1 and 2.2.3.7.2 
were conducted by Dr Deborah Simpson of the Centre for Proteome Research, 
University of Liverpool. 
 
2.2.3.7.1 Sample preparation for proteomic analysis 
Rapigest solution (0.06% (w/v) solution in 25 mM NH4HCO3) was applied to 
each plate and the surface covered by manual rotation. The plates were placed on 
an orbital shaker for 30 minutes (200 rpm) at room temperature then incubated at 
80C for 10 minutes and allowed to cool. Protein extracts were transferred to low-
bind tubes and samples were reduced by the addition of 60 mM DTT in 25 mM 
NH4HCO3 followed by sample incubation at 60C for 10 minutes. Alkylation was 
carried out by the addition of 180 mM iodoacetamide in 25 mM NH4HCO3 and the 
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sample incubated at room temperature for 30 minutes in the dark. 0.05 µg/µl 
trypsin was added to samples before incubation at 37C overnight. Digests were 
terminated by the addition of trifluoroacetic acid (TFA) and incubated at 37C for 45 
minutes, before centrifugation at 17,200 g for 30 minutes and transfer of the 
clarified digest to fresh low-bind tubes. 
 
2.2.3.7.2 LC-MS/MS proteomic analysis 
Data-dependent liquid chromatography tandem mass spectrometry (LC-
MS/MS) analyses were conducted on a QExactive HF quadrupole-Orbitrap mass 
spectrometer (Scheltema et al., 2014; Williamson et al., 2016) coupled to a Dionex 
Ultimate 3000 RSLC nano-liquid chromatograph. Sample digest (8 µl) was loaded 
onto a trapping column (Acclaim PepMap 100 C18, 75 µm x 2 cm, 3 µm packing 
material, 100 Å) using a loading buffer of 0.1% (v/v) TFA, 2% (v/v) acetonitrile in 
water for 7 minutes at a flow rate of 9 µl min-1.  The trapping column was then set 
in-line with an analytical column (EASY-Spray PepMap RSLC C18, 75 µm x 50 cm, 2 
µm packing material, 100 Å) and the peptides eluted using a linear gradient of 
96.2% A (0.1% [v/v] formic acid):3.8% B (0.1% [v/v[ formic acid in water:acetonitrile 
[80:20] [v/v]) to 50% A:50% B over 30 minutes at a flow rate of 300 nL min-1. This 
was followed by washing at 1% A:99% B for 5 minutes and re-equilibration of the 
column to starting conditions.  The column was maintained at 40oC and the effluent 
introduced directly into the integrated nano-electrospray ionisation source 
operating in positive ion mode.  The mass spectrometer was operated in data 
dependent acquisition (DDA) mode with survey scans between m/z 300-2000 
acquired at a mass resolution of 70,000 (FWHM) at m/z 200.  The maximum 
injection time was 250 ms and the automatic gain control was set to 1e6.  The 10 
most intense precursor ions with charge states of between 2+ and 5+ were selected 
for MS/MS with an isolation window of 2 m/z units.  The maximum injection time 
was 100 ms and the automatic gain control was set to 1e5.  Fragmentation of the 
peptides was by higher-energy collisional dissociation using a normalised collision 
energy of 30%.  Dynamic exclusion of m/z values to prevent repeated fragmentation 
of the same peptide was used with an exclusion time of 20 seconds.   
 
77 
 
2.2.3.7.3 Proteomic data analysis 
For protein identification and label-free quantification raw data files were 
imported into PEAKS v.8 (Bioinformatics Solutions Inc) (Zhang et al., 2012) and de 
novo and database PEAKS searches were carried out using the UniProt canine 
protein database. The instrument configuration was set to Q Exactive, and the 
following parameters were used for each search: Enzyme: trypsin; Fragment mass 
error tolerance: 0.01 Da; Parent mass error tolerance: 10 ppm; Precursor mass 
search type: monoisotopic; Non-specific cleavage: none; Maximum missed 
cleavages: 1; Fixed modifications: carbamidomethyl 57.02; Variable modifications: 
oxidation (M) 15.99, oxidation or hydroxylation 15.99; Maximum variable PTM per 
peptide: 3. Search results were filtered using the following parameters: False 
discovery rate: 1%; Proteins -10lgP ≥ 15; Unique peptides ≥ 2; De novo only ALC (%) 
≥ 50. For label-free quantification the following parameters were also used: RT 
range: 0-90; Fold change ≥ 2; Quality ≥ 0.2; Charge: 2-5; Confident in 3 samples. 
LDSC and ligamentocyte groups were compared using the PEAKS compare function. 
Protein identifications and gene ontology were analysed using the UniProt canine 
protein database and the Matrisome Project database (Naba et al., 2016) and 
protein interaction network analysis was performed using STRING software (SIB). 
Differential protein expression was compared between LDSC and ligamentocyte 
groups and protein identification and gene ontology were analysed using the 
UniProt canine protein database. 
For analysis of heavy isotope metabolic labelling, peptides for ECM proteins 
labelled with 13C lysine were initially identified using MASCOT (Matrix Science). The 
following parameters were applied for all MASCOT searches: Enzyme: trypsin; 
Maximum missed cleavages: 1; Fixed modifications: carbamidomethyl; Variable 
modifications: oxidation (M), Label:13C(6) (K); Mass values: monoisotopic; 
Fragment mass tolerance: 0.01 Da; Peptide mass tolerance: 10 ppm; Unique 
peptides ≥ 2; Peptides -10lgP ≥ 15. Raw data files were imported into Xcalibur 
(Thermo Fisher Scientific) for analysis of extracted ion chromatograms and raw 
mass spectra. Heavy (H) and light (L) peaks were identified for each labelled peptide 
based on the observed m/z ratio and the scan number obtained from MASCOT. The 
area under each peak was recorded and relative isotope abundance (RIA) was 
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calculated as H/(L+H) and the total protein pool was calculated as H+L. These 
parameters were plotted against time to produce dynamic protein charts for 
protein synthesis and turnover. 
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2.2.4 Statistical analysis 
 
Statistical analysis was performed using SPSS (IBM) and SigmaPlot (Systat 
Software Inc). To ensure data was normally distributed Shapiro Wilk tests were 
performed. For normally distributed data parametric tests were used for pairwise 
comparisons. For data which was not normally distributed Log10 data 
transformations were performed before parametric tests were used. For comparing 
two groups paired or independent Student’s t-tests were used. For comparing three 
or more groups a one-way ANOVA with Tukey post-hoc test was performed. For 
comparing three or more groups with multiple factors a two-way ANOVA was used, 
with Tukey post-hoc test. For comparing three or more groups with multiple factors 
and repeated measures, a two-way ANOVA with repeated measures and a Holm-
Sidak post-hoc test was used. p-values of <0.05 were taken to be statistically 
significant. 
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Chapter 3 
 
Equine tendon-derived stem cell characterisation 
and investigation of the equine tendon stem cell 
niche  
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3.1 Introduction 
 
The identification of tendon-derived stem cells (TDSCs) holds potential for 
the treatment of tendinopathies in both humans and animals. TDSCs are a subset of 
cells most likely derived from mesenchymal stromal cells (MSCs) due to the similar 
characteristics possessed by both cell types. TDSCs express similar markers to MSCs, 
such as Oct-4 and nucleostemin (Zhang and Wang, 2010b) as well as a variety of CD 
markers (Lee et al., 2012). TDSCs also express tenogenic markers which is where 
they differ from MSCs, these markers include tenomodulin (Bi et al., 2007) and 
tenascin C (Rui et al., 2010), however these markers are also expressed by other 
tendon cells such as tenocytes. Therefore it is necessary to use a panel of markers 
to isolate TDSCs, as no single marker has yet been identified for effective isolation 
of these cells. TDSCs are also able to form colonies (Bi et al., 2007), which is a basic 
hallmark of a stem cell. Another feature of TDSCs is their multi-lineage 
differentiation potential, specifically osteogenic, adipogenic and chondrogenic 
differentiation (Rui et al., 2010), which is a characteristic shared with MSCs. Certain 
factors affect the growth and function of TDSCs, including age (Zhou et al., 2010) 
and passage number (Tan et al., 2012a), as well as the environment of the stem cell, 
known as the ‘niche’. The niche comprises many aspects of the cell’s environment 
and oxygen tension (Lee et al., 2012), mechanical strain (Zhang and Wang, 2010d), 
biological mediators (Rui et al., 2013b), additional cell types (Kraus et al., 2013) and 
the protein composition of the niche (Bi et al., 2007) have all been shown to affect 
TDSCs.  
TDSCs could provide a potential therapy for aged or degenerated tendon, 
and current preliminary studies have shown promising results. A number of 
different tissue engineering approaches involving the introduction of TDSCs to 
tendon injury have shown increased healing compared with controls (Ni et al., 
2012; Yin et al., 2013; Zhang et al., 2011a). 
TDSCs have been isolated from a number of different species, including 
human, mouse (Bi et al., 2007), rat (Rui et al., 2010), rabbit (Zhang and Wang, 
2010b), cow (Yang et al., 2016) and horse (Lovati et al., 2011), however this study 
will focus on equine TDSCs. Tendinopathy in horses is a well-documented problem 
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(Ely et al., 2009) and a new, effective treatment strategy is currently being sought, 
with TDSCs high on the list of possible therapies. In addition, research into equine 
TDSCs is important for its translatability into humans (Innes and Clegg, 2010). To 
date, only one study has previously investigated the presence of TDSCs in equine 
tendon, which demonstrated the restricted differentiation potential of a cell 
population within equine tendon with limited stem cell properties (Lovati et al., 
2011). Furthermore, there have been no studies investigating the composition of 
the equine TDSC niche or the effect of the niche on equine TDSCs. 
 
3.2 Hypothesis 
 
I hypothesise that a native tendon progenitor cell population resides within 
equine SDFT and which can be differentially isolated from other tendon cell types 
by low-density plating and/or differential adhesion to fibronectin substrates. This 
progenitor cell population will demonstrate all of the hallmark properties of stem 
cells, including clonogenicity, multipotency and stem cell marker expression, as well 
as expression of tenogenic markers. The progenitor cell population will differ from 
tenocytes with the latter cell type demonstrating reduced stemness when 
compared with progenitor cell populations. 
 
3.3 Aims 
 
1. To characterise equine TDSCs and tenocytes isolated from the SDFT; 
including analysis of stem cell and tenogenic marker expression, colony-
forming ability, cell proliferation and multipotency. Furthermore, to 
compare the differences in phenotype between TDSCs and tenocytes. 
 
2. To characterise the TDSC and tenocyte niche; including analysis of gene and 
protein expression of ECM components and microscopic examination of 
SDFT tissue to highlight potential niches within the tissue. Furthermore, to 
compare differences in niche composition between TDSCs and tenocytes. 
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3.4 Results 
 
3.4.1 Tenocyte and TDSC morphology and colony formation 
 
Tendon cells were isolated and seeded using three different methods: high 
density for isolation of tendon fibroblasts (tenocytes); low density for isolation of 
TDSCs (TDSC-L); and low density on fibronectin substrates also for isolation of TDSCs 
(TDSC-F) (Chapter 2, Section 2.2.1.1). 
For all three cell types there was identification and growth of two 
phenotypically distinct cell types with a differing morphology and colony forming 
ability. Fibroblastic cells grew in large, sparse, widely spread colonies, whereas 
more rounded cells, with a cobblestone-like appearance grew in dense, compact, 
smaller colonies (Fig.3.1.A). All cell types exhibited the same pattern of colony 
growth, with similar colony numbers for tenocytes and TDSC-F at 21% and 5% 
oxygen. TDSC-L demonstrated slightly more varied colony numbers with a 
difference seen between the two oxygen tensions, although this was not significant. 
Average colony size was also fairly uniform across all three cell types and both 
oxygen tensions, with no significant differences seen, although tenocytes 
demonstrated a slight increase in colony size, and TDSC-L a slight decrease 
(Fig.3.1.B-C). 
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Figure 3.1. Tenocyte and tendon-derived stem cell (TDSC) morphology and colony formation at 
21% and 5% oxygen tension. Representative images of cell morphology and colony forming ability 
are shown. Cells were grown for 7 days before staining with crystal violet and imaging for cell 
morphology analysis and colony formation. White bars = 100 μm, black bars = 1 cm (A). Colonies 
were counted (B) and measured (C) using ImageQuantTL software. n=3 biological replicates, error 
bars shown represent SEM. Pairwise comparisons were performed using a two-way ANOVA with 
Tukey post-hoc tests. 
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3.4.2 Tenocyte and TDSC proliferation 
 
Cell population doubling times were similar for all three cell types, 
particularly at 21% oxygen, with a mean (±SEM) of 33.4 (±3.8), 32.1 (±5.3) and 36.9 
(±10.2) hours per cell doubling for tenocytes, TDSC-F and TDSC-L respectively. The 
doubling times for cells at 5% oxygen were more varied, with means of 35.8 (±4.5), 
27.8 (±0.8) and 48.2 (±2.1) hours per doubling for tenocytes, TDSC-F and TDSC-L 
respectively. There were no statistically significant differences in doubling times 
between cell types or between oxygen tensions (Fig.3.2). 
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Figure 3.2. Population doubling times for tenocytes and TDSCs at 21% and 5% 
oxygen tension. n=4 biological replicates for tenocytes and n=3 for TDSCs, error bars 
shown represent SEM. Pairwise comparisons were performed using a two-way 
ANOVA with Tukey post-hoc tests. 
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3.4.3 Tenocyte and TDSC marker expression 
 
Tenocyte and TDSC marker expression was assessed using flow cytometry, 
immunohistochemistry and qRT-PCR for analysis of gene expression.  
Flow cytometric analysis showed a slight shift in the fluorescence peak for 
both CD105 and CD73 in all three cell types (Fig.3.3.A), however when quantified 
(Fig.3.3.B-D) this was only significant for tenocytes at 21% oxygen. Conversely, CD90 
was highly expressed in all three cell types, with statistically significant increases in 
expression for all cell types at both oxygen tensions, excluding TDSC-L at 21% 
oxygen, when compared with zero controls. In general there was an increase in 
marker expression in TDSC-F compared with TDSC-L and tenocytes, particularly 
CD90 expression.  
Gene expression analysis of stem cell markers in tenocytes and TDSCs 
showed similar expression levels across all three cell types and both oxygen 
tensions, and no significant differences in gene expression between cell types or 
oxygen tensions, except for THBS4 (Fig.3.4). The pluripotency markers octamer-
binding transcription factor 4 (Oct4) and Nanog showed extremely low gene 
expression in all three cell types with the highest levels seen in TDSC-F for Oct4. 
Conversely the lowest expression of Nanog was seen in TDSC-F, and the highest in 
tenocytes and TDSC-L. The MSC markers CD90 and CD73 were both highly 
expressed in tenocytes and TDSC-F, with variable expression seen in TDSC-L. The 
expression of early growth response hormone-1 (EGR-1), a transcription factor 
involved in stem cell differentiation, showed no clear pattern with varied expression 
between cell types and oxygen tensions. The early tendon markers Mohawk (MKX) 
and scleraxis (SCX) were highly expressed in TDSC-F and tenocytes. The early 
tenogenic marker tenascin C (TNC) showed similar expression between cell types. 
Other tenogenic markers, thrombospondin-4 (THBS4) and tenomodulin (TNMD) 
were expressed highly in tenocytes with reduced levels seen in TDSCs, although 
very low gene expression levels were seen generally for TNMD. The expression of 
THBS4 in tenocytes was significantly higher than TDSC-F and TDSC-L. Finally the 
expression of haematopoietic markers CD34 and CD144 were generally low, except 
in tenocytes and TDSC-F which showed slightly higher expression of CD34. 
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Immunohistochemical analysis of frozen equine SDFT tissue sections showed 
no expression of CD73 and abundant expression of CD90. CD90 expression was 
mainly localised to the IFM, probably due to the abundance of cells in this area, 
however expression was also seen within fascicles where cells also reside. Not all 
cells were stained indicating that not all cells within equine SDFT expressed CD90 
(Fig.3.5). 
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Figure 3.3. Flow cytometric analysis of stem cell markers expressed by tenocytes and TDSCs at 21% 
and 5% oxygen. (A) shows representative flow cytometry plots. Black/blue peaks represent control 
samples and red peaks represent samples in the presence of each antibody. This data has been 
quantified (B) to show percentage of positive cells after subtraction of control fluorescence 
(99.5%). n=3 biological replicates, error bars shown represent SEM. Pairwise comparisons were 
performed using a two-way ANOVA. P-values: a=0.036, b=0.024. 
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Figure 3.4. Gene expression analysis of stem cell markers in tenocytes and TDSCs at 21% and 5% oxygen. Values are 
shown on a logarithmic scale and normalised to GAPDH. n=6 biological replicates for tenocytes and TDSC-F at 5% oxygen, 
n=4 for all other samples. Error bars shown represent SEM. Pairwise comparisons were performed using a two-way 
ANOVA and Tukey post-hoc test after Log10 transformation. P-values: a= 0.042, b=0.036. 
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Figure 3.5. Analysis of stem cell marker expression of SDFT by immunohistochemistry. Control 
frozen sections were incubated with secondary antibody only (A) and mouse IgG and secondary 
antibody (B). Frozen sections of SDFT were stained with anti-CD90 (C-D) and anti-CD73 (no 
staining observed so images not shown). Bar = 100 μm.  
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3.4.4 Tenocyte and TDSC tri-lineage differentiation potential 
 
The ability of tenocytes and TDSCs to differentiate into different cell lineages 
was analysed by staining, glycosaminoglycan (GAG) assays and qRT-PCR for gene 
expression analysis following tri-lineage differentiation. 
All three cell types showed osteogenic differentiation as assessed by 
BCIP/NBT and alizarin red (AR) staining. The BCIP/NBT staining procedure stains 
active alkaline phosphatase enzyme and exhibits as dark purple or black staining as 
well as the formation of dark precipitate. Alizarin red stains calcium nodules and 
manifests as a red stain. Conversely no adipogenic differentiation was seen in any 
cell type as assessed by Oil red O (ORO), which stains oil droplets and which also 
exhibits as a red stain. Chondrogenic pellets were sectioned and stained with alcian 
blue (AB) to highlight the presence of GAGs, which was mostly clearly seen in TDSC-
F, however the intensity of stain did not alter between the negative (control media) 
and positive (chondrogenic induction media) pellets for tenocytes or TDSC-L 
(Fig.3.6). There was a significant increase in GAG production in positive pellets 
compared with negative pellets for TDSC-F and TDSC-L. For TDSC-F there was an 
increase in the mean (±SEM) GAG content from 1.5 (±0.3) µg in the negative pellet 
to 3.8 (±0.3) µg in the positive pellet. Similarly for TDSC-L there was an increase 
from 0.9 (±0.5) µg to 3.7 (±0.6) µg (Fig.3.7). 
Gene expression analysis of lineage specific genes showed a lack of 
osteogenic differentiation in all three cell types. There were small increases seen for 
some osteogenic markers when comparing the negative and positive samples, for 
example runt-related transcription factor-2 (RUNX2), osteocalcin (OC) and 
particularly osterix, which was significantly increased in tenocytes and TDSC-F. 
However for many of the osteogenic markers there was no alteration in expression 
or a decrease was observed; for example COL1A1 and osteoprotegerin (OPG) which 
showed significant decreases in gene expression in positive samples of tenocytes 
and TDSC-F. The expression of adipogenic markers was increased in the positive 
samples compared with the negative samples for all cell types, however these 
increases were small and not significant. Chondrogenic gene expression varied 
between cell types, with no significant alterations (Fig.3.8). 
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Figure 3.6. Histological analysis of tri-lineage differentiation potential of tenocytes and TDSCs at 5% oxygen. Representative images are shown for each cell 
type after induction of osteogenic, adipogenic and chondrogenic differentiation (positive) and also for control samples (negative), after appropriate staining. 
Cells subjected to osteogenic differentiation media were stained for both alkaline phosphatase (ALP) activity and calcium deposits using alizarin red (AR). 
Cells subjected to adipogenic differentiation media were stained for oil droplet formation using oil red O (ORO), and cell pellets exposed to chondrogenic 
differentiation media, for GAG formation using alcian blue (AB). Bar = 100 μm. n=3 biological replicates for tenocytes, n=5 for TDSC-F and n=4 for TDSC-L. 
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Figure 3.7. Total glycosaminoglycan (GAG) content of cell pellets with (positive) or 
without (negative) chondrogenic induction at 5% oxygen. n=3 biological 
replicates for tenocytes, n=5 for TDSC-F and n=4 for TDSC-L, error bars shown 
represent SEM. Pairwise comparisons were performed using paired Student’s t-
tests. P-values: a=0.005, b=0.003. 
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Figure 3.8. Gene expression analysis of lineage specific markers by tenocytes and TDSCs at 5% oxygen. Values are shown on a logarithmic scale 
and normalised to GAPDH. n=3 biological replicates for tenocytes, n=4 for TDSC-L and n=5 for TDSC-F, error bars shown represent SEM. Pairwise 
comparisons were performed after Log10 transformations using paired Student’s t-tests. P-values: a=0.049, b=0.049, c=0.049, d=0.009, e=0.009, 
f=0.047. 
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3.4.5 Tenocyte and TDSC niche composition 
 
Histological analysis of equine SDFT tissue showed distinct regions or 
‘niches’ within tendon. Haematoxylin and eosin staining (3.9.A) showed highly 
cellular interfascicular matrix (IFM) regions and less cellular fascicular regions. The 
morphology of the cells also differed between regions with those residing in the 
IFM having a more rounded shape and those in between the fascicles being flatter 
and more spindle shaped. In addition, Masson’s Trichrome staining (3.9.B) showed 
that SDFT is poorly vascularised and that the vasculature is confined to the IFM 
region.  
Immunohistochemical analysis revealed obvious staining for tenascin C 
(3.9.C) which was restricted to the IFM, conversely the large quantities of decorin 
(3.9.D) seen in SDFT were predominantly found within the fascicular regions, 
however decorin was also shown to be present within the IFM. 
Gene expression analysis of SDFT ECM components showed only small and 
insignificant differences between cell types and oxygen tensions (Fig.3.10).  
Radioactive labelling of equine SDFT ECM proteins showed similar profiles 
for all three cell types and both oxygen tensions. Due to the reduced incorporation 
of 14C proline the bands corresponding to collagenous proteins were not as clear as 
the non-collagenous protein bands, and there appeared to be several bands seen at 
21% oxygen which were not seen at 5%, however this pattern was consistent across 
the cell types. The labelling profile for 14C lysine and arginine appears to be the 
same for all three cell types and both oxygen tensions. 
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Figure 3.9. Equine SDFT histology (A & B) and immunohistochemistry (C & D) images. 
Paraffin embedded sections of equine SDFT were stained with haematoxylin and eosin (A) 
or Masson’s Trichrome (B). Frozen sections of equine SDFT were stained with antibodies 
raised against tenascin C (C) and decorin (D). Representative images are shown. Bar = 100 
μm. 
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Figure 3.10. Gene expression analysis of ECM components in tenocytes and TDSCs 
at 21% and 5% oxygen. Values are shown on a logarithmic scale and normalised to 
GAPDH. n=4 biological replicates for tenocytes and n=3 for TDSCs. Error bars shown 
represent SEM. Pairwise comparisons were performed using a two-way ANOVA 
with Tukey post-hoc tests after Log10 transformation. 
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Figure 3.11.
 
14C labelling of tenocytes (A) TDSC-F (B) and TDSC-L (C). 14C proline (P) labelled 
collagenous proteins produced by tendon cells and 14C lysine (K) and arginine (R) labelled non-
collagenous proteins which were analysed by autoradiography. 21% and 5% represent cells 
grown at 21% and 5% oxygen tensions respectively. Representative images are shown. 
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3.5 Discussion 
 
3.5.1 Isolation of equine tendon cells 
 
TDSCs have been isolated from a number of different species, including 
human, mouse (Bi et al., 2007), rat (Rui et al., 2010), rabbit (Zhang and Wang, 
2010b), cow (Yang et al., 2016) and horse (Lovati et al., 2011). Species variation may 
account for some of the differences seen in the properties and phenotype of TDSCs, 
as may other factors including age and source. The method of TDSC isolation and 
the conditions in which the cells are cultured is another factor that could potentially 
have a large impact on TDSC survival and function. The majority of studies to date 
have used variations of a single method to isolate TDSCs. This method, known as 
the ‘low-density plating method’ involves seeding tendon cells after digestion, at 
very low density (Bi et al., 2007), the exact density varies from study to study. The 
cells are then cultured at 21% oxygen, 5% carbon dioxide and 37°C for varying 
lengths of time before colonies are selected and propagated (all studies discussed 
below have used this method). This study was unable to replicate the findings 
shown in the literature based on this method, the reasons for which will be 
discussed below. Therefore alternative methods were investigated in order to 
isolate TDSCs from equine tendon. Hypoxia has been shown to promote the viability 
of stem cells from a variety of sources, including MSCs from cord blood (Co et al., 
2014) and TDSCs from tendon (Zhang and Wang, 2013b). In addition, seeding 
freshly isolated cells on to certain substrates promotes the growth of stem cell-like 
cells. For example, bovine articular cartilage was digested and seeded on to 
fibronectin substrates and cells with stem cell-like properties showed differential 
adhesion to fibronectin, these cells were further cultured (Dowthwaite et al., 2004). 
Endothelial progenitor cells have also been differentially isolated by adhesion to 
fibronectin substrates (Bueno-Betí et al., 2013), indicating the potential use of this 
method for isolation of a range of progenitor cells. 
This study aimed to characterise stem/progenitor cells derived from equine 
superficial digital flexor tendon and provide a comparison with tenocytes (tendon 
fibroblasts). Several properties of these cells were assessed in order to determine 
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whether the cells were true stem cells or a form of progenitor cell. TDSCs are 
clonogenic, multipotent and express both stem cell and tenogenic markers (Bi et al., 
2007). All of these properties are hallmarks of MSCs, as outlined by the 
International Society for Cellular Therapy (ISCT) and are the specific criteria by 
which MSCs are identified and characterised (Dominici et al., 2006). As a subset of 
MSCs, TDSCs can also be identified and characterised using the same criteria. 
 
3.5.2 Clonogenic potential and morphology of equine tendon cells 
 
Three cell types were investigated in this study: tenocytes; TDSCs isolated by 
adhesion to fibronectin substrates (TDSC-F); and TDSCs isolated by the conventional 
low-density plating method (TDSC-L), and all cell types were analysed after culture 
at both 21% and 5% oxygen tension. All cell types demonstrated a similar pattern of 
growth, with similar morphologies and colony forming ability (Fig.3.1.A). For all 
three cell types there appeared to be growth of two different cell populations, 
directly after seeding and at further passages. Cells with a fibroblast-like spindle-
shaped morphology, typical of fibroblasts, grew in large, sparse colonies, whereas 
cells with a more rounded, cobblestone-like appearance grew in smaller, very dense 
clusters (Fig.3.1.A). Tenocytes have consistently been shown to demonstrate a 
typically fibroblastic morphology (Lohberger et al., 2015; Wang et al., 2003; Zhang 
and Wang, 2010b), consistent with this study. In contrast, there are mixed reports 
on the morphology of TDSCs, with some studies showing a tenocyte-like 
morphology (Nagura et al., 2016; Salingcarnboriboon et al., 2003; Shi et al., 2012a), 
some a rounded, cobblestone appearance (Tao et al., 2015; Zhang and Wang, 
2010b, 2014) and others demonstrating an intermediate fusiform morphology (Yang 
et al., 2016). Equine TDSCs have been shown to demonstrate a fibroblastic 
morphology (Lovati et al., 2011), which is partially consistent with this study, 
however there have been no reports of rounded, cobblestone-like cells in equine 
tendon. In addition, studies characterising equine MSCs have also reported a 
fibroblast-like cell morphology for these cells (Hillmann et al., 2015; Lovati et al., 
2012; Violini et al., 2009). 
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The studies discussed above only noted one cell population in their tendon 
cell cultures, however I have demonstrated the presence of two distinct cell 
morphologies in equine tendon cell cultures. The previous literature has reported 
the requirement for low seeding densities when isolating stem cells, as cell contact 
has been shown to regulate cell differentiation in cortical stem cells (Tsai and 
McKay, 2000). Additionally, for TDSCs low density plating has been found to 
promote stem cell growth, proliferation  and viability, as well as producing pure cell 
cultures (Lee et al., 2012; Rui et al., 2010; Tan et al., 2012a). Therefore in this study I 
seeded tendon cells at a very low density, either on plastic (TDSC-L) or fibronectin 
(TDSC-F) in order to select for TDSCs. Any tenocytes present would not survive due 
to the low density and the requirement for cell-cell contact (Güngörmüş and 
Kolankaya, 2008; Schulze-Tanzil et al., 2004). According to the literature this 
method should provide a pure culture of TDSCs. Conversely I seeded cells at a high 
density in order to select for tenocytes, as any TDSCs present would be unable to 
proliferate and would differentiate into tenocytes (Güngörmüş and Kolankaya, 
2008; Schulze-Tanzil et al., 2004), which should provide a pure culture of fibroblast 
cells. However this was not the case and two distinct cell populations were seen for 
all three cell types. This may be expected for tenocyte populations as all cells from 
the tendon digest were seeded together. However for TDSCs, after initial plating 
and colony formation, individual colonies were isolated leaving behind any 
contaminating tenocytes. Regardless of this precaution, fibroblastic cells, which 
based on previous literature I identify as tenocytes, appear to have contaminated 
rounded, cobblestone-like TDSC populations. Ideally fluorescently activated cell 
sorting (FACS) or a similar technique would be employed to definitively isolate 
TDSCs from tenocytes, however there are several problems with this. Firstly, there 
are no specific markers for TDSCs, so a panel of markers would need to be used 
which would complicate the isolation procedure. Secondly, it is not known how the 
phenotype of the elongated fibroblastic cells differs from that of the rounded 
cobblestone-like cells and therefore it is not determined which markers would be 
useful to select for separation of these two cell types. Finally, the lack of antibodies 
for equine research would severely limit which markers could be used, if any. For 
these reasons I was unable to isolate pure cultures of tendon cells, and the cell 
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populations used for further analysis are most likely a heterogeneous mixture of 
cells at different stages of differentiation. One other study has demonstrated the 
presence of two distinct cell populations in tendon cell cultures. Ruzzini and others 
(2013) noted growth of both rounded, cobblestone-like cells as well as elongated 
fibroblast-like cells when isolating human TDSCs (Ruzzini et al., 2013). They state 
that the former cells they determined to be TDSCs and the latter cells tenocytes. 
They separated these two cell populations based on CD44 expression and all further 
analysis was performed on CD44+ cells (Ruzzini et al., 2013). Although in theory this 
is the most logical protocol to adopt, CD44 expression is not specific to TDSCs or 
stem cells in general. Tenocytes have also been reported to express CD44 (Crockett 
et al., 2010), which means the cells isolated by Ruzzini and others (2013) may still 
have been contaminated with tenocytes and therefore also a heterogeneous 
mixture of cells. 
The first criterion for the characterisation of MSCs is the ability of the cells to 
form colonies (Dominici et al., 2006) and in this study both tenocytes and TDSCs 
formed heterogeneous colonies (Fig.3.1.A). Previous studies have all demonstrated 
the ability of TDSCs to form colonies, although the appearance of these colonies has 
been shown to differ between studies. Bi and others (2007) found mouse TDSCs 
form heterogeneous cell colonies, in terms of colony size, shape and cell density, 
whereas human TDSCs formed more homogenous, dense colonies (Bi et al., 2007). 
Similarly, other studies have also reported heterogeneity in colony size as well as 
cell density and morphology (Mienaltowski et al., 2013; Rui et al., 2010; Zhang and 
Wang, 2010b), consistent with this study. Ruzzini and others (2013), the only study 
to identify two tendon cell populations, found that the rounded, cobblestone-like 
cells formed colonies, whereas the fibroblast-like cells did not (Ruzzini et al., 2013) 
which is partially consistent with my data. Hypoxia has been shown to increase the 
colony-forming ability of human TDSCs, with increased colony numbers and 
increased cell density (Lee et al., 2012; Zhang and Wang, 2013b). No significant 
differences between oxygen tensions were observed in this study for colony 
number or size (Fig.3.1.B-C). This is in contrast to the aforementioned studies; the 
reason for this discrepancy may be due to species variation, as discussed previously 
(Bi et al., 2007). 
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3.5.3 Proliferation of equine tendon cells 
 
The current literature shows a great deal of variation in relation to the 
population doubling times (PDT) of TDSCs. This variation can generally be attributed 
to species variation as well as differences in tendon types. However extreme 
variation has also been shown between studies focussing on the same tendon 
within the same species (Lee et al., 2012; Zhang and Wang, 2014), which may be 
attributable to differences in culture conditions, passage number, patient age (Zhou 
et al., 2010) or patient exercise history (Rui et al., 2013a). 
This study found no significant differences in PDT for tenocytes and TDSCs 
(Fig.3.2) and only one other study has compared the properties of these two cell 
types. Zhang and others (2010b) demonstrated a significant increase in PDT for 
tenocytes isolated from rabbit patellar and Achilles tendon when compared with 
TDSCs (Zhang and Wang, 2010b), which is inconsistent with my data. The larger 
differences seen in their study may be due to species and tendon type differences, 
as well as variation in culture conditions. The values observed in this study are 
considerably higher than those reported by Lovati and others (2011) for TDSCs 
isolated from equine SDFT (Lovati et al., 2011). This difference in PDT may be due to 
the different initial seeding densities used, with this study seeding cells at 100 
cells/cm2 and Lovati and others (2011) seeding at 10,000 cells/cm2 (Lovati et al., 
2011). The different cell seeding densities may select for slightly different tendon 
cell populations. Lee and others (2012) showed a similar PDT for human patella 
TDSCs in both hypoxic and normoxic conditions (Lee et al., 2012), similarly this study 
found no significant differences between the PDT of cell types grown at 5% and 21% 
oxygen. In addition, no differences were seen in a study investigating the PDT of 
human tenocytes at 20%, 10% and 2.7% oxygen (Webster and Burry, 1982).  
 
3.5.4 Stem cell and tenogenic marker expression of equine tendon cells 
 
To date there is no one marker which identifies a cell as a TDSC, therefore a 
panel of markers need to be used, which include traditional pluripotency markers, 
MSC markers and tenogenic markers. Together, this panel of markers will ensure 
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that isolated cells are both stem cell-like and from the tenogenic lineage, rather 
than from blood or surrounding tissue. In this study marker expression of tenocytes 
and TDSCs was analysed using flow cytometry and qRT-PCR, as well as investigating 
marker expression in whole tendon tissue sections using immunohistochemistry. 
Flow cytometric analysis of TDSCs and tenocytes showed high expression of 
CD90 in this study for all cell types at both oxygen concentrations, particularly TDSC-
F at 5% oxygen with this cell type expressing significantly higher levels of CD90 than 
tenocytes and TDSC-L (Fig.3.3). This is in accordance with the literature which also 
demonstrates high expression of CD90 in TDSCs (Alberton et al., 2014; Chen et al., 
2015c) and equine tenocytes (Cadby et al., 2014). I found much lower expression of 
CD73 and CD105 across all three cell types (Fig.3.3) which is in contrast to previous 
studies which have demonstrated high expression of both markers in human (Lee et 
al., 2012; Stanco et al., 2014), mouse (Alberton et al., 2014) and rat (Rui et al., 
2013a) TDSCs. These differences may be due to the species, however equine 
tenocytes also highly express CD105 (Cadby et al., 2014), as do equine MSCs, 
although these cells did not express CD73 (Braun et al., 2010). Another study found 
that equine MSCs did not express either CD105 or CD73 (Hillmann et al., 2015) 
which mirrors the results found in this study. The discrepancies between studies 
may be due to differences in breed or age of the horses, or due to differences in 
sample collection, for example the first study isolated MSCs from live horses, 
whereas the latter study isolated from cadavers. Alternatively, the differences in 
marker expression may be due to variations in the culture conditions of the cells, as 
one study found significant differences in rat TDSC gene expression with prolonged 
cell culture periods (Guo et al., 2016). Another possibility to explain the 
discrepancies between this study and others is the use of antibodies. Equine 
antibodies are poorly defined and validated, and although all of the antibodies used 
in this study had been carefully selected based on use in previous studies, there is 
still a possibility that the antibodies chosen were unable to bind the antigen. I was 
unable to isolate MSCs as a positive control cell type due to material restrictions, 
which would have aided antibody validation. Across all cell types no significant 
differences in CD90, CD73 or CD105 marker expression were observed in this study 
between 21% and 5% oxygen which is in accordance with published data for human 
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TDSCs (Lee et al., 2012). As can be seen on the flow cytometry plots, there are two 
peaks for many of the samples, particularly TDSC-L and tenocytes. This may be due 
to cellular debris and other particles, however the use of a threshold gates out any 
small particles. Therefore it is possible that the two peaks relate to two different 
cell populations, and that each sample, rather than being a pure culture of TDSCs or 
tenocytes, is actually a heterogeneous mixture of cells at different stages of 
differentiation. 
As mentioned previously the ISCT have published minimal criteria to define 
MSCs, the second of these criterion was that the isolated cells expressed CD90, 
CD105 and CD73 (Dominici et al., 2006). As I have shown, this study found high 
expression of CD90, but low expression of CD105 and CD73 in equine TDSCs, and as 
TDSCs are believed to be a subset of MSCs it would be expected that these cells 
conformed to the criteria for defining MSCs. The reason for this discrepancy may be 
that TDSCs have a slightly different phenotype to MSCs, however many studies have 
shown expression of all three markers in TDSCs as discussed previously. Another 
possibility is species variation. The criteria outlined by the ISCT are based on human 
MSCs, so it is possible that equine MSCs or TDSCs may have a slightly different 
phenotype to human cells. This may indeed be the case as studies investigating MSC 
and tenogenic marker expression in horses have produced varying and conflicting 
results (Burk et al., 2014; Radcliffe et al., 2010; Ranera et al., 2011). In addition, the 
lack of equine antibodies is also problematic for identification of equine MSC 
markers, as discussed previously. Another issue with this criterion from the ISCT is 
the lack of specificity of the three markers. Although CD90, CD105 and CD73 have 
traditionally been used to identify MSCs, they are also present on a number of other 
cell types including tendon fibroblasts (Cadby et al., 2014; Tsuzaki et al., 2005), 
dermal fibroblasts and hepatocytes (Lupatov et al., 2015). For this reason, using 
only CD90, CD105 and CD73 as markers for positive identification of TDSCs is 
insufficient and other markers must also be utilised. It is necessary to use stem cell 
markers, MSC markers and tenogenic markers to ascertain if the isolated tendon 
cells are indeed TDSCs. Due to the limited number of equine antibodies available, 
particularly for stem cell markers, I decided to investigate gene expression of a 
panel of markers. The most interesting outcome from this data was the lack of any 
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statistically significant differences in gene expression between cell types or oxygen 
tensions, except for one gene: thrombospondin-4, which may be a false-positive 
result. This is suggestive of a similar gene expression profile for the three different 
cell types, or that the cell types are all very similar. 
Gene expression of the pluripotency markers Oct4 and Nanog was generally 
low in all cell types (Fig.3.4), which is consistent with some of the literature, which 
has shown no expression of Oct4, and low expression of Nanog in TDSCs (Alberton 
et al., 2014) and tenocytes (Cadby et al., 2014; Zhang and Wang, 2010b). This is also 
consistent with reports that Oct4 expression is restricted to embryonic stem cells 
only and not somatic cells (Lengner et al., 2008). However other studies have shown 
expression of Oct4 in equine TDSCs (Lovati et al., 2011) and both Oct4 and Nanog in 
rat (Tan et al., 2013) and human (Zhang and Wang, 2013b) TDSCs. These studies 
may have been identifying non-functional pseudogenes. 
Mohawk (MKX), scleraxis (SCX) and early growth response 1 (EGR-1) are all 
transcription factors involved in tendon development. They are expressed by 
tendon progenitor cells and are involved in tendon cell differentiation (Lejard et al., 
2011; Liu et al., 2010; Schweitzer et al., 2001; Tao et al., 2015). These three markers 
were more highly expressed than the pluripotency markers, however there were no 
significant differences (Fig.3.4). SCX has been shown to be expressed in mouse 
(Alberton et al., 2014), rat (Chen et al., 2015c) and human (Lee et al., 2012) TDSCs 
and equine tenocytes (Cadby et al., 2014). No significant differences in SCX gene 
expression have been seen at different oxygen tensions (Lee et al., 2012), consistent 
with this study. EGR-1 has been shown to be expressed in rabbit TDSCs, where it 
promotes tendon differentiation and therefore the expression of tenogenic 
markers, including SCX and tenomodulin (Tao et al., 2015). SCX is expressed in all 
tendon cells during development, in mature tendon and in terminally differentiated 
cells, whereas MKX is only expressed by tendon cells during development and 
TDSCs in mature tendon (Liu et al., 2010). The only study to demonstrate MKX 
expression in TDSCs used bovine foetal tendon, and found that expression declined 
during later developmental stages (Yang et al., 2016). Therefore, the expression of 
MKX by tenocytes seen in this study is surprising, and may provide further evidence 
that this cell population is heterogeneous. 
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Using flow cytometry I have shown that tenocytes and TDSCs express CD90 
but only low levels of CD73, however the gene expression of these markers was also 
analysed. Consistent with the flow cytometry data I found high expression of CD90 
in all cell types, however in contrast to the earlier data I also found high expression 
of CD73 (Fig.3.4). The reason for the high gene expression of CD73 when compared 
with protein expression may be due to post-transcriptional degradation of mRNA 
(Greenbaum et al., 2003) or possibly due to the equine antibody used, as discussed 
previously. 
Tenascin C (TNC), tenomodulin (TNMD) and thrombospondin-4 (THBS4) are 
glycoproteins found in the tendon extracellular matrix and are therefore used as 
tendon markers (Kannus, 2000; Thorpe et al., 2013). TNC was highly expressed in all 
cell types in this study (Fig.3.4), consistent with findings in rat (Chen et al., 2012a), 
human (Lee et al., 2012), mouse (Zhang and Wang, 2013b) and rabbit (Zhang and 
Wang, 2010a) TDSCs as well as human tenocytes (Lohberger et al., 2015). Hypoxic 
environments have been shown to have no impact on TNC expression in human 
TDSCs (Lee et al., 2012), consistent with this study. TNC, whilst predominantly 
expressed in developing tissues, persists in adult differentiated tendon (Schweitzer 
et al., 2001), and therefore its expression in both tenocytes and TDSCs is to be 
expected. Expression of TNMD was low in all cell types (Fig.3.4), however high 
expression of TNMD has been demonstrated in mouse (Alberton et al., 2014), rat 
(Chen et al., 2015c), human (Lee et al., 2012) and rabbit (Tao et al., 2015) TDSCs. 
This discrepancy is most likely due to species variation, as Cadby and others (2014) 
have demonstrated very low expression of TNMD in equine tenocytes (Cadby et al., 
2014), consistent with this study. Hypoxia has been shown to increase the 
expression of TNMD in human TDSCs (Lee et al., 2012), which is inconsistent with 
my data. As with TNC, TNMD is highly expressed during development, however it is 
also expressed in adult tendon, where it plays a role in the regulation of tenocyte 
proliferation (Docheva et al., 2005). The low expression of TNMD in this study may 
account for the increased PDTs, when compared with other equine studies. THBS4 
expression was high in tenocytes, however significantly lower in TDSCs (Fig.3.4). 
THBS4 has been shown to be expressed in rat TDSCs (Ning et al., 2015) and 
tenocytes (Jelinsky et al., 2010), although expression levels in tenocyte cell cultures 
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were considerably lower than expression in tendon tissue. Barsby and others (2014) 
induced equine embryonic stem cells to differentiate into tenocytes in 3D culture 
and the resulting cells expressed THBS4 (Barsby et al., 2014). 
CD34 and CD144 are haematopoietic stem cell (HSC) markers and it is 
necessary to ensure that any tendon cell cultures are not contaminated with HSCs. 
As the tendon proper is largely avascular, the likelihood of contamination is low, 
however this can still occur as the endotenon and peritenon contain blood vessels. 
CD144 expression in this study was very low for all cell types, however CD34 
expression was slightly higher, although the level of expression was still low 
(Fig.3.4), consistent with the literature (Cadby et al., 2014; Mienaltowski et al., 
2013; Stanco et al., 2014).  
Whole SDFT tissue sections were stained in order to look at the expression, 
location and distribution of CD markers. CD90 was expressed predominately in the 
interfascicular matrix (IFM) (Fig.3.5.C-D) which was to be expected due to the 
increased cellularity of this part of the tendon. Cells residing between fascicles also 
expressed CD90, however interestingly not all cells within the IFM or between 
fascicles expressed CD90, suggesting the presence of at least two different cell 
phenotypes within equine tendon tissue. In contrast there was no expression of 
CD73 throughout the tissue (Fig.3.5.E-F). These results are consistent with the flow 
cytometric analysis of tendon cells, however not with the gene expression data, 
which demonstrated both CD90 and CD73 expression in tendon cells. The possible 
reasons for this discrepancy have been discussed previously. 
 
3.5.5 Multipotency of equine tendon cells 
 
The final criterion outlined by the ISCT for positive identification of MSCs is 
the tri-lineage differentiation potential of the cells; the ability to differentiate into 
osteogenic, adipogenic and chondrogenic cells (Dominici et al., 2006). This study has 
demonstrated the ability of equine TDSCs and tenocytes to differentiate down 
osteogenic and chondrogenic lineages, but not adipogenic. 
The presence of alizarin red staining, which stains calcium nodules, and 
BCIP/NBT staining, which stains for alkaline phosphatase, both indicated that 
113 
 
osteogenic differentiation had occurred. Staining was observed for all cell types 
(Fig.3.6), consistent with the literature for rat (Rui et al., 2010; Rui et al., 2011b), 
mouse (Alberton et al., 2014) and human (Lee et al., 2012; Yin et al., 2010) TDSCs. 
The pattern of staining seen in this study was not wholly consistent with the gene 
expression data. Although expression of some of the osteogenic marker genes was 
increased in the positive sample (osteogenic induction media), when compared with 
the negative (control media), the majority of these increases were not significant 
(Fig.3.8). In fact only osterix expression was significantly increased in tenocytes and 
TDSC-F. Osterix is a transcription factor vital for osteoblast differentiation and bone 
formation (Sinha et al., 2014). Expression of many of the osteogenic marker genes 
was similar between the negative and positive groups, the reason for which may be 
due to a lack of induction in the positive samples. Alternatively, some of the genes 
may be expressed during the early stages of osteogenic differentiation, therefore 
when gene expression was analysed after 21 days the expression of such genes had 
started to decrease, or return to control levels. This may be the case for Runx2, 
which is a transcription factor with an early role in osteoblast differentiation, 
whereas osterix is expressed later in the differentiation process (Sinha et al., 2014). 
However this does not account for the low level expression of genes encoding bone 
proteins such as osteocalcin (OC) and osteomodulin (OMD). In addition, some of the 
genes were significantly decreased in the positive samples, compared with the 
negative, the reasons for which are unclear. A possible explanation may be due to 
the primer sequences used, however all primers were validated (see Appendix B). 
The expression of osteogenic marker genes observed in this study is not wholly 
consistent with the literature. Rat TDSCs have been shown to express significantly 
increased levels of Runx2, osteocalcin and osteopontin in induced samples, when 
compared with controls (Rui et al., 2010). Similarly, TDSCs isolated from mice 
demonstrated increased expression of alkaline phosphatase and osterix, as well as 
osteocalcin and osteopontin, after osteogenic induction (Salingcarnboriboon et al., 
2003). Rabbit (Zhang and Wang, 2010b) and human (Zhang and Wang, 2013b) 
TDSCs have also been shown to express increased levels of Runx2 after induction of 
osteogenic differentiation. The study conducted by Bi and others (2007) 
demonstrated differences in osteogenic gene expression between species, with no 
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increase seen in alkaline phosphatase gene expression in mice, but an increase in 
human TDSCs (Bi et al., 2007). They also demonstrated an increase in osteopontin in 
murine TDSCs after osteogenic induction, but no difference in expression of 
osteocalcin in human TDSCs (Bi et al., 2007). The apparent species variation in 
osteogenic marker expression may account for the lack of induction of many 
osteogenic markers genes seen in this study. However, Lovati and others (2011) 
demonstrated increases in the expression of osteocalcin and osteopontin in equine 
TDSCs (Lovati et al., 2011), although these increases were not quantified, and 
therefore cannot be directly compared with this study. The data obtained in this 
study and others may indicate that alizarin red staining is not a completely reliable 
in vitro assay for osteogenic differentiation.  
No adipogenic differentiation of tenocytes or TDSCs was observed in this 
study (Fig.3.6) as assessed by oil red O staining, which stains intracellular oil 
droplets. This is in stark contrast to the previous literature which has demonstrated 
the ability of TDSCs to differentiate into adipocytes in a number of different species, 
including mouse, human (Bi et al., 2007), rat (Rui et al., 2010), rabbit (Zhang and 
Wang, 2010b) and horse (Lovati et al., 2011). Although it should be noted that oil 
red O staining is not uniform, and for all the studies referenced above there were 
only isolated areas of staining, indicating that not all of the cells were adipocytes. 
There are many possible reasons for the discrepancy between my results and those 
in the literature. These include differences in species, tendon type, age and exercise 
history of subjects and culture conditions. This assay was validated in other species 
(see Chapter 4) therefore technical error cannot account for the absence of oil red 
O staining seen here. As with the osteogenic assays, the adipogenic staining pattern 
seen in this study is not entirely consistent with the gene expression data. Generally 
an increase in all adipogenic marker genes for all three cell types was observed in 
this study, however none of the increases were significant (Fig.3.8). Previous studies 
have demonstrated increased adipogenic marker gene expression consistent with 
their oil red O staining. For example, Rui and others (2010) observed an increase in 
Peroxisome Proliferator-Activated Receptor Gamma 2 (PPARγ2) in rat TDSCs after 
adipogenic induction, compared with controls (Rui et al., 2010). In mice TDSCs, 
expression of FABP4 and PPARγ2 was increased after adipogenic induction 
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(Salingcarnboriboon et al., 2003). Similarly, in rabbit TDSCs, expression of PPARγ2 
was significantly increased after induction (Zhang and Wang, 2010b). 
Chondrogenic differentiation of equine TDSCs was observed with an 
increase seen in alcian blue staining, which stains for glycosaminoglycans (GAGs), 
for TDSC-F, however the increase in stain intensity was less for TDSC-L and 
tenocytes (Fig.3.6). This is consistent with the literature, with staining seen in 
human (Cheng et al., 2014a), mouse (Asai et al., 2014) and equine (Lovati et al., 
2011) TDSCs. The GAG content of the pellets for each cell type was assessed as an 
indication of the extent of chondrogenic differentiation, and I found an increase in 
GAG content after chondrogenic induction in all three cell types, however this was 
only significant in TDSCs (Fig.3.7). This is consistent with the literature which has 
shown an increase in GAG content in human TDSCs after chondrogenic induction 
(Stanco et al., 2014). Although Lovati and others (2011) did not observe a significant 
increase in GAG content of equine TDSCs after chondrogenic differentiation (Lovati 
et al., 2011). The discrepancy with this study may be due to experimental variation 
or differences in age and exercise history of the horses. The chondrogenic staining 
pattern is fairly consistent with the chondrogenic gene expression data in this study. 
Small insignificant increases in chondrogenic marker gene expression in tenocytes 
and TDSC-F were observed, however there was very little change in gene expression 
in TDSC-L (Fig.3.8). This is inconsistent with the previous literature as increases in 
COL2, ACAN and SOX9 after chondrogenic induction have all been reported in 
human (Lee et al., 2012) and rat (Rui et al., 2010) TDSCs, and COL2 and SOX9 in 
rabbit (Zhang and Wang, 2010b) TDSCs. 
I found that tenocytes exhibited the same differentiation potential as TDSCs: 
osteogenic and chondrogenic differentiation, but no adipogenic. Previous research 
conducted on tenocytes isolated from equine SDFT found them to possess 
osteogenic and adipogenic differentiation potential, however they did not test for 
chondrogenic differentiation (Cadby et al., 2014). Consistent with this study they 
demonstrated insignificant increases in Runx2 expression, but significant increases 
in osterix expression. Inconsistent with my study was the adipogenic potential of 
tenocytes (Cadby et al., 2014), the possible reasons for this discrepancy mirror 
those for TDSCs and are discussed previously. Analysis of the multipotency of rabbit 
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tenocytes showed no differentiation potential (Zhang and Wang, 2010b) and the 
reason for this inconsistency is likely due to species differences, as highlighted 
previously. 
 
3.5.6 Equine tendon stem cell niche 
 
One of the initial aims of this study was to analyse the TDSC niche and 
investigate the differences between the extracellular matrix (ECM) of tenocytes and 
TDSCs. Therefore I initially performed histology and immunohistochemistry on SDFT 
sections in order to analyse the structure of the tendon and identify any potential 
cell niches. Haematoxylin and eosin staining revealed that the majority of cells were 
located within the interfascicular matrix (IFM) with sparse cells found between the 
collagen-rich fascicles (Fig.3.9.A). Masson’s trichrome stain again demonstrated the 
presence of many cells within the IFM, as well as blood vessels (Fig.3.9.B). 
Immunohistochemistry revealed the presence of tenascin C predominantly within 
the IFM (Fig.3.9.C). Tenascin C is an ECM glycoprotein with important roles during 
development. In adulthood tenascin C is restricted to areas of high tensile strength, 
for example tendon, and tissues with high cell turnover, such as stem cell niches 
(Chiquet-Ehrismann et al., 2014). Tenascin C has been shown to play a role in a 
number of different stem cell niches including neural (Garcion et al., 2004), hair 
follicle (Tucker et al., 2013) and osteogenic (Kilian et al., 2008) niches. Therefore, 
the presence of tenascin C within the IFM indicates a potential location for the TDSC 
niche. The expression of decorin within tendon tissue was also assessed, which was 
observed predominantly between fascicles, but also within the IFM (Fig.3.9.D). 
Decorin is a proteoglycan located between tendon fibres, fibrils and fascicles and 
links collagen fibrils together (Thorpe et al., 2013), therefore its location within the 
fascicular region of tendon is expected. This demonstrates the different regions 
within tendon, which could provide a niche for TDSCs. 
As discussed previously there were very few differences between tenocytes 
and TDSCs isolated in this study, therefore I expected to see few differences 
between the surrounding ECM composition of the different cell types. The gene 
expression of some of the major known constituents of the tendon ECM was 
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analysed to compare differences between tenocytes and TDSCs. I found no 
significant differences in expression of any of the ECM markers between cell types 
or oxygen tensions (Fig.3.10). 
Radioactive labelling of cells allows analysis of proteins that are being 
actively synthesised during the labelling period. Radioactive proline is primarily 
incorporated into collagenous proteins, and radioactive lysine and arginine into 
both collagenous and non-collagenous proteins. The purpose of the experiment was 
to assess whether there were differences in protein production between tenocytes 
and TDSCs which would be indicative of their environment and niche. However no 
differences in protein production between the different cell types or oxygen 
tensions were observed (Fig.3.11). If tenocytes and TDSCs were different cell types 
and demonstrated different phenotypes then it would be expected that they would 
require different environments or niches in which to survive and function, therefore 
I would expect to see production of different ECM proteins, however this was not 
the case. This suggests that the cell types analysed in this study are cells with a 
similar phenotype, or a heterogeneous mixture of tendon cells at different stages of 
differentiation. Alternatively, synthesis of niche components may not be maintained 
in in vitro culture or beyond certain developmental stages. 
 
3.5.7 Conclusion 
 
In this study I have isolated a population of tendon cells that possess some 
stem cell properties, including the expression of some stem cell markers, 
clonogenicity and multipotency. However these cells did not express all of the 
desired markers and they were unable to differentiate into adipogenic cells. These 
results are not wholly consistent with the previous literature, which has found 
TDSCs from a number of different species to express all desired stem cell and 
tenogenic markers and differentiate down all three cell lineages. There are many 
possible reasons for these discrepancies, the most obvious of which is species 
variation. As outlined above there has been considerable variation between species 
both within (Bi et al., 2007) and between studies (Asai et al., 2014; Rui et al., 
2013a). Intraspecies variation is also common when investigating TDSCs (Kohler et 
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al., 2013; Lee et al., 2012; Ruzzini et al., 2013; Zhang and Wang, 2014). The other 
possible reasons for these discrepancies include the age of the animal, which has an 
impact on many aspects of TDSCs, as well as injury. I found no impact of age on 
tendon cell function, however due to material limitations I did not have sufficient 
numbers of animals at each age to perform any quantitative analysis (data not 
shown). Gross examination of each SDFT and forelimb revealed no apparent 
injuries, however I had no details of the animals’ medical background and so cannot 
completely rule out the possibility of other injuries or illnesses that could affect 
tendon function. Another factor which can affect the function of TDSCs is tendon 
mechanics. The forces applied to tendons and the level of stretch they are 
subjected to can have effects on cell phenotype and function. Throughout the in 
vitro experiments no mechanical forces were applied to the cells, however I had no 
information relating to the exercise history of the horses used, therefore I do not 
know what forces the tendons were subjected to during the animals’ lifetime. 
Previous literature has demonstrated the beneficial nature of moderate exercise, 
and the detrimental effects of intensive exercise. Moderate exercise has been 
shown to promote tenogenic differentiation, whereas intensive exercise promotes 
both tenogenic and non-tenogenic differentiation (Zhang and Wang, 2010d, 2013a). 
It is possible that the horses used in this study were subjected to moderate exercise 
throughout their lifetimes, which promoted tenogenic differentiation of the 
resident TDSCs, rather than non-tenogenic differentiation. 
One of the aims of the study was to compare the differences between 
tenocytes and TDSCs, both their phenotype and their extracellular environment. 
Very few differences between tenocytes and TDSCs were observed during this 
study, which was unexpected. Unfortunately there is only one study to date that 
has directly compared tenocytes and TDSCs from the same species in a single 
experiment (Zhang and Wang, 2010b). Zhang and Wang (2010b) found large 
differences between the two cell types, with tenocytes unable to differentiate down 
osteogenic, adipogenic or chondrogenic lineages, as well as being negative for stem 
cell markers. In addition, tenocytes had an elongated cell morphology, whereas 
TDSCs were cobblestone-like in appearance (Zhang and Wang, 2010b). However, 
other studies investigating equine tenocytes have found that they are multipotent, 
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clonogenic and express stem cell markers (Cadby et al., 2014). These results are 
highly consistent with my own and suggest that tenocytes are not distinct from 
TDSCs, or alternatively that cell separation and isolation techniques require 
optimisation. When SDFT cells were plated there was growth of two distinct cell 
populations, which I attempted to separate using cloning cylinders, however it is 
possible that either cell type contaminated the other and therefore none of the cell 
populations were pure and were a mixture of tendon cells at different stages of 
differentiation. This is supported by the immunohistochemical analysis of CD90 
expression in SDFT tissue. Cells within the IFM and between the fascicles stained 
positively for CD90, however not all of the cells in either region were positive, 
indicating that neither the IFM nor the fascicular regions contain one distinct cell 
type. Based on previous literature and some of my preliminary findings I expected 
to observe TDSCs within the IFM and tenocytes in the fascicular regions. This 
hypothesis is supported to a certain extent by some of my data, for example the 
localised expression of tenascin C, known to play a role in stem cell niches, in the 
IFM. However much of my data is contradictory to this hypothesis, predominantly 
the lack of any real difference between tenocytes and TDSCs. The differential 
expression of CD90 throughout SDFT tissue, as well as the remarkably similar 
protein labelling profile of tenocytes and TDSCs suggests that the cells are not 
residing within different environments. The most likely explanation is that the cells 
isolated, both tenocytes and TDSCs, are in fact a mixture of cells at different stages 
of differentiation. In order to further investigate equine TDSCs and tenocytes and 
their niche, it is first necessary to isolate the different cell types effectively. The 
most useful tool to do this would be FACS, or a similar technique, however this 
method has its own disadvantages as discussed previously. However, possibly the 
largest problem is the lack of a specific TDSC marker. At present a panel of markers 
has to be used to correctly identify a cell as being a TDSC, which encompass 
pluripotency, MSC and tenogenic markers. If one specific marker could be found for 
identification of TDSCs then this would allow great advances in future research in 
this field. Similarly, if a standard protocol for isolation of TDSCs could be devised, 
this would also aid the development of research within this area and promote 
consistency across studies. 
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Despite the restricted differentiation potential of the tendon cells isolated in 
this study, they may still be used therapeutically to treat tendinopathies. Current 
practices extract MSCs from equine bone marrow and adipose tissue, which can 
involve complicated and painful procedures, before culturing the cells and 
implanting them at the site of injury (Carvalho et al., 2013; Conze et al., 2014; Smith 
et al., 2013). If the equine TDSC niche could be characterised, and those 
components which promote stem cell viability and function identified, then it may 
be possible to artificially introduce those components to the site of injury. This 
would have the effect of promoting and stimulating native TDSCs to repair the 
injured tendon. The restricted differentiation potential of equine TDSCs may 
actually provide a benefit during times of injury, possibly reducing the tendency 
towards non-tenogenic differentiation. This research, as well as having potential 
implications for veterinary medicine, is also translatable for human research. There 
have been many analogies demonstrated between human and equine tendon, in 
structure, function and pathogenesis (Innes and Clegg, 2010). Similarities between 
the two species have also been demonstrated on a cellular level, with MSCs isolated 
from equine and human adipose tissue demonstrating similar stem cell 
characteristics (Hillmann et al., 2015). 
Further research needs to be conducted into the characterisation of equine 
TDSCs, commencing with the optimisation of isolation procedures and the 
identification of suitable markers, however current data is encouraging and may 
provide the basis for future treatment options for tendinopathy. 
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Chapter 4 
 
Murine tendon-derived stem cell 
characterisation 
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4.1 Introduction 
 
As described in Chapters 1 and 3, tendon-derived stem cells (TDSCs) have 
the potential to treat a range of tendinopathies in both humans and animals. As a 
form of tendon progenitor cell they can be induced to, and spontaneously, 
differentiate into tenocytes, the predominant cellular component of tendon and the 
manufacturers of extracellular matrix (ECM). Therefore they are likely to play a role 
in natural tendon healing, but also may be of use in tissue engineering strategies. 
Before such advances can be made, TDSCs, as well as their environment and the 
interaction between the two, must be fully characterised. 
The main focus of this study was to investigate TDSCs in equine tendon, 
however, as described in Chapter 3, I was unable to replicate previous studies either 
for equine TDSCs, or other species. Therefore, I decided to try and replicate some of 
the earlier published studies that focused on murine TDSCs to ensure that methods 
and techniques were appropriate and that previous studies were replicable. 
There have been numerous studies published characterising murine TDSCs, 
investigating the effects of specific factors on these cells, as well as their use in 
tissue engineering strategies. Murine TDSCs have been shown to form colonies, 
express stem cell markers, as well as differentiate into osteogenic, adipogenic and 
chondrogenic cell types (Bi et al., 2007), all characteristics indicative of 
mesenchymal stromal cells (MSCs) (Dominici et al., 2006). 
The majority of studies investigating murine TDSCs have used patellar or 
Achilles tendons for TDSC isolation, however in this study I was unable to obtain 
cells from these tendons. Both collagenase digest and cell outgrowth methods were 
employed however no cell growth was observed. Therefore, for all experiments 
detailed below, murine tail tendons were used for isolation of TDSCs and tenocytes, 
and in addition I also analysed murine MSCs as a positive control.  
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4.2 Hypothesis 
 
I hypothesise that a native tendon progenitor cell population resides within 
murine tail tendon which can be differentially isolated from other tendon cell types 
by low-density plating. This progenitor cell population will demonstrate all of the 
hallmark properties of MSCs, including clonogenicity, multipotency and stem cell 
marker expression, however the cell population will differ from MSCs with the 
increased expression of tenogenic markers. The progenitor cell population will 
differ from tenocytes with the latter cell type demonstrating reduced stemness 
when compared with progenitor cell populations. 
 
4.3 Aim 
 
1. To characterise murine TDSCs and tenocytes isolated from tails, as well as 
murine MSCs, as a methodological validation of the study of equine TDSC 
characterisation. Characterisation will include analysis of stem cell and 
tenogenic marker expression, colony-forming ability, cell proliferation and 
multipotency. 
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4.4 Results 
 
4.4.1 Isolation of murine TDSCs 
 
Murine patellar tendon was isolated immediately post-mortem from 
individual mice before performing a collagenase/trypsin digest, however no cells 
were observed 14 days after plating. Murine patellar tendons were also pooled in 
order to increase cell numbers, however after extraction, digestion and culture of 
four biological replicates there was still an absence of cell growth. Finally, murine 
patellar tendons were placed in cell culture dishes with appropriate media to allow 
outgrowth of cells from tissue explants, however again, there was still an absence of 
cell growth. All subsequent experiments used murine tail tendon for isolation of 
tendon cells (Chapter 2, Section 2.2.1.2). 
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4.4.2 Tenocyte, TDSC and MSC morphology and colony formation 
 
All three cell types exhibited slightly varying cell morphologies. Tenocytes 
demonstrated a fairly compact cell morphology, neither rounded nor fibroblastic, 
whereas TDSCs displayed a rounded morphology. MSCs had a more fibroblastic 
appearance, however there were dense areas of growth where the cells were more 
rounded (Fig.4.1.A). 
All three cell types were able to form colonies, however these colonies were 
not homogeneous. Tenocytes generally formed large sparse colonies, whereas 
TDSCs formed more compact, dense colonies. MSCs formed smaller fairly sparse 
colonies with areas of compact cell growth (Fig.4.1.A). When quantified there was 
very little difference in colony number between tenocytes and MSCs, however 
there was a statistically significant difference between tenocytes and TDSCs 
(Fig.4.1.B). A similar pattern was observed for colony size, with all three cell types 
exhibiting similar colony sizes, with tenocytes the smallest and MSCs the largest 
(Fig.4.1.C).  
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Figure 4.1. Tenocyte, TDSC and MSC morphology and colony formation. Representative 
images of cell morphology and colony forming ability are shown. Cells were grown for 7 days 
before staining with crystal violet and imaging for cell morphology analysis and colony 
formation. White bars = 100 μm, black bars = 1 cm (A). Colonies were counted (B) and 
measured (C) using ImageQuantTL software. n=3 biological replicates for tenocytes, n=4 for 
TDSCs and n=1 for MSCs, error bars shown represent SEM. Pairwise comparisons were 
performed using Student’s t-tests. P-values: a=0.01.  
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4.4.3 Tenocyte, TDSC and MSC proliferation 
 
Tenocytes and TDSCs proliferated very slowly and demonstrated very long 
population doubling times (PDT) with a mean (± SEM) of 354 (±81) and 508 (±28) 
hours respectively. In contrast MSCs had a much shorter PDT: 24 hours (Fig.4.2). 
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Figure 4.2. Population doubling time for tenocytes, TDSCs and MSCs. n=3 biological 
replicates, error bars shown represent SEM. Pairwise comparisons were performed 
using Student’s t-tests. 
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4.4.4 Tenocyte, TDSC and MSC marker expression 
 
The gene expression of stem cell and tenogenic markers was assessed by 
qRT-PCR (Fig.4.3). The majority of stem cell and early tenogenic markers were more 
highly expressed in TDSCs when compared with tenocytes and MSCs, and this 
increase was significant for Nanog, scleraxis, mohawk and CD73, when compared 
with tenocytes. The stem cell marker Sca-1 was similarly expressed in all cell types, 
and CD90 was expressed at similar levels in tenocytes and TDSCs, but expression 
was reduced in MSCs. Markers found in developed tendon, such as tenascin C, 
thrombospondin-4 and tenomodulin, exhibited higher expression in tenocytes, 
moderate expression in TDSCs, however expression in MSCs was low. The 
haematopoietic stem cell (HSC) marker CD34 was highly expressed in all cell types, 
whereas CD45 demonstrated low expression in all three cell types, with significantly 
higher levels observed for tenocytes. 
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Figure 4.3. Gene expression analysis of stem cell markers in tenocytes, TDSCs and MSCs. Values are shown on a logarithmic 
scale and normalised to Gapdh. n=6 biological replicates for tenocytes, n=4 for TDSCs and n=1 for MSCs. Error bars shown 
represent SEM. Pairwise comparisons were performed using Student’s t-tests after Log10 transformations. P-values: a=0.008, 
b=0.011, c=0.001, d=0.011, e=0.011, f=0.011. 
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4.4.5 Tenocyte, TDSC and MSC tri-lineage differentiation capacity 
 
The ability of tenocytes, TDSCs and MSCs to differentiate into different cell 
lineages was analysed by staining, glycosaminoglycan (GAG) assays and qRT-PCR for 
gene expression analysis. 
All three cell types demonstrated osteogenic differentiation as assessed by 
alkaline phosphatase levels and alizarin red staining, however MSCs exhibited only 
small amounts of alizarin red staining (Fig.4.4). No adipogenic differentiation was 
observed for tenocytes, however some oil red O staining was seen in MSCs, and 
considerably more for TDSCs (Fig.4.4). Tenocytes demonstrated some chondrogenic 
differentiation, with an increase in the intensity of safranin O staining, although the 
intensity of alcian blue staining did not appear to increase following differentiation 
(Fig.4.4). MSCs demonstrated stronger chondrogenic differentiation with a 
moderate increase in stain intensity for safranin O (Fig.4.4). Due to low cell 
numbers, chondrogenic differentiation assays were not performed on TDSCs. 
There was an increase in mean GAG formation for tenocytes from 0.25 
(±0.12) µg to 0.5 (±0.22) µg, however this was not significant, and for MSCs from 2.5 
µg to 3.6 µg. GAG content was not analysed in TDSCs due to low cell numbers 
(Fig.4.5). 
Gene expression analysis of lineage specific genes showed very low level 
expression of the majority of osteogenic markers for all three cell types, with 
significant decreases seen in expression of some genes for tenocytes and TDSCs. 
However there was a significant increase in Runx2 and Opn expression for TDSCs. 
There were small increases seen for some osteogenic markers for MSCs, however 
statistical analysis was not performed due to few biological replicates. There were 
small increases in all adipogenic genes for tenocytes and MSCs, and much larger 
significant increases for TDSCs. Similarly there was an increase in the majority of 
chondrogenic markers in tenocytes and MSCs, although these were not significant. 
Chondrogenic markers were not analysed in TDSCs due to low cell numbers 
(Fig.4.6). 
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Figure 4.4. Histological analysis of tri-lineage differentiation potential of tenocytes, TDSCs and MSCs. Representative images are shown for 
each cell type after induction of osteogenic, adipogenic and chondrogenic differentiation (positive) and also for control samples (negative), 
after appropriate staining. Cells subjected to osteogenic differentiation media were stained for both alkaline phosphatase (ALP) activity and 
calcium deposits using alizarin red (AR). Cells subjected to adipogenic differentiation media were stained for oil droplet formation using oil 
red O (ORO), and cell pellets exposed to chondrogenic differentiation media, for GAG formation using alcian blue (AB) and safranin O (SO). 
Bar = 100 μm. n=6 biological replicates for tenocytes, n=4 for TDSC-L and n=1 for MSCs. 
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Figure 4.5. Total glycosaminoglycan (GAG) content of cell pellets with (positive) or 
without (negative) chondrogenic induction. n=6 biological replicates for tenocytes, 
n=1 for MSCs, error bars shown represent SEM. Pairwise comparisons were 
conducted using paired Student’s t-tests. 
 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
Tenocytes MSCs
G
A
G
 c
o
n
te
n
t 
(u
g)
 
Negative
Positive
135 
 
 
  
0.00001
0.0001
0.001
0.01
0.1
1
LEPTIN PPAR FABP4
2
^Δ
C
T 
Negative Positive
0.000001
0.0001
0.01
1
2
^Δ
C
T 
Negative Positive
Osteogenic Adipogenic Chondrogenic 
Te
n
o
cy
te
s 
TD
SC
-L
 
M
SC
s 
0.00001
0.0001
0.001
0.01
0.1
1
AGG COL2 SOX9
2
^Δ
C
T 
Negative Positive
0.0000001
0.00001
0.001
0.1
10
2
^Δ
C
T 
Negative Positive
0.000001
0.00001
0.0001
0.001
0.01
0.1
1
LEPTIN PPAR FABP4
2
^Δ
C
T 
Negative Positive
0.00001
0.0001
0.001
0.01
0.1
1
AGG COL2 SOX9
2
^Δ
C
T 
Negative Positive
0.0000001
0.00001
0.001
0.1
10
2
^Δ
C
T 
Negative Positive
0.00001
0.0001
0.001
0.01
0.1
1
LEPTIN PPAR FABP4
2
^Δ
C
T 
Negative Positive
j   
i   
h   
  
 
a   b   
g   
d   
e   
f   
c 
136 
 
Figure 4.6. Gene expression analysis of lineage specific markers for tenocytes, TDSCs and MSCs. Values are shown on a logarithmic scale and 
normalised to Gapdh. n=6 biological replicates for tenocytes, n=4 for TDSC-L and n=1 for MSCs. Error bars shown represent SEM. Pairwise 
comparisons were performed after Log10 transformations using paired Student’s t-tests. P-values: a=0.004, b=0.004, c=0.01, d=0.021, e=0.02, f=0.02, 
g=0.021, h=0.021, i=0.021, j=0.021. 
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4.5 Discussion 
 
4.5.1 Isolation of murine tendon cells 
 
The initial studies that identified and characterised TDSCs were conducted in 
mice (Bi et al., 2007; Salingcarnboriboon et al., 2003). Both of these studies, as well 
as the majority of subsequent murine TDSC studies, have used patellar or Achilles 
tendon for TDSC isolation. As detailed above, I was unable to isolate cells from 
these tendons and there are a number of reasons why this may have occurred, 
many of which are due to the limitations imposed by the use of spare material. As 
the purpose of this study was to validate the methods and techniques used for 
equine research, I used fresh spare murine material from other studies. By 
obtaining tissue in this manner, and not using additional mice for this study alone, I 
reduced the number of animals used for scientific research, one of the three R’s 
outlined by the National Centre for the Replacement, Refinement and Reduction of 
Animals in Research (NC3Rs) (Burden et al., 2015). For this reason, I had no control 
over the strain, age, gender, history or number of mice I was able to use. The mice 
from which I isolated patellar tendon were considerably older than those used 
previously: 6-31 months in this study, compared with 4-8 weeks in previous studies 
(Bi et al., 2007; Mienaltowski et al., 2014; Salingcarnboriboon et al., 2003), which 
may account for reduced cell numbers. In addition, some previous studies pooled as 
many as eight tendons (Mienaltowski et al., 2013), although others used individual 
tendons (Bi et al., 2007) and still observed cell growth. As far as information was 
available, I followed the isolation procedures provided in previous studies, however 
it is still possible that experimental and culture conditions may have had an impact 
on tendon cell growth. 
Due to the lack of cells provided by patellar tendon digestion, I used murine 
tail tendon, as cells had been previously successfully isolated from tail tendon in my 
group. The mice used for isolation of tail tendon cells were 6-8 weeks old and 
therefore considerably younger than the mice used for patellar tendon cell 
isolation. Only one other study has previously isolated TDSCs from murine tail 
tendon (Alberton et al., 2014), therefore I followed their protocol for digestion and 
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culture, however no cell seeding density was provided. A low cell seeding density 
was selected based on my own previous work and other studies, however the 
density selected may be the reason for any differences observed between my 
findings and those of previous studies. Seeding density has been shown to play a 
key role in stem cell and tenocyte isolation and growth (Güngörmüş and Kolankaya, 
2008; Lee et al., 2012; Schulze-Tanzil et al., 2004; Tsai and McKay, 2000) and 
previous studies on TDSC isolation in mice and other species have specified the 
requirement for low seeding densities (Cheng et al., 2014a; Lee et al., 2012; 
Mienaltowski et al., 2014; Ni et al., 2012; Rui et al., 2010), although many studies on 
murine TDSCs did not specify the seeding density used. Interestingly, the isolation 
of murine MSCs from bone marrow does not appear to be dependent on seeding 
density with published methods varying from extremely low densities, akin to TDSC 
isolation methods (Eslaminejad et al., 2006), to extremely high densities, exceeding 
those used for tenocyte isolation (Soleimani and Nadri, 2009; Sun et al., 2003). If 
TDSCs are a subset of MSCs then it would be expected that isolation methods would 
be similar. It is possible that higher seeding densities for tendon cells could promote 
TDSC-tenocyte interactions and promote TDSC differentiation, which necessitates 
low seeding densities to select for TDSCs only. Whereas the presence of tenocytes is 
clearly not a factor for MSC isolation and culture, and therefore higher seeding 
densities are acceptable. Alternatively it is possible that the differences in seeding 
density reported for TDSCs and MSCs and the observed differences in phenotype 
could be an indication that these two cell types are more distinct from each other 
than originally thought. This is supported by previous studies (Bi et al., 2007) as well 
as my own and could account for the differences observed between these two cell 
types. 
The lack of information on optimal seeding densities for murine tail TDSC 
isolation may be the reason why I was unable to replicate the findings of previous 
studies. I found that murine TDSCs isolated from tail tendon had very slow rates of 
proliferation, and stopped growing at early passages, making certain assays 
impossible to perform due to low cell numbers. For further comparison and 
validation tenocytes were isolated from tail tendon and murine MSCs were 
purchased. No studies to date have investigated the stem cell properties of murine 
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tenocytes, or provided a comparison with murine TDSCs. Conversely, there is a 
wealth of literature on the characterisation of murine MSCs, and the widely 
reported similarities between MSCs and TDSCs made MSCs a useful cell type for 
comparison of stem cell characteristics. Due to the limited availability and stockists 
of murine MSCs, only one biological replicate was obtained, therefore no statistical 
comparisons could be performed and subsequently limited the usefulness of these 
cells as a comparative cell type. 
 
4.5.2 Clonogenic potential and morphology of murine tendon cells 
 
One of the hallmarks of a stem cell, including TDSCs and MSCs, is the ability 
to form colonies in culture. Previous studies have shown that TDSCs in mice are able 
to form colonies, however these colonies are heterogeneous in nature (Bi et al., 
2007; Zhang and Wang, 2013a). In this study I observed growth of dense 
heterogeneous colonies in both TDSCs and tenocytes (Fig.4.1.A), which is consistent 
with the previous literature for TDSCs. I also observed growth of colonies in murine 
MSCs, however these colonies were sparse and heterogeneous (Fig.4.1.A), which is 
also consistent with some of the literature (Lei et al., 2013), although one study 
found that MSCs did not form colonies (Nadri et al., 2007). Similar colony numbers 
and colony sizes were observed between tenocytes and MSCs in this study, 
however TDSCs demonstrated fewer colonies than the other cell types, which is 
possibly due to the slow growth of these cells (Fig.4.1.B-C). 
The morphology of cells can also be indicative of their function and 
specialisation. The general consensus of the current literature on TDSCs suggests 
that they are rounded in shape, not fibroblastic (Zhang and Wang, 2010c; Zhang and 
Wang, 2013a). This is partially consistent with my findings, which have shown a 
rounded morphology for TDSCs, however the cells were heterogeneous and there 
were also some fibroblastic cells present. Tenocyte morphology was also 
heterogeneous, with both fibroblastic and rounded cells present (Fig.4.1.A). 
Considering tenocytes as tendon fibroblasts, I expected to see a typical fibroblastic 
spindle-like morphology, as seen in other species (Zhang and Wang, 2010b), 
however tenocytes with a rounded, or polygonal morphology have previously been 
140 
 
reported in mice (Shimada et al., 2014). A considerable amount of heterogeneity in 
the morphology of MSCs was observed in this study, with some rounded cells, some 
fibroblastic, as well as intermediate polygonal cells (Fig.4.1.A). This is consistent 
with the literature, which reports solely fibroblastic cells (Nadri et al., 2007; Sun et 
al., 2003; Tropel et al., 2004), as well as heterogeneous mixtures of fibroblastic and 
rounded cells (Eslaminejad et al., 2006; Lei et al., 2013; Peister et al., 2004).  
 
4.5.3 Proliferation of murine tendon cells 
 
As noted above, very slow growth of TDSCs was observed (508 hours), 
however tenocytes were also found to have very slow population doubling times 
(PDTs) (354 hours) (Fig.4.2). Previous literature on murine TDSCs is highly variable, 
with some studies reporting very short PDTs, ranging between 20 and 25 hours (Bi 
et al., 2007; Zhang and Wang, 2015) for cells isolated from patellar tendon. 
Whereas other studies have shown PDTs of 50 and 93 hours for cells isolated from 
the same tendon, and 100 and 167 hours for cells from Achilles tendon (Zhang et 
al., 2010; Zhang and Wang, 2013a). These differences may be due to variation in cell 
culture or other experimental practices, although the same group (Zhang and 
Wang) demonstrated very variable PDTs, therefore experimental differences seem 
unlikely. Possibly the strain of mice used may have an effect on the characteristics 
of the isolated cells, as shown in MSCs (Peister et al., 2004), however three of the 
four studies mentioned above used C57BL/6 mice, therefore this cannot account for 
the differences in PDT. Even the higher PDTs demonstrated by some of the studies 
are considerably lower than those seen in this study. I am unsure why the cells used 
in this study, both TDSCs and tenocytes, had such long PDTs, or in fact stopped 
growing completely. I followed the protocol and methods provided by previous 
studies, particularly Alberton and others (2014), as this is the only study published 
which has characterised murine TDSCs from tail tendon (Alberton et al., 2014). Their 
study demonstrated a PDT of approximately 25 hours for TDSCs, which is clearly 
considerably lower than that shown in this study. The reasons for this are unclear, it 
is possibly due to strain variation, however as Alberton and others (2014) did not 
state the strain of mice used in their study, I cannot confirm this. Another possible 
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reason is the age of the mice used, as age has been shown to reduce murine TDSC 
proliferation and increase PDT (Zhang and Wang, 2015). However all of the studies 
previously discussed including my own have used young mice of comparable age. 
Conversely a much shorter population doubling time was observed for MSCs 
compared with tendon cells in this study (Fig.4.2), which is inconsistent with the 
literature. Previous studies have noted doubling times of around 60 hours for 
murine MSCs (Baghaban Eslaminejad and Fallah, 2013; Lei et al., 2013), which is 
considerably higher than that seen in this study, although variation within strains 
was observed (Lei et al., 2013). 
 
4.5.4 Stem cell and tenogenic marker expression of murine tendon cells 
 
Expression of certain markers is also indicative of stem cell populations. 
Generally in this study increased expression of stem cell markers was observed in 
TDSCs compared with tenocytes and MSCs, and increased expression of tenogenic 
markers in tenocytes and TDSCs compared with MSCs (Fig.4.3). The pluripotency 
marker Nanog was poorly expressed in all cell types, evident by the low CT values, 
however it was most highly expressed in TDSCs (Fig.4.3). The expression of Nanog 
has been previously reported in murine tail TDSCs (Alberton et al., 2014) and MSCs 
(Katsara et al., 2011). Sca-1, a murine specific MSC marker, was expressed in similar 
levels by all three cell types (Fig.4.3). Sca-1 has been shown to be expressed by 
murine TDSCs in a number of previous studies (Asai et al., 2014; Bi et al., 2007; 
Mienaltowski et al., 2013; Zhang and Wang, 2015). The expression of Sca-1 by 
tenocytes was unexpected as this is a stem cell marker and the expression of Sca-1 
is thought to be restricted to cells with stem cell properties. It is possible that the 
tenocyte population isolated in this study is a heterogeneous mixture of cells at 
different stages of differentiation and therefore contains some multipotent cells 
expressing Sca-1. As Sca-1 is a MSC marker, its expression has been widely 
demonstrated in these cells (Baddoo et al., 2003; Eslaminejad et al., 2006; Lei et al., 
2013; Nadri and Soleimani, 2007; Sun et al., 2003), consistent with this study. CD90 
and CD73 are cell surface markers traditionally associated with MSCs and used as a 
criterion for MSC identification (Dominici et al., 2006), although more recently these 
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markers have also been identified on other cell types, including fibroblasts (Lupatov 
et al., 2015; Tsuzaki et al., 2005), making them less reliable stem cell markers. In this 
study high expression of CD90 was observed in TDSCs and tenocytes and reduced 
expression in MSCs (Fig.4.3). The data for CD90 expression in TDSCs is consistent 
with the literature, which has shown expression of CD90 in these cells (Alberton et 
al., 2014; Bi et al., 2007; Mienaltowski et al., 2013). Although CD90 expression has 
not been previously demonstrated in murine tenocytes, it has in tenocytes from 
other species (Cadby et al., 2014; Tsuzaki et al., 2005). Interestingly, although 
considered a MSC marker, CD90 expression in murine MSCs was reduced when 
compared with TDSCs. The reasons for this are unclear, however previous studies 
have also reported reduced expression of CD90 in murine MSCs, when compared 
with other CD and MSC markers (Lei et al., 2013; Nadri and Soleimani, 2007). 
Similarly, CD73 expression was reduced in murine MSCs when compared with 
TDSCs, however expression in tenocytes was also reduced (Fig.4.3). CD73 
expression has been poorly characterised in murine tendon cells, with only one 
study demonstrating CD73 expression in TDSCs (Alberton et al., 2014), however the 
study by Alberton and others (2014) is consistent with my own. I observed reduced 
expression of CD73 in MSCs when compared with TDSCs, which is consistent with a 
previous study (Baghaban Eslaminejad and Fallah, 2013), although another study 
observed high expression of CD73 in murine MSCs (Abdallah et al., 2015). 
Interestingly, the same study noted that the expression of CD73 decreased in MSCs 
which were committed to the osteogenic lineage (Abdallah et al., 2015). Therefore 
it is possible that the MSCs in this study had already begun to differentiate, which 
would account for the reduced expression of CD73. Scleraxis (Scx) and Mohawk 
(Mkx) are both transcription factors involved in tendon development and expressed 
by tendon cells early in development, and in the case of Scx, by mature tendon cells 
(Liu et al., 2010; Schweitzer et al., 2001). For this reason I expected to see increased 
expression of these two markers in tendon cells, particularly TDSCs, and reduced 
expression in MSCs, which is generally what was observed, with increased 
expression in TDSCs and reduced expression in MSCs, although expression in 
tenocytes was also low. Both markers were highly expressed in TDSCs (Fig.4.3) 
consistent with the literature for Scx (Alberton et al., 2014; Asai et al., 2014; Bi et 
143 
 
al., 2007; Salingcarnboriboon et al., 2003), although no studies to date have 
analysed the expression of Mkx in murine TDSCs. The expression of both markers 
was reduced in tenocytes when compared with TDSCs, however that is to be 
expected. As both markers are involved in tendon development they are most 
highly expressed in tendon progenitor cells, and although expression of Scx is also 
observed in mature tendon, the expression of these transcription factors in 
differentiated tendon cells would be expected to be reduced. Although the 
expression levels were reduced in tenocytes, there is still fairly high expression of 
these markers and this is consistent with the literature (Wada et al., 2015). 
Moderate expression of the two transcription factors was observed in MSCs 
(Fig.4.3), which may be due to the fact that MSCs are able to differentiate into 
tendon cells (Dai et al., 2015), and therefore would require the ability to express 
tendon developmental genes. Although not demonstrated in murine MSCs, Scx and 
MKX expression has been shown in MSCs from other species including human and 
rat (Dai et al., 2015; Otabe et al., 2015). Tenascin C (Tnc), thrombospondin-4 
(Thbs4) and tenomodulin (Tnmd) are all glycoproteins found in the tendon 
extracellular matrix (ECM) and have therefore been proposed as tendon markers. 
All three markers were more highly expressed in tendon cells when compared with 
MSCs, as expected, with the highest expression seen in tenocytes (Fig.4.3). Tnc 
expression has been demonstrated in murine TDSCs (Bi et al., 2007) consistent with 
this study, however expression in tenocytes has only been observed in other species 
(Pauly et al., 2010). Thbs4 expression has not previously been demonstrated in 
murine TDSCs or tenocytes, however it has in TDSCs and tenocytes from rat 
(Jelinsky et al., 2010; Ni et al., 2013; Ning et al., 2015), which is consistent with this 
study. Tnmd was expressed at slightly lower levels than the other two tendon ECM 
markers, with a significant increase seen in tenocytes when compared with TDSCs 
(Fig.4.3). Tnmd expression has been extensively demonstrated in murine TDSCs 
(Alberton et al., 2014; Mienaltowski et al., 2014; Zhang and Wang, 2013a), which is 
consistent with this study. The expression of Tnmd in murine tenocytes has also 
been reported (Wada et al., 2015). The expression of these ECM markers in MSCs 
was low, particularly for Tnmd and Thbs4, however this was expected as these 
proteins are components of the tendon ECM. Although no studies have analysed 
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the expression of these markers in murine MSCs, their expression has been 
demonstrated in other species. Low level expression of Tnc has been demonstrated 
in rat MSCs (Dai et al., 2015), and when compared directly with expression in 
tendon tissue, a 200-fold decrease was observed (Burk et al., 2014), this is not 
dissimilar to my own observations which noted a fold decrease of approximately 
1000. Tnmd expression has also been well characterised in MSCs of several species 
(Dai et al., 2015; Tong et al., 2012), including mice, where direct comparison of 
Tnmd expression between MSCs and TDSCs showed reduced expression in MSCs 
(Brown et al., 2015), consistent with this study. CD34 and CD45 are haematopoietic 
and endothelial cell markers, and are used to ensure there is no contamination of 
tendon cell and MSC populations with these cells. CD34 expression was fairly high in 
all cell types (Fig.4.3), which may be due to problems associated with the primer 
used, although all primers were tested for homology, efficiency and dissociation 
curves. Alternatively, a previous study reported an increase in CD34 expression in 
MSCs which had started to differentiate down the osteogenic lineage (Abdallah et 
al., 2015), therefore it is possible that the cells used in this study had already 
started the process of differentiation before RNA was extracted for gene expression 
analysis. Alternatively the cell populations isolated in this study could have been 
contaminated with HSCs, however frequent media changes were performed to 
prevent this (Soleimani and Nadri, 2009) and tendon is poorly vascularised, 
therefore the likelihood of contamination is small. CD45 expression was much 
lower, particularly for TDSCs and MSCs (Fig.4.3). 
 
4.5.5 Multipotency of murine tendon cells 
 
Another hallmark of a stem cell is the ability to differentiate into a range of 
cell types, specifically for TDSCs and MSCs: osteogenic, adipogenic and 
chondrogenic cells. This property was investigated using staining methods, gene 
expression analysis and glycosaminoglycan (GAG) assays. Tenocytes, TDSCs and 
MSCs all demonstrated the ability to differentiate into osteogenic cells as analysed 
by BCIP/NBT and alizarin red staining (Fig.4.4). BCIP/NBT staining for alkaline 
phosphatase can manifest in different ways, with dark brown or black precipitate, 
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or purple staining. The formation of dark precipitate was observed for tenocytes 
and purple staining for TDSCs and MSCs. Alizarin red staining, which stains calcium 
nodules formed during osteogenic differentiation, was observed for all three cell 
types. There were similar levels of staining for tenocytes and TDSCs, however much 
less staining observed for MSCs. My data is consistent with previous studies 
investigating murine TDSCs, which observed osteogenic differentiation of TDSCs, as 
assessed by alizarin red staining (Alberton et al., 2014; Bi et al., 2007; Mienaltowski 
et al., 2013; Salingcarnboriboon et al., 2003). Interestingly, I observed only small 
amounts of alizarin red staining for murine MSCs, much less than for TDSCs. The 
majority of previous literature on murine MSCs has shown strong osteogenic 
differentiation as determined by both alizarin red (Baddoo et al., 2003; Baghaban 
Eslaminejad and Fallah, 2013; Eslaminejad et al., 2006; Nadri and Soleimani, 2007) 
and alkaline phosphatase staining (Sun et al., 2003; Tropel et al., 2004). However 
several studies have highlighted the variation in stem cell properties, including 
differentiation potential, both between different mice strains and also within the 
same strain. For example, Peister and others (2004) reported strong alizarin red 
staining for MSCs isolated from C57BL/6J mice, but reduced staining for BALB/c 
(Peister et al., 2004). In contrast, Phinney and others (1999) found that MSCs from 
C57BL/6J mice did not readily expand in culture and could not be used for further 
analysis (Phinney et al., 1999). Lei and others (2013) cultured four different cell lines 
from one strain (the specific strain was not noted), which all exhibited different 
morphologies (Lei et al., 2013). There were significant differences in the osteogenic 
potential of the different cell lines, with rounded and fibroblastic cells showing no 
differentiation and fusiform and polygonal cells showing varying degrees of 
osteogenic differentiation (Lei et al., 2013). Although MSCs isolated from C57BL/6J 
mice were used for this study, which have previously shown strong osteogenic 
potential, it is clear that there is a great deal of variation within murine MSCs and it 
is likely for this reason that variable alizarin red staining was observed in this study. 
The gene expression data is only partially consistent with the staining pattern 
observed for all three cell types, but particularly for tendon cells. This is similar to 
the data I produced for equine TDSCs (see Chapter 3), which also saw discrepancies 
between the staining and gene expression data. Tenocytes and TDSCs generally 
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showed a decrease or no change in gene expression between the positive and 
negative samples (Fig.4.6). The possible reasons for this mirror those for equine 
TDSCs (see Chapter 3), however in brief: lack of induction of the gene; early 
expression of the gene which decreased by 21 days; problems associated with the 
primers used, although all primer efficiencies and dissociation curves were tested. 
There was a significant increase seen in only two genes in TDSCs, and none for 
tenocytes. These results are inconsistent with some of the literature which has 
shown positive expression of alkaline phosphatase (Mienaltowski et al., 2013) in 
murine TDSCs, although there was no comparison with a non-differentiated control. 
My data is consistent with Bi and others (2007) as they observed an increase in 
osteopontin expression in positive samples when compared with controls, as well as 
demonstrating no increase in alkaline phosphatase expression (Bi et al., 2007). The 
only study to quantify osteogenic gene expression found considerably higher 
expression of the markers than shown in this study, however, again there was no 
non-differentiated control (Salingcarnboriboon et al., 2003). The study also noted 
considerable variation between cell clones from one donor, with some clones 
showing no expression of alkaline phosphatase or osterix and others positive 
expression. As with MSCs, it is clear that variation is a major factor in determining 
the phenotype of these cells. MSC gene expression was similar when comparing the 
negative and positive samples for certain genes, and increased in the positive 
samples for others (Fig.4.6), although due to having only one biological replicate, no 
statistical analysis could be performed. Previous studies have demonstrated the 
expression of osteocalcin, osteopontin and Runx2 (Baddoo et al., 2003; Baghaban 
Eslaminejad and Fallah, 2013; Eslaminejad et al., 2006; Nadri and Soleimani, 2007) 
by MSCs, and although they were more highly expressed in the positive samples, 
compared with the controls, they were not quantified. In contrast, Tropel and 
others (2004) observed smaller increases in the expression of Col1a1, osteopontin, 
osteocalcin and osteonectin between positive and negative samples in murine MSCs 
(Tropel et al., 2004), which is more consistent with this study. Consistent with their 
staining pattern, Lei and others (2004) only observed expression of osteocalcin and 
osteopontin in fusiform and polygonal MSC lines, not rounded or fibroblastic (Lei et 
al., 2013). 
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Adipogenic differentiation, as assessed by oil red O staining which stains for 
oil droplets, also showed a variable staining pattern across the different cell types. 
No staining was observed for tenocytes, however staining was present for TDSCs 
and MSCs (Fig.4.4). The positive staining seen in TDSCs is consistent with other 
published data (Alberton et al., 2014; Asai et al., 2014; Bi et al., 2007; Mienaltowski 
et al., 2013; Salingcarnboriboon et al., 2003; Zhang and Wang, 2015). However, 
there was considerable variation in the quantity of staining between the different 
studies, with large amounts of staining observed in some studies (Alberton et al., 
2014; Mienaltowski et al., 2013) and only a few droplets seen in others (Asai et al., 
2014; Bi et al., 2007; Salingcarnboriboon et al., 2003). Adipogenic differentiation of 
MSCs was observed in this study, although only a few oil droplets formed. As with 
the previous literature on osteogenic differentiation of murine MSCs, there are 
many studies demonstrating the adipogenic potential of MSCs (Baddoo et al., 2003; 
Baghaban Eslaminejad and Fallah, 2013; Eslaminejad et al., 2006; Nadri and 
Soleimani, 2007; Sun et al., 2003; Tropel et al., 2004), however there are also 
several studies highlighting the difference between and within strains. For example, 
Peister and others (2004) observed adipogenic differentiation in all strains of mice, 
excluding DBA1, which showed no differentiation at all (Peister et al., 2004). In 
addition, Peister and others (2004) demonstrated a considerable amount of oil red 
O staining for BALB/c mice (Peister et al., 2004), whereas Nadri and others (2007) 
only observed formation of a few oil droplets (Nadri and Soleimani, 2007). This 
highlights the variance both between and within strains, which is also demonstrated 
by Lei and others (2013) who found that different cell lines from the same strain 
also demonstrate distinct differentiation patterns. They found that rounded and 
polygonal cell lines differentiated into adipogenic cells, however fibroblastic and 
fusiform cells did not (Lei et al., 2013). The expression of adipogenic marker genes 
in this study was consistent with the staining pattern for TDSCs and MSCs, but not 
for tenocytes. As no staining was observed in tenocytes, I expected to see no 
expression of adipogenic marker genes, however there were increases in all three 
markers in tenocytes (Fig.4.6). Consistent with the staining pattern observed, 
significant increases in adipogenic marker genes were seen in TDSCs. Previous 
studies have shown the expression of Fabp4 and Ppar-γ by murine TDSCs (Bi et al., 
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2007; Mienaltowski et al., 2013; Salingcarnboriboon et al., 2003). In this study small 
increases were observed for all genes in murine MSCs in the positive samples when 
compared with the negative. This is consistent with the majority of the previous 
literature, which report increases in Ppar-γ (Baghaban Eslaminejad and Fallah, 2013; 
Tropel et al., 2004), although Lei and others (2013) only noted an increase for 
rounded and polygonal cells, not fibroblastic or fusiform (Lei et al., 2013). 
Due to the large number of cells required for chondrogenic differentiation 
assays and the slow growth observed for TDSCs in this study I was unable to 
perform such assays on these cells, however I did analyse chondrogenic 
differentiation of tenocytes and MSCs. There was no increase in the intensity of 
alcian blue staining for tenocytes, however there was an increase in safranin O 
staining (Fig.4.4). Previous studies investigating chondrogenic differentiation of 
murine TDSCs observed increases in both alcian blue and safranin O staining 
(Alberton et al., 2014; Asai et al., 2014; Mienaltowski et al., 2013; Zhang and Wang, 
2015). Due to the size of the negative pellets it was difficult to compare the 
intensity of staining for MSC pellets, however there appeared to be an increase in 
the intensity of safranin O staining, but not alcian blue (Fig.4.4). Previous literature 
on chondrogenic differentiation of murine MSCs differs to that for osteogenic and 
adipogenic staining, as there seems to be little or no variation between or within 
strains, with all studies reporting chondrogenic differentiation of murine MSCs 
(Baddoo et al., 2003; Baghaban Eslaminejad and Fallah, 2013; Eslaminejad et al., 
2006; Lei et al., 2013; Peister et al., 2004; Sun et al., 2003). The expression of 
chondrogenic marker genes observed in this study was consistent with the staining 
pattern, with increases seen in all chondrogenic marker genes in MSCs and in two 
genes in tenocytes (Fig.4.6), although these were not significant. Previous literature 
on TDSCs also reported expression of aggrecan and collagen type II after 
chondrogenic induction (Bi et al., 2007; Mienaltowski et al., 2013), consistent with 
this study for tenocytes. Likewise, previous data on murine MSCs demonstrates 
expression of collagen type II after induction (Baghaban Eslaminejad and Fallah, 
2013), although in some studies the increase in collagen type II and aggrecan 
expression seen between positive and negative samples was less pronounced 
(Eslaminejad et al., 2006; Tropel et al., 2004), which is more consistent with this 
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study. Despite chondrogenic staining for all cell lines, Lei and others (2013) only 
observed aggrecan and collagen type II gene expression in fusiform and polygonal 
cells, not rounded or fibroblastic (Lei et al., 2013), highlighting the variability within 
MSCs. Glycosaminoglycan (GAG) content of cell pellets after chondrogenic induction 
was also analysed in this study as an indicator of chondrogenic differentiation. 
There was a small increase in GAG content in the positive samples when compared 
with the negative for tenocytes, although this was not significant (Fig.4.5). There 
was also an increase in GAG production by MSCs after chondrogenic induction. The 
quantity of GAGs in MSC pellets was considerably higher than tenocytes for both 
positive and negative samples (Fig.4.5). No previous data is available on the ability 
of murine tendon cells or MSCs to form GAGs, however increased GAG production 
in induced cell pellets has been reported in human TDSCs (Stanco et al., 2014).  
 
4.5.6 Conclusion 
 
In this study I have isolated a population of cells in murine tendon that 
demonstrate many of the traditional hallmarks of a stem cell: the ability to form 
colonies, the expression of stem cell markers and multipotency (Dominici et al., 
2006), although chondrogenic differentiation potential is unconfirmed. My findings 
are consistent with the published literature on TDSCs. Murine MSCs were also 
analysed as a positive control, however I found reduced differentiation potential of 
these cells as well as reduced expression of stem cell markers. As described above, 
these properties may be due to variation between and within strains, which has 
been demonstrated extensively in murine MSCs, particularly the variation in 
multipotency. A study conducted by Lei and others (2013) which investigated the 
properties of different cell lines obtained from one MSC donor, found that cells with 
differing morphologies demonstrated different properties (Lei et al., 2013). The 
MSCs used in this study were similar in morphology to the fusiform “MSC3” line 
used in the Lei study, and this cell line did not demonstrate adipogenic 
differentiation. This is inconsistent with my results, as I observed adipogenic 
differentiation of murine MSCs, albeit only low levels. As a subset of MSCs, TDSCs 
have an extremely similar phenotype to MSCs and share many properties. The 
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TDSCs isolated in this study had a rounded morphology, consistent with “MSC1” in 
the Lei study, however this cell line demonstrated adipogenic differentiation, but no 
osteogenic differentiation (Lei et al., 2013). Again, this is inconsistent with my 
findings and highlights the variability within and between different strains, as well 
as individual differences. 
Many differences were observed in this study between tenocytes and TDSCs 
suggesting that these cells are distinct populations with differing properties. They 
demonstrated different cell morphologies and colony forming ability as well as 
significant differences in the expression of certain stem cell markers, and some 
differences in multipotency. TDSCs conformed to the criteria of a MSC, as specified 
by the ISCT (Dominici et al., 2006), whereas tenocytes did not. The main similarity 
between tenocytes and TDSCs was the expression of tenogenic markers, which was 
expected due to the fact that both cell populations were derived from tendon 
tissue. More unexpected were the differences observed between TDSCs and MSCs, 
however as mentioned above this may be due to strain variation, as well as the use 
of only one biological replicate for MSCs. No studies have previously compared 
murine tenocytes and TDSCs, however this has been done in other species (Zhang 
and Wang, 2010b) and the differences seen between the two cell types in rabbits 
mirrors that seen in mice in this study. A comparison of TDSCs and MSCs has 
previously been published in mice (Bi et al., 2007) and the differences in marker 
expression seen in the study are suggestive of considerable variability between 
these two cell types, which is consistent with my own findings. 
The initial aim of this study was to validate the methods and assays used in 
Chapter 3. As I observed restricted differentiation potential of equine TDSCs I 
wished to ensure that these findings were not due to technical errors or issues with 
isolating and culturing the cells. Therefore I opted to repeat the isolation 
procedures and stem cell characterisation assays in mice, a species previously well 
characterised. I was able to reproduce previous studies in mice, and noted no 
restricted differentiation potential of murine TDSCs (although I was unable to 
confirm chondrogenic differentiation potential). This indicates that the restricted 
differentiation potential of equine TDSCs is a feature of this cell population and not 
due to technical problems with the assays. As outlined in Chapter 3, the reasons for 
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the restricted differentiation potential of equine TDSCs may be due to the exercise 
and medical history of the horses. However, the restricted differentiation potential 
of these cells may provide an advantage during times of injury or degeneration. 
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Chapter 5 
 
Canine ligament-derived stem cell 
characterisation 
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5.1 Introduction 
 
Following the identification of stem cells within tendon (Salingcarnboriboon 
et al., 2003), a cell population with similar properties was also identified in ligament 
(Seo et al., 2004). Seo and others (2004) isolated ligament-derived stem cells 
(LDSCs) from periodontal ligament and many subsequent studies have also used 
periodontal ligament for investigation of LDSCs, however more recently research 
has turned to other ligament types, including the anterior cruciate ligament (ACL). 
Cell populations derived from such ligaments are most likely a subset of 
mesenchymal stromal cells (MSCs) and share many properties with these cells. For 
example anterior cruciate LDSCs (ACLDSCs) express stem cell and MSC markers 
including Oct-4, CD90, CD44, CD73 and CD105 (Steinert et al., 2011; Zhang et al., 
2011b). In addition, ACLDSCs have been shown to form colonies (Fu et al., 2015) 
and differentiate into osteogenic, adipogenic and chondrogenic cell types (Cheng et 
al., 2009; Steinert et al., 2011). These properties are all characteristics of MSCs 
(Dominici et al., 2006) however LDSCs differ in that they also express tenogenic 
markers, for example scleraxis (SCX) and tenomodulin (TNMD) (Fujii et al., 2008; 
Steinert et al., 2011). 
LDSCs hold the potential to treat ligament injury and degeneration, and 
studies to date have shown promising results. The majority of these studies have 
focussed on periodontal ligament repair (Fujii et al., 2008; Yang et al., 2009), with 
only one study investigating the use of LDSCs for repair of a non-dental ligament 
(Jiang et al., 2015). LDSCs isolated from rabbit medial collateral ligament (MCL) have 
been shown to aid repair and function of damaged MCL (Jiang et al., 2015), 
suggesting that ACLDSCs may aid ACL repair after injury or degeneration. LDSCs 
from non-dental origins have only been isolated from human (Cheng et al., 2009; 
Steinert et al., 2011), rabbit (Jiang et al., 2015) and horse (Shikh Alsook et al., 2015) 
ligaments and this study will focus on the isolation and characterisation of canine 
LDSCs from cranial cruciate ligament (CCL) which is comparable to the human ACL 
(Cook et al., 2010). No studies to date have investigated the presence of a LDSC 
population in canine CCL, however ligament injuries in dogs are well documented 
(Witsberger et al., 2008). The increase in lifespan and obesity in dogs has resulted in 
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a rise in the number of CCL injuries (Adams et al., 2011; Witsberger et al., 2008). In 
addition, certain dog breeds have been found to be genetically predisposed to CCL 
injury, including Labrador Retrievers, Newfoundlands and Staffordshire terriers 
(Baird et al., 2014a; Whitehair et al., 1993; Wilke et al., 2006; Witsberger et al., 
2008). To date, in dogs, there are no effective treatments dealing directly with the 
injured CCL in terms of regeneration and repair. The use of a canine model for 
investigating LDSCs is also translatable into humans, as the structure and function of 
the CCL is very similar to the human ACL (Cook et al., 2010), and non-contact injury 
and degeneration often occur in both ligaments in a similar manner (Cimino et al., 
2010; Comerford et al., 2011; Comerford et al., 2005; Hasegawa et al., 2013; Tang 
et al., 2009), making the dog a possible model for human LDSC research. 
 
5.2 Hypothesis 
 
I hypothesise that a native ligament progenitor cell population resides within 
canine CCL which can be differentially isolated from other ligament cell types by 
low-density plating and/or differential adhesion to fibronectin substrates. This 
progenitor cell population will demonstrate all of the hallmark properties of MSCs, 
including clonogenicity, multipotency and stem cell marker expression, however the 
cell population will differ from MSCs with the increased expression of 
ligamentogenic markers. The progenitor cell population will differ from 
ligamentocytes with the latter cell type demonstrating reduced stemness when 
compared with progenitor cell populations. 
 
5.3 Aims 
 
1. To characterise canine LDSCs and ligamentocytes isolated from the CCL; 
including analysis of stem cell and ligamentogenic marker expression, 
colony-forming ability, cell proliferation and multipotency. 
2. To compare the differences in phenotype between LDSCs and 
ligamentocytes as well as a comparison with canine MSCs as a positive 
control cell type.  
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5.4 Results 
 
5.4.1 Ligamentocyte, LDSC and MSC morphology and colony formation 
 
Ligament cells were isolated and seeded using three different methods: high 
density for isolation of ligament fibroblasts (ligamentocytes); low density for 
isolation of LDSCs (LDSC-L); and low density on fibronectin substrates also for 
isolation of LDSCs (LDSC-F). In addition, MSCs were isolated from femurs of dogs 
with osteoarthritic hip joints as a comparative cell type (Chapter 2, Section 2.2.1.3 
and 2.2.1.4). 
All ligament cell types demonstrated a similar cell morphology after 
passaging, with a typically fibroblastic appearance (Fig.5.1.A), however LDSC-F 
showed a rounded morphology upon initial plating (Fig.5.1.D) which was lost with 
passaging. MSCs exhibited a slightly more fusiform morphology, neither rounded 
nor fibroblastic. 
All cell types grew in heterogeneous colonies (Fig.5.1.A), with 
ligamentocytes, LDSC-L and MSCs forming fairly sparse colonies, whereas LDSC-F 
formed dense colonies. This is further apparent when colony numbers were 
quantified with comparatively similar numbers between all cell types (Fig.5.1.B). 
Colony size was variable between the cell types as ligamentocytes had a larger 
average colony size than LDSC-F and MSCs which was statistically significant. LDSCs 
had the next largest average colony size followed by MSCs (Fig.5.1.C).  
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Figure 5.1. Canine ligamentocyte, ligament-derived stem cell (LDSC) and mesenchymal stem cell (MSC) 
morphology and colony formation at 5% oxygen. Representative images of cell morphology and 
colony formation are shown. Cells were grown for 7 days before staining with crystal violet and 
imaging for cell morphology analysis and colony formation. White bars = 100 μm, black bars = 1 cm 
(A). Colonies were counted (B) and measured (C) using ImageQuantTL software. n=7 biological 
replicates for ligamentocytes and LDSC-F, n=3 for LDSC-L and n=6 for MSCs. Error bars shown 
represent SEM. Pairwise comparisons were performed using a one-way ANOVA with a Tukey post-hoc 
test. P-values: a=<0.0001, b=0.018. Representative images shown of LDSC-F after initial plating to 
emphasise differences in morphology. White bars = 100 μm (D). 
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5.4.2 Ligamentocyte, LDSC and MSC proliferation 
 
Population doubling times were consistent for all ligament cell types with a 
mean (±SEM) of 27 (±1.4), 29 (±0.8) and 35 (±8.3) hours per doubling for 
ligamentocytes, LDSC-F and LDSC-L respectively. MSCs had a considerably longer 
population doubling time of 96 (±13) hours. There was a statistically significant 
difference between MSCs and all ligament cell types (Fig.5.2). 
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Figure 5.2. Population doubling time for canine ligamentocytes, LDSCs and MSCs at 5% oxygen. 
n=10 biological replicates for ligamentocytes, n=5 for LDSC-F, n=3 for LDSC-L and n=4 for MSCs. 
Error bars shown represent SEM. Pairwise comparisons were performed using a one-way ANOVA 
with a Tukey post-hoc test. P-values: a=<0.0001. 
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5.4.3 Ligamentocyte, LDSC and MSC marker expression 
 
The gene expression of stem cell and tenogenic markers was assessed by 
qRT-PCR (Fig.5.3). 
Expression of the pluripotency marker Oct4 was generally low with no 
significant differences between cell types, although higher levels were recorded for 
LDSC-F and MSCs (Fig.5.3). CD markers, markers used for identification of MSCs, 
were highly expressed in all cell types. CD105 was most highly expressed in LDSC-F 
and MSCs however there were no statistically significant differences between cell 
types. There was similar expression of CD44 in all cell types, whereas there were 
statistically significant differences in CD90 expression between cell types, with 
increased expression seen in ligamentocytes and LDSC-F when compared with 
MSCs. Likewise, there were statistically significant differences in CD73 expression 
between cell types, with increased expression seen in LDSC-F when compared with 
all other cell types (Fig.5.3). Tenogenic markers were expressed at much lower 
levels than CD markers, with no statistically significant differences in expression of 
SCX and mohawk (MKX) between cell types, although SCX and MKX were both more 
highly expressed in MSCs. Tenomodulin expression was significantly increased in 
MSCs when compared with all ligament cell types (Fig.5.3). CD34 and CD45 
expression was generally low with similar levels seen in all cell types except for 
LDSC-L in which levels were decreased (Fig.5.3). 
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Figure 5.3. Gene expression analysis of stem cell markers in ligamentocytes, LDSCs and MSCs at 5% oxygen. Values are shown on a 
logarithmic scale and normalised to GAPDH. n=11 biological replicates for ligamentocytes, n=9 for LDSC-F, n=3 for LDSC-L and n=6 
for MSCs. Error bars shown represent SEM. Pairwise comparisons were conducted using a one-way ANOVA with a Tukey post-hoc 
test after Log10 transformation of data. P-values: a=0.034, b=0.001, c=0.014, d=0.011, e=0.038, f=<0.0001, g=<0.0001, h=0.004. 
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5.4.4 Ligamentocyte, LDSC and MSC tri-lineage differentiation capacity 
 
The ability of ligamentocytes, LDSCs and MSCs to differentiate into different 
cell lineages was analysed by staining, glycosaminoglycan (GAG) assays and qRT-PCR 
for gene expression analysis. 
All cell types exhibited signs of osteogenic differentiation as assessed by 
BCIP/NBT and/or alizarin red staining. LDSC-L demonstrated no alizarin red staining 
and only a small amount of BCIP/NBT staining for alkaline phosphatase, and 
ligamentocytes showed only low levels of both stain. Levels of both stains were 
considerably increased in LDSC-F and MSCs (Fig.5.4). Adipogenic differentiation, as 
assessed by oil red O staining was only observed in LDSC-F (Fig.5.4). Chondrogenic 
differentiation was varied between cell types. There was very little change in the 
intensity of alcian blue or safranin O staining for ligamentocytes, LDSC-L and MSCs. 
There was an increase in stain intensity of both stains for LDSC-F (Fig.5.4). 
There was an increase in GAG content for all ligament cell types after 
induction of chondrogenic differentiation, however these increases were not 
significant when compared with controls. There was a small decrease in GAG 
content between samples for MSCs, however again this was not statistically 
significant (Fig.5.5). 
Gene expression analysis of lineage specific genes showed an increase in 
osteogenic markers for all cell types, with statistically significant increases seen for 
Runx2 in ligamentocytes and LDSC-F and for OC and Runx2 in MSCs. There were also 
increases in adipogenic marker genes for all cell types and this was most 
pronounced in ligamentocytes and LDSC-F both of which demonstrated statistically 
significant increases in PPARγ and FABP4. There was also a significant increase in 
leptin gene expression in MSCs. There were increases in chondrogenic marker 
genes, including aggrecan and collagen type II for all ligament cell types and MSCs 
although the increases were small and not statistically significant (Fig.5.6).  
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Figure 5.4. Histological analysis of tri-lineage differentiation potential of 
ligamentocytes, LDSCs and MSCs at 5% oxygen. Representative images are 
shown for each cell type after induction of osteogenic, adipogenic and 
chondrogenic differentiation (positive) and also for control samples 
(negative), after appropriate staining. Cells subjected to osteogenic 
differentiation media were stained for both alkaline phosphatase (ALP) 
activity and calcium deposits using alizarin red (AR). Cells subjected to 
adipogenic differentiation media were stained for oil droplet formation 
using oil red O (ORO), and cell pellets exposed to chondrogenic 
differentiation media, for GAG formation using alcian blue (AB) and 
safranin O (SO). Bar = 100 μm. n=8 biological replicates for 
ligamentocytes, n=9 for LDSC-F, n=3 for LDSC-L and n=6. 
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Figure 5.5. Total glycosaminoglycan (GAG) content of cell pellets with (positive) or 
without (negative) chondrogenic induction at 5% oxygen. n=8 biological replicates 
for ligamentocytes, n=9 for LDSC-F, n=3 for LDSC-L and n=6 for MSCs. Error bars 
shown represent SEM. Pairwise comparisons were conducted using paired 
Student’s t-tests. 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
G
A
G
 c
o
n
te
n
t 
(u
g)
 
Negative
Positive
165 
 
0.001
0.01
0.1
1
OPN OC RUNX2
2
^Δ
C
T 
Negative Positive
Osteogenic Adipogenic Chondrogenic 
Li
ga
m
en
to
cy
te
s 
LD
SC
-F
 
LD
SC
-L
 
a 
0.0001
0.001
0.01
0.1
1
10
LEPTIN PPAR FABP4
2
^Δ
C
T 
Negative Positive
0.01
0.1
1
AGG SOX9 COL2
2
^Δ
C
T 
Negative Positive
c 
b 
0.001
0.01
0.1
1
OPN OC RUNX2
2
^Δ
C
T 
Negative Positive
0.0001
0.001
0.01
0.1
1
OPN OC RUNX2
2
^Δ
C
T 
Negative Positive
d 
0.001
0.01
0.1
1
10
LEPTIN PPAR FABP4
2
^Δ
C
T 
Negative Positive
e 
f 
0.00001
0.0001
0.001
0.01
0.1
1
LEPTIN PPAR FABP4
2
^Δ
C
T 
Negative Positive
0.001
0.01
0.1
1
10
AGG SOX9 COL2
2
^Δ
C
T 
Negative Positive
0.001
0.01
0.1
1
10
AGG SOX9 COL2
2
^Δ
C
T 
Negative Positive
166 
 
Osteogenic Adipogenic Chondrogenic 
M
SC
s 
0.001
0.01
0.1
1
OPN OC RUNX2
2
^Δ
C
T 
Negative Positive
h 
g 
0.0001
0.001
0.01
0.1
1
LEPTIN PPAR FABP4
2
^Δ
C
T 
Negative Positive
i 
0.0001
0.001
0.01
0.1
1
10
AGG SOX9 COL2
2
^Δ
C
T 
Negative Positive
Figure 5.6. Gene expression analysis of lineage specific markers for canine ligamentocytes, LDSCs and MSCs at 5% oxygen. Values are shown on a 
logarithmic scale and normalised to GAPDH. n=8 biological replicates for ligamentocytes, n=9 for LDSC-F, n=3 for LDSC-L and n=6 for MSCs. Error bars 
shown represent SEM. Pairwise comparisons were conducted using paired Student’s t-tests, after Log10 transformations. P-values: a=0.001, b=0.04, 
c=0.001, d=0.004, e=0.004, f=<0.0001, g=0.006, h=0.004, i=0.02. 
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5.5 Discussion 
 
5.5.1 Isolation of canine ligament cells 
 
The majority of research conducted into LDSCs has focused on periodontal 
ligament (PDL) in various species with only a few studies investigating the presence 
of stem cells within intra-articular ligaments such as the ACL. These studies have 
used a variety of methods for isolation of LDSCs including explant cultures and cell 
seeding after tissue digestion at a range of densities, the majority between 5000 – 
10,000 cells/cm2 (Cheng et al., 2010; Seo et al., 2004). LDSCs isolated from canine 
ACL tissue have not previously been reported, therefore exact isolation procedures 
were unknown. Based on my previous work on murine and equine TDSCs (see 
Chapters 3 and 4) (Williamson et al., 2015) I decided to use the same isolation 
procedures for canine LDSCs. Therefore, cells were isolated by seeding at low 
density on plastic substrate (LDSC-L) and onto fibronectin substrate for differential 
adhesion (LDSC-F) and finally at high density for isolation of ligament fibroblasts 
(ligamentocytes). Ligamentocytes were used as a comparative cell type to ensure 
the LDSC populations isolated were true stem cells and not fibroblasts 
demonstrating some stem cell properties and some distinct and significant 
differences were noted between the two cell types (Fig.5.3 and Fig.5.4). 
Mesenchymal stromal cells (MSCs) were also used as another comparative cell type, 
as LDSCs are thought to be a subset of MSCs (Huang et al., 2008; Segawa et al., 
2009) I expected to see a similar phenotype for both cell types. Due to the ease of 
material availability and collection the MSCs were isolated from dogs undergoing 
total hip arthroplasty, having presented with marked osteoarthritic (OA) joints. The 
initial aim was not to investigate the effects of disease on MSCs, however due to 
the interesting results observed, namely the restricted differentiation potential of 
these cells, I decided to investigate MSCs from healthy canine femurs also. 
Unfortunately I was unable to obtain fresh healthy MSCs due to material 
restrictions, therefore historic samples from a previous project in my group were 
used. These cells proliferated extremely slowly and some biological replicates 
ceased growth altogether. For this reason only a small number of assays were 
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performed on one or two replicates and no statistical analysis could be completed, 
limiting the usefulness of these cells as a comparative cell type. Therefore, the data 
for these cells has not been included. However this work did not suggest any 
differences between healthy MSCs and the cells isolated from arthritic joints, most 
likely due to the age of these cells and the length of time stored at -80°C. 
 
5.5.2 Clonogenic potential and morphology of canine ligament cells 
 
One of the criteria outlined by the International Society for Cellular Therapy 
(ISCT) for identification of MSCs is clonogenic potential (Dominici et al., 2006) and 
heterogeneous colony formation was observed  for all of the cell types in this study. 
LDSC-F mainly formed dense, compact colonies, whereas all of the other cell types 
formed larger and sparser colonies (Fig.5.1.A). Colony number was consistent across 
all cell types, whereas colony size was more variable with ligamentocytes forming 
the largest colonies and MSCs the smallest. There was a significant decrease in 
colony size between ligamentocytes and both LDSC-F and MSCs (Fig.5.1.B-C). My 
findings are consistent with the literature which has reported heterogeneous colony 
formation of human periodontal ligament stem cells (PDLSCs) (Hakki et al., 2014; Liu 
et al., 2014b; Prateeptongkum et al., 2015), canine PDLSCs (Lee et al., 2014b) as 
well as human ACLDSCs (Cheng et al., 2009; Zhang et al., 2011b). There are no 
studies to date that have investigated the clonogenic capacity of ligamentocytes. 
Colony formation of canine MSCs has been previously demonstrated (Rozemuller et 
al., 2010; Takemitsu et al., 2012) which agrees with my data. No differences in the 
clonogenic potential of LDSCs and MSCs was observed in this study, however 
previous studies have reported an increased clonogenic potential of human LDSCs 
when compared with MSCs (Cheng et al., 2010; Gay et al., 2007). The reason for this 
inconsistency may be due to species variation as both of the studies reporting a 
difference were conducted using human LDSCs. 
The morphology of cells isolated in this study was similar across all cell 
types. After passaging, all cell types displayed a predominantly spindle-shaped 
fibroblastic morphology with MSCs demonstrating a slightly less elongated 
morphology than the other cells (Fig.5.1.A). This is consistent with the literature 
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which has also reported a fibroblastic morphology for human PDLSCs (Eleuterio et 
al., 2013; Fujii et al., 2008; Liu et al., 2014b), canine PDLSCs (Sedigh et al., 2010) and 
human ACLDSCs (Cheng et al., 2009; Singhatanadgit et al., 2009; Zhang et al., 
2011b). In addition, previous studies have also reported a fibroblastic morphology 
of human PDL-derived ligamentocytes (Zhang et al., 2013), as well as canine MSCs 
(Csaki et al., 2007). After passaging, all cell types exhibited a fairly homogeneous 
morphology, however upon initial seeding growth of colonies composed of 
fibroblastic cells as well as colonies of rounded cobblestone-like cells for LDSC-F 
were observed in this study (Fig.5.1.D). These rounded cells disappeared with 
passaging, which may be due to changes in cell phenotype or differentiation of 
these cells into ligamentocytes. Alternatively, the fibroblastic shaped cells may have 
outgrown the rounded cells and caused a loss of this cell type. These observations 
are consistent with some previous studies which have also noted a rounded 
morphology upon initial plating and a fibroblastic morphology after passaging cells 
derived from human ACL remnants (Fu et al., 2015). In addition, other studies have 
reported heterogeneous cell morphology of equine and human ligament cells after 
passaging (Shikh Alsook et al., 2015; Singhatanadgit et al., 2009).  
 
5.5.3 Proliferation of canine ligament cells 
 
A similar population doubling time (PDT) was observed for all ligament cell 
types, with the PDT for MSCs being significantly higher (Fig.5.2). Previous studies 
have reported similar PDTs for human ACLDSCs, ranging between 40 and 58 hours 
(Cheng et al., 2010; Singhatanadgit et al., 2009; Uefuji et al., 2014). These values are 
slightly higher than those reported in this study (ranging between 27 and 35 hours 
for ligament cells), however not considerably. In contrast, another study reported a 
PDT of 120 hours for human ACLDSCs, which is approximately four to five times the 
PDT observed in this study. The same study found a significantly lower PDT for cells 
isolated from the medial collateral ligament (MCL) (Zhang et al., 2011b) indicating 
the variation between ligament types. In addition, cells isolated from equine 
suspensory ligaments demonstrated a PDT of 24 hours (Shikh Alsook et al., 2015) 
much similar to that seen in this study, possibly suggestive of variation between 
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species. Previous studies in canine MSCs have also demonstrated large PDTs (Linon 
et al., 2014) and a study comparing LDSCs and MSCs found LDSCs to proliferate 
faster than MSCs (Gay et al., 2007) which is consistent with my work. 
 
5.5.4 Stem cell and tenogenic marker expression of canine ligament cells 
 
Another criterion for the identification of MSCs, as outlined by the ISCT 
(Dominici et al., 2006) is the expression of certain stem cell markers. Normally this 
would be assessed using antibodies and flow cytometry, however I was unable to 
analyse marker expression using this method and therefore analysed gene 
expression of stem cell and tenogenic markers instead. The reason for this is due to 
the limited availability of canine antibodies and the lack of validation for those 
antibodies that are available. Rozemuller and others (2010) analysed 43 antibodies 
against MSC markers for cross-reactivity across a variety of species, including dogs 
(Rozemuller et al., 2010). Only a very small number of antibodies demonstrated any 
reactivity with canine MSCs and those that did were extremely weak. This indicates 
that most antibodies raised against MSC markers in humans or other species are 
not compatible for use in dogs and therefore any antibodies required for canine 
work need to be specifically designed. Unfortunately very few of these antibodies 
are currently available. 
In this study no distinct patterns in marker gene expression were observed, 
however generally LDSC-F and MSCs demonstrated the highest expression of stem 
cell markers and MSCs the highest expression of tenogenic markers. However 
expression of tenogenic markers was generally low for all cell types when compared 
with stem cell marker expression. Oct4 expression was generally low across all cell 
types with the highest levels seen in LDSC-F and MSCs (Fig.5.3). This is consistent 
with the literature which has demonstrated low level expression of Oct4 in human 
ACLDSCs (Zhang et al., 2011b). My results are also consistent with reports that Oct4 
expression is restricted to embryonic stem cells only and not somatic cells (Lengner 
et al., 2008), which would explain the low expression seen here. The CD markers 
were expressed in higher levels than Oct4 and were generally more highly 
expressed in LDSC-F. CD105 was expressed highly in LDSC-F and MSCs (Fig.5.3) 
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which is consistent with the literature which has demonstrated expression of CD105 
in human PDLSCs (Eleuterio et al., 2013; Hakki et al., 2014; Liu et al., 2014b), canine 
PDLSCs (Wang et al., 2012), human ACLDSCs (Cheng et al., 2009; Steinert et al., 
2011) equine suspensory ligaments (Shikh Alsook et al., 2015) and canine MSCs 
(Csaki et al., 2007). CD44 expression was similar between all cell types (Fig.5.3) and 
has previously been reported in human PDLSCs (Eleuterio et al., 2013; 
Prateeptongkum et al., 2015), canine PDLSCs (Lee et al., 2014b), human ACLDSCs 
(Cheng et al., 2009; Singhatanadgit et al., 2009; Zhang et al., 2011b), human 
ligamentocytes (Kowalski et al., 2015) and canine MSCs (Linon et al., 2014; 
Takemitsu et al., 2012). In this study, CD90 expression was more variable between 
cell types with significant differences seen between MSCs and both LDSC-F and 
ligamentocytes with LDSC-F showing the highest expression and MSCs the lowest 
(Fig.5.3). CD90 expression has previously been reported in human PDLSCs (Eleuterio 
et al., 2013; Hakki et al., 2014; Liu et al., 2014b), canine PDLSCs (Lee et al., 2014b), 
human ACLDSCs (Cheng et al., 2009; Steinert et al., 2011; Zhang et al., 2011b), 
equine suspensory ligaments (Shikh Alsook et al., 2015) and canine MSCs (Csaki et 
al., 2007). Similarly to CD90, CD73 expression was also variable between cell types 
with increased levels seen in LDSC-F, which were significant when compared with all 
other cell types (Fig.5.3). CD73 expression has previously been demonstrated in 
human PDLSCs (Eleuterio et al., 2013; Hakki et al., 2014), human ACLDSCs (Cheng et 
al., 2009; Steinert et al., 2011) and human MSCs from OA joints (Stiehler et al., 
2016). Tenogenic markers that may be involved in ligament development and 
expressed by LDSCs and/or ligamentocytes (Brandau et al., 2001; Nakahara et al., 
2013; Seo et al., 2004) were also analysed. All of the markers analysed were more 
highly expressed in MSCs when compared with ligament-derived cells. Similar levels 
were seen between ligament cell types with a decrease observed in LDSC-L for 
some of the markers. Expression levels of all three tenogenic markers were low, 
compared with CD markers (Fig.5.3). SCX expression has been previously reported 
in human PDLSCs (Fujii et al., 2008; Seo et al., 2004; Zhang et al., 2015) and canine 
PDLSCs (Wang et al., 2012). No studies have reported SCX expression in canine 
MSCs however expression has been demonstrated in MSCs isolated from rats (Dai 
et al., 2015). The expression of MKX has not previously been demonstrated in LDSCs 
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of any species or canine MSCs, however expression has been observed in rat and 
human MSCs (Dai et al., 2015; Otabe et al., 2015). SCX and MKX are transcription 
factors expressed by tendon and ligament cells during development as well as in 
mature tendon for SCX (Liu et al., 2010; Mendias et al., 2012; Nakahara et al., 2013; 
Schweitzer et al., 2001). Therefore, I expected to see increased levels in LDSCs 
compared with ligamentocytes however the differences were small and not 
statistically significant (Fig.5.3). I also expected to observe lower levels of expression 
in MSCs as these cells are not committed to the tenogenic/ligamentogenic lineage 
and therefore would not express tenogenic markers. This is in agreement with 
previous studies on tendon which have reported a reduction in SCX expression in 
MSCs when compared with tendon tissue (Burk et al., 2014). In contrast, increased 
expression of tenogenic markers was observed in MSCs when compared with 
ligament cells in this study. This may be due to the fact that the MSCs in this study 
were isolated from OA joints, as other cell types isolated from tissues present in OA 
joints have shown an increase in SCX expression when compared with cells from 
healthy joints (Hasegawa et al., 2013). TNMD expression was significantly increased 
in MSCs compared with all ligament cell types (Fig.5.3). TNMD expression has been 
demonstrated in human ACLDSCs and MSCs (Steinert et al., 2011), where TNMD 
levels were increased in MSCs compared with LDSCs, consistent with this study. 
CD34 and CD45 are haematopoietic and endothelial cell markers and negative 
expression is essential to confirm that there are no contaminating cell types. 
Expression was low in all cell types but particularly for LDSC-L (Fig.5.3). This is 
consistent with the literature which has reported low expression of CD34 and CD45 
in LDSCs (Liu et al., 2014b; Singhatanadgit et al., 2009) and canine MSCs (Csaki et 
al., 2007). 
In this study increased expression of stem cell markers was observed in 
LDSC-F and MSCs when compared with ligamentocytes, as expected. However I did 
not expect to see increased expression of tenogenic markers in MSCs when 
compared with ligament cells, although the literature has reported increased 
expression of some tenogenic markers in MSCs when compared with LDSCs 
(Steinert et al., 2011) which is consistent with this study. This may be due to the fact 
that MSCs are able to differentiate into ligamentocytes and therefore would require 
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the ability to express tendon/ligament developmental genes. Similar expression of 
tenogenic markers between the different ligament cell types was observed in this 
study as expected (Fig.5.3).  
 
5.5.5 Multipotency of canine ligament cells 
 
The final criterion for the identification of MSCs is the ability to differentiate 
into different cell lineages, specifically osteogenic, adipogenic and chondrogenic 
lineages (Dominici et al., 2006). Osteogenic differentiation was assessed by staining 
for alkaline phosphatase (ALP) activity using BCIP/NBT and calcium formation using 
alizarin red (AR) (Fig.5.4) as well as expression of osteogenic markers (Fig.5.6). 
Moderate amounts of ALP staining were observed for ligamentocytes and LDSC-L 
and increased amounts for LDSC-F and MSCs. Similarly, for AR staining I observed 
small amounts of staining for ligamentocytes, no staining for LDSC-L and increased 
levels for LDSC-F and MSCs. This is consistent with the literature which has shown 
ALP and AR positive staining in human PDLSCs (Eleuterio et al., 2013; Gay et al., 
2007; Seo et al., 2004), canine PDLSCs (Lee et al., 2014b), human ACLDSCs (Cheng et 
al., 2009; Steinert et al., 2011) and human ligamentocytes, although reduced 
amounts of staining were observed when compared with LDSCs (Kowalski et al., 
2015). Osteogenic marker gene expression was consistent with the staining 
described above with an increase in osteopontin (OPN), osteocalcin (OC) and Runx2 
observed in all cell types, however larger increases were seen for MSCs and LDSC-F. 
Again this is consistent with the current literature with increases in OPN, OC and 
Runx2 observed in human ACLDSCs (Cheng et al., 2009; Zhang et al., 2011b), PDLSCs 
and ligamentocytes (Fujii et al., 2008). The expression of Runx2 reported in one 
study in ALCDSCs was considerably lower than the level reported in this study (Fu et 
al., 2015), however this may be due to the reduced differentiation period of two 
weeks used by Fu et al (2015) compared to the three weeks used in this study. No 
studies to date have analysed the expression of these markers in canine MSCs, 
however expression has been reported in other species such as humans and mice 
(Stiehler et al., 2016; Tropel et al., 2004). Similar expression levels between LDSC-F 
and MSCs were observed in this study, which is inconsistent with the literature, 
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which has demonstrated increased osteogenic marker expression in human MSCs 
when compared with ACLDSCs (Cheng et al., 2010; Singhatanadgit et al., 2009; 
Steinert et al., 2011). 
Adipogenic differentiation was assessed by the staining of oil droplets using 
oil red O (ORO) (Fig.5.4), as well as analysis of adipogenic marker expression 
(Fig.5.6). Adipogenic differentiation was only observed for LDSC-F and not in any 
other cell type analysed. Although this was the result I expected for ligamentocytes 
and LDSC-F, it was unexpected for MSCs. ORO staining has previously been reported 
in human PDLSCs (Fujii et al., 2008; Liu et al., 2014b; Seo et al., 2004), canine 
PDLSCs (Lee et al., 2014b; Wang et al., 2012) and human ACLDSCs (Cheng et al., 
2010; Steinert et al., 2011; Zhang et al., 2011b), consistent with this study. ORO 
staining has also been reported in human ACL-derived ligamentocytes (Kowalski et 
al., 2015) whereas I observed no staining in canine ligamentocytes. This may reflect 
differences between species or possible contamination of ligamentocyte 
populations with progenitor cells. As discussed previously no ORO staining for 
canine MSCs was seen in this study which was unexpected as the adipogenic 
potential of MSCs is well documented in many species, including dogs (Takemitsu et 
al., 2012). Several studies have directly compared the differentiation potential of 
human MSCs and ACLDSCs with some studies finding no differences in the 
adipogenic potential of the two cells types (Cheng et al., 2010; Steinert et al., 2011) 
and with some finding an increase in adipogenic potential in MSCs when compared 
to ACLDSCs (Singhatanadgit et al., 2009). The results of these studies are 
inconsistent with my findings and as previously discussed this may be due to the 
source of the MSCs for this study which were from femurs of dogs with 
osteoarthritic hip joints. To my knowledge no studies have investigated the effects 
of OA on MSC characteristics in dogs, however such studies have been conducted in 
humans. Two studies found that ORO staining decreased in bone marrow MSCs 
derived from OA joints compared with those derived from healthy controls (Murphy 
et al., 2002; Stiehler et al., 2016). This is consistent with my data and may indicate 
that the lack of adipogenic differentiation seen in canine MSCs is due to the effects 
of OA on the joint environment and the native cells. This may be due to changes in 
the composition and structure of the ECM, or alterations in growth factors and 
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cytokines, as well as oxidative stress, all of which are associated with OA (Loeser, 
2009). Adipogenic marker gene expression was partially consistent with the pattern 
of ORO staining. There was an increase in all three markers for all cell types, despite 
the lack of ORO staining in all but LDSC-F, however the highest levels and largest 
increases between positive and negative samples were seen in LDSC-F. This is 
consistent with the literature which has shown expression of PPARγ in human 
PDLSCs (Fujii et al., 2008; Liu et al., 2014b; Seo et al., 2004) and canine MSCs (Csaki 
et al., 2007). FABP4 and PPARγ expression has also been demonstrated in human 
ACLDSCs (Cheng et al., 2010; Zhang et al., 2011b). I observed reduced expression of 
PPARγ in MSCs when compared with LDSC-F, however the literature reports the 
opposite with increased levels seen in human MSCs compared with ACLDSCs 
(Singhatanadgit et al., 2009). This may be due to the fact that I used MSCs from 
canine OA joints which demonstrated a reduction in adipogenic differentiation, as 
discussed previously. The expression of adipogenic marker genes in ligamentocytes, 
LDSC-L and MSCs does not correlate with the lack of ORO staining observed, 
however this may be due to discrepancies in gene and protein expression and 
RNA/protein degradation.  
Chondrogenic differentiation was assessed by staining for proteoglycan 
deposition using alcian blue (AB) and safranin O (SO) (Fig.5.4), analysis of 
glycosaminoglycan (GAG) content (Fig.5.5) and chondrogenic marker genes 
(Fig.5.6). For ligamentocytes, LDSC-L and MSCs there were small increases in stain 
intensity indicative of limited chondrogenic differentiation potential. There were 
larger increases seen in stain intensity for LDSC-F suggestive of a greater 
chondrogenic differentiation potential than the other cell types. This is consistent 
with previous studies that have reported SO staining in human PDLSCs (Zhou et al., 
2014) and AB and SO staining in human ACLDSCs (Cheng et al., 2009; Kowalski et al., 
2015; Uefuji et al., 2014). Chondrogenic staining has also been demonstrated for 
ligamentocytes derived from human ACL (Kowalski et al., 2015) as well as canine 
MSCs (Csaki et al., 2007). Analysis of GAG content of cell pellets after chondrogenic 
induction in different cell types showed increases in GAG content in all ligament cell 
types, however due to large variation between biological replicates these 
differences were not significant. A decrease in GAG content was observed in the 
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positive samples compared with the negative samples for MSCs which was 
unexpected. Several studies have analysed the formation of GAGs after 
chondrogenic differentiation in human ligament cells and MSCs. One study 
observed similar levels of GAG formation in human ACLDSCs and ligamentocytes 
(Kowalski et al., 2015), as reported in this study. Another study reported GAG 
formation in ACLDSCs and MSCs with increased levels produced by MSCs (Steinert 
et al., 2011), inconsistent with my data. The reason for this is most likely due to the 
OA source of the MSCs used in this study. A previous study using human MSCs 
found a decrease in GAG formation in MSCs from OA joints compared with healthy 
controls (Murphy et al., 2002) which correlates with my findings. Gene expression 
of chondrogenic markers was weak for all cell types, with little difference observed 
between positive and negative samples. This is inconsistent with the literature, 
which has generally demonstrated greater induction of chondrogenic markers than 
reported in this study. Collagen type II (COL2) and SOX9 expression has been 
reported in human PDLSCs (Gay et al., 2007; Zhou et al., 2014) and COL2, SOX9 and 
aggrecan (AGG) expression in human ACLDSCs (Cheng et al., 2010; Cheng et al., 
2009; Steinert et al., 2011; Zhang et al., 2011b). Although some studies have also 
reported lower expression of chondrogenic markers in human ACLDSCs with 
reduced expression levels of AGG, SOX9 and COL2 (Fu et al., 2015; Singhatanadgit et 
al., 2009) as demonstrated by my data. I observed the same expression levels 
between positive and negative samples for canine MSCs. This is inconsistent with 
the previous literature which has demonstrated COL2 and SOX9 expression in 
canine MSCs (Csaki et al., 2007), however as mentioned previously this is most likely 
due to the OA source of MSCs in this study. One study observed only moderate 
staining of chondrogenic pellets for COL2 in MSCs from OA joints (Murphy et al., 
2002)  which may explain the lack of chondrogenic marker expression in this study. 
 
5.5.6 Conclusion 
 
I have successfully isolated a population of cells from canine cranial cruciate 
ligament (CCL) which demonstrate many of the hallmark properties of stem cells 
(Dominici et al., 2006). They are able to form colonies, express a variety of stem cell 
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markers, as well as possessing the ability to differentiate into osteogenic, 
adipogenic and chondrogenic cell types. To date no other studies have isolated such 
cells from canine CCL, however LDSCs have been isolated from human ACL, and 
these cells demonstrate the same properties as the cells isolated in this study 
(Cheng et al., 2010; Steinert et al., 2011; Zhang et al., 2011b).  
The LDSCs I have characterised were isolated by differential adhesion to 
fibronectin substrates. Although no previous studies on LDSCs have used this 
method for cell isolation it has been used previously for isolation of cartilage stem 
cells from bovine articular cartilage (Dowthwaite et al., 2004), as well as human 
endothelial progenitor cells (Bueno-Betí et al., 2013), indicating the potential use of 
this method for isolation of a range of progenitor cells. I also used this method for 
the isolation of equine tendon-derived stem cells (TDSCs) (see Chapter 3) alongside 
the more traditional low-density plating method. I initially attempted isolation of 
LDSCs using the low-density plating method as this method has been successfully 
employed to isolate TDSCs in a number of studies and I have also used this method 
to successfully isolate murine TDSCs. Unfortunately this method did not yield 
ligament cells with the desired phenotype, demonstrating reduced stem cell and 
tenogenic marker expression and a restricted differentiation potential. Even though 
this method has been successfully employed to isolate stem cells from tendon 
tissue in a number of species (Bi et al., 2007) and despite the similarities between 
tendon and ligament, it might not be an appropriate method for isolation of LDSCs. 
This may be due to species or tissue differences (Kharaz et al., 2016) or the cellular 
environment. Previous studies that have isolated LDSCs have used higher seeding 
densities than those used in this study and this may be due to the variation in 
phenotype seen at lower densities, which have been observed here. Due to the 
restricted phenotype of cells isolated by low-density plating, cells were also seeded 
at slightly higher densities on to fibronectin substrates to promote differential 
adhesion. This method was more successful and I was able to isolate a population of 
cells with stem cell properties, as previously described. Ligamentocytes (ligament 
fibroblasts) were also isolated as a comparative cell type. There are few studies that 
have investigated the stem cell properties of ligamentocytes or compared these 
cells with LDSCs, however I noted a number of differences between ligamentocytes 
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and LDSC-F. Namely, differences in colony formation, stem cell marker expression 
and multipotency. Conversely very few differences were seen between 
ligamentocytes and LDSC-L suggesting that LDSC-L are not stem cells. This is 
concurrent with the literature which has demonstrated similar characteristics 
between human ligamentocytes and LDSC-L (Fujii et al., 2008). The MSCs isolated in 
this study did not demonstrate the expected characteristics as demonstrated in 
previous studies for canine MSCs (Csaki et al., 2007; Takemitsu et al., 2012). The 
main difference being the restricted differentiation potential with a lack of 
adipogenic differentiation seen in MSCs isolated in this study. I also observed 
several differences between MSCs and LDSC-F. As LDSCs are a subset of MSCs I 
expected to see many similarities between these cell types, however I observed 
differences in colony formation, cell proliferation, stem cell and tenogenic marker 
expression and multipotency. A small number of studies have directly compared the 
characteristics of human LDSCs and MSCs and generally observed similar 
characteristics between cell types with MSCs demonstrating reduced colony 
formation but increased multipotency when compared with LDSCs (Cheng et al., 
2010; Gay et al., 2007). As described previously, the differences seen here are most 
likely due to the source of the MSCs used in this study which were from femurs of 
dogs with osteoarthritic hip joints. The effects of OA on cells within the joint is well-
documented with MSCs showing changes in stem cell marker expression as well as 
reduced multipotency (Chua et al., 2014; Grogan et al., 2009; Murphy et al., 2002), 
as seen here. 
The cell population I have isolated from canine CCL could hold therapeutic 
potential for the treatment of ligament injuries. Many studies have investigated the 
use of PDLSCs for repair of periodontal ligament with many successful outcomes 
(Fujii et al., 2008; Liu et al., 2008; Yang et al., 2009), however no studies have yet 
investigated the use of ACLDSCs to repair ACL injuries. One study has assessed the 
ability of LDSCs isolated from rabbit medial collateral ligament (MCL) to promote 
ligament repair (Jiang et al., 2015). The study found that LDSCs promoted ligament 
repair and remodelling (Jiang et al., 2015) and highlights the potential use of LDSCs 
for the repair of injured and degenerated ligament. The cells isolated in this study 
could potentially be used in a similar manner. The majority of animal tissue 
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engineering studies using stem cells involve extracting the cells from the tissue of 
euthanized animals, culturing them, seeding them on to scaffolds or matrices 
before implanting them into induced injury sites of other animals (Chen et al., 2014; 
Jiang et al., 2015; Lui et al., 2014; Xu et al., 2014). This technique is useful and 
provides an insight into the repair potential of certain cell types for particular 
injuries, however this approach is not translatable in a clinical setting. Clinically this 
is not a feasible approach as it would involve surgery to extract LDSCs and culture of 
these cells over an uncertain time period, before further surgery to re-implant the 
cells. For this reason MSCs are commonly used to treat tendon and ligament injuries 
as they are easier to extract from bone marrow and adipose tissue and many 
studies have demonstrated successful tissue repair with such cells (Carvalho et al., 
2013; Conze et al., 2014; Linon et al., 2014; Smith et al., 2013). These studies 
injected the MSCs into the lesion, which avoided invasive surgical procedures and 
could provide a potential route for the administration of LDSCs into injury sites. 
Regardless of the success of using MSCs for tendon and ligament repair, several 
studies have shown the inferiority of such cells when compared with native cells 
isolated from the tissue of interest (Huang et al., 2008; Pietschmann et al., 2013; 
Tan et al., 2012b). Therefore, the use of LDSCs for ligament repair would be 
preferable over MSCs. The use of allogeneic LDSCs, and injection of these cells into 
the lesion could provide a potential treatment strategy for ligament injuries in 
animals and humans, however there are many issues associated with the use of 
allogeneic cells, for example the requirement for immunosuppression (Lane et al., 
2014). 
 Alternatively, a less invasive and high-risk method could be 
employed which would involve knowledge of the extracellular environment of 
LDSCs. If the extracellular environment of the LDSCs, or stem cell niche, could be 
characterised and factors which promote stem cell viability and beneficial 
differentiation identified, then those factors could form the basis of a treatment 
strategy. These factors could be introduced artificially to the lesion where they 
would promote native stem cell proliferation and viability as well as differentiation 
into ligamentocytes and ECM production. This approach has been used successfully 
to modulate the niche of various stem cell types in order to treat a range of 
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conditions (Cianfarani et al., 2006; Olnes et al., 2012). Therefore analysis of the 
LDSC niche and the factors that promote LDSC viability will form the basis of future 
work in this area. In addition, future work would include further analysis of LDSC-F 
populations, with particular emphasis on the differences in phenotype of the 
different cell morphologies seen upon initial plating compared with later passages. 
Identification of markers specific to LDSCs would also be beneficial for LDSC 
characterisation and analysis, as well as for clinical implementation of this research. 
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Chapter 6 
 
Proteomic analysis of the canine ligament-
derived stem cell niche 
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6.1 Introduction 
 
The stem cell niche is the environment in which stem cells reside and 
consists of a number of different cellular and molecular factors (Lane et al., 2014). 
One example is the protein composition of the extracellular matrix (ECM) which 
has been shown to be integral for stem cell survival and function in a number of 
different cell populations. For example, neural stem cells are regulated by a 
number of factors including the ECM protein tenascin C (Garcion et al., 2004; 
Garwood et al., 2004). Tenascin C is highly expressed in the mammalian central 
nervous system and tenascin C-deficient mice have altered numbers of neural 
stem cells (Garcion et al., 2004) as well as increased migration and reduced 
proliferation of neural precursors (Garcion et al., 2001). The lack of tenascin C 
expression by neural stem cells also promotes early differentiation (Garwood et 
al., 2004). The haematopoietic stem cell (HSC) niche is also regulated by ECM 
composition. Fibronectin and collagen have both been found to regulate HSCs 
(Yokota et al., 1998). Fibronectin and laminin promoted growth and colony 
formation of HSCs (Sagar et al., 2006; Yokota et al., 1998) whereas collagen type I 
caused a decrease in HSC expansion unless present in combination with other 
ECM proteins (Çelebi et al., 2011), indicating the importance of ECM protein 
interactions in stem cell regulation. Tendon-derived stem cells (TDSCs) are also 
regulated by the ECM, with the genetic inactivation of fibromodulin and biglycan 
causing increased clonogenicity and proliferation, but a decrease in the ability of 
TDSCs to differentiate into tenocytes, with decreased expression of tendon 
markers such as scleraxis and collagen. Erroneous differentiation of TDSCs was 
promoted with both ossification and chondrogenesis being observed (Bi et al., 
2007). The role of ECM proteins in stem cell regulation in these tissues, 
particularly tendon, is suggestive of the importance of the LDSC niche in LDSC 
regulation. 
The study of the entire complement of proteins produced by a cell or 
tissue, otherwise known as the proteome, is known as proteomics (Wilkins et al., 
1996). This technique is now widely used to investigate the proteomes of many 
tissue types, including musculoskeletal tissues such as cartilage, tendon and 
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ligament (Kharaz et al., 2016; Little et al., 2014; Peffers et al., 2014a; Peffers et al., 
2014b; Wilson et al., 2010). Proteomics is able to identify proteins present, as well 
as protein interactions, modifications and structure (de Hoog and Mann, 2004). 
Mass spectrometry (MS) is a commonly utilised method for proteomic 
analysis and this technique firstly involves digestion and separation of the proteins 
to aid analysis. Digestion is normally achieved using a protease such as trypsin to 
produce peptides with specific molecular weights, defined by the peptide 
sequence. Peptide separation can be achieved using gel electrophoresis, or for 
high throughput experiments, liquid chromatography (LC) can be used (de Hoog 
and Mann, 2004). Proteins were digested using trypsin and separated using LC in 
this study due to the complexity of the protein sample. Mass spectrometry 
involves three parts: ion source, mass analyser and detector (Aebersold and 
Mann, 2003). Peptides are ionised using either electrospray ionisation (ESI) or 
matrix-assisted laser desorption/ionisation (MALDI) (Aebersold and Mann, 2003). 
ESI is preferred for complex samples and is easily coupled to LC, therefore this 
method was used for this study. After ionisation peptides of a particular mass are 
passed through to a mass analyser for fragmentation. There are four main types of 
mass analyser: ion trap, quadrupole, time-of-flight (TOF) and Fourier transform ion 
cyclotron (FT-MS) (Aebersold and Mann, 2003). Each mass analyser is designed for 
a particular purpose and has advantages and disadvantages, therefore it is 
common to use multiple mass analysers in tandem. This study utilised tandem MS 
using quadrupole and ion trap mass analysers. Peptides are then fragmented by 
either collision induced dissociation (CID) or higher energy collisional dissociation 
(HCD) in the second mass analyser (Aebersold and Mann, 2003). Finally, the 
detector allows visualisation of mass spectra for further analysis (de Hoog and 
Mann, 2004). 
Protein identification is achieved by converting the raw MS spectra into 
lists of peptides and proteins using software such as PEAKS or MASCOT and then 
comparing the profile of peptides produced from the sample in question with 
species-specific theoretical peptide library databases such as UniProt or RefSeq 
(Matthiesen and Jensen, 2008). Proteins can then be quantified using either 
absolute or relative quantitation. Relative quantitation has been used in this study 
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with two sample groups being compared. There is also a choice of whether to use 
label-free or label-based methods, with both techniques providing certain 
advantages and disadvantages. In this study I have used a stable heavy isotope 
metabolic labelling method based on the ‘stable isotope labelling with amino acids 
in cell culture’ (SILAC) technique. Label-based proteomic analysis provides 
increased quantitative accuracy when compared with label-free methods 
(Bantscheff et al., 2007; Chen et al., 2015d; Collier et al., 2010; Liu et al., 2013; 
Merl et al., 2012). In addition, metabolic labelling methods enable analysis of 
protein synthesis and turnover (Doherty et al., 2009; Doherty et al., 2005; 
Schwanhäusser et al., 2009). Proteomic analysis of a cell or tissue provides only a 
snapshot of that cell or tissue’s proteome at a single point in time. The proteome 
is constantly changing as proteins are synthesised and degraded reflecting the 
developmental, physiological and pathological status of the cell or tissue (Claydon 
and Beynon, 2012; Pratt et al., 2002). Therefore, the investigation of proteome 
dynamics is integral in order to fully understand the function and role of proteins 
within their environment.  
 
6.2 Hypothesis 
 
I hypothesise that LDSCs isolated from canine cranial cruciate ligament (CCL) 
reside within a specific niche within ligament tissue and this is reflected in the 
specific ECM composition of the LDSC environment and which differs to the 
ligamentocyte environment. There will be differences in the rate of synthesis and 
turnover of specific ECM components, with increased synthesis and turnover of 
non-collagenous proteins compared with collagenous proteins. There will also be 
differences in protein synthesis and turnover rates between LDSCs and 
ligamentocytes. 
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6.3 Aims 
 
1. To characterise the LDSC niche in canine CCL in terms of ECM composition 
and compare the extracellular environments of LDSCs and ligamentocytes. 
2. To investigate the rate of protein synthesis and degradation of ECM 
components in the LDSC and ligamentocyte niche. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
186 
 
6.4 Results 
 
6.4.1 Optimisation of cellular and extracellular matrix extraction methods 
 
Three different cellular extraction methods were tested (see Chapter 2, 
Section 2.2.3.3): EDTA, trypsin and detergent for their ability to remove cells and 
leave the ECM intact. Cells were subjected to each extraction method and light 
microscopy was used to detect any remaining cellular matter. EDTA was unable to 
remove cells (Fig.6.1.A) and therefore was not included in further experiments. 
Trypsin removed the majority of cells with a few remaining (Fig.6.1.B) whereas 
detergent appeared to remove all cells leaving behind possible ECM remnants 
(Fig.6.1.C). 
Next, the quantity and complement of ECM proteins extracted using a urea 
extraction buffer and a sample buffer in combination with the cellular extraction 
methods previously discussed were analysed, as well as the ability of canine 
ligament cells to incorporate heavy labelled amino acid isotopes during protein 
synthesis (Fig.6.2). The use of trypsin to remove cells resulted in an increased 
number of ECM proteins identified when compared with detergent for which there 
was little protein present (Fig.6.2.A). There was also increased incorporation of 14C-
labelled amino acids in the trypsin samples compared with the detergent (Fig.6.2.B), 
most likely due to the increased number and quantity of proteins in the trypsin 
samples. The urea extraction buffer yielded fewer proteins than the sample buffer 
(Fig.6.2.A), however incorporation of 14C-labelled amino acids appeared to be 
similar between extraction buffers (Fig.6.2.B). Due to the potential incompatibility 
of the sample buffer with downstream processing the urea extraction buffer was 
used for subsequent ECM extractions and trypsin for cellular removal. 
Validation of this method using mass spectrometry was then performed, 
however only 135 protein hits were recorded, therefore another extraction 
technique was tested using Rapigest. After removal of cells with trypsin ECM 
proteins were extracted using a Rapigest buffer which yielded 603 protein hits (data 
not shown). 
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A C B 
Figure 6.1. Comparison of cellular extraction methods. LDSCs grown in monolayer were subjected to 
varying cellular extraction methods for ECM denuding: EDTA (A); trypsin (B); and detergent (C). Scale bars 
= 100 µm. 
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1      2       3      4       5       6      7      8 1       2      3      4       5      6      7      8 
Figure 6.2. Comparison of extracellular matrix and cellular extraction methods. LDSCs 
grown in monolayer were labelled with either [14C]L-proline (pro) for labelling of 
collagenous proteins, or [14C]L-lysine (lys) and [14C]L-arginine (arg) for labelling of non-
collagenous proteins. Cells were then subjected to varying cellular/ECM extraction 
method combinations: 1 – Pro – trypsin/urea buffer; 2 – Lys/arg – trypsin/urea buffer; 
3 – Pro – trypsin/sample buffer; 4 – Lys/arg – trypsin/sample buffer; 5 – Pro – 
detergent/urea buffer; 6 – Lys/arg – detergent/urea buffer; 7 – Pro – 
detergent/sample buffer; 8 – Lys/arg – detergent/sample buffer. ECM protein extracts 
were then separated by electrophoresis and stained with GelCode (A). The gels were 
then dried and analysed using a phosphorimager to detect incorporation of 14C-
labelled amino acids into ECM proteins (B). 
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6.4.2 Optimisation of heavy lysine labelling for proteomic analysis 
 
After determining that heavy labelled amino acid isotopes could be 
incorporated into canine ligament cells I next determined that such incorporation 
could be detected by mass spectrometry. Using the urea extraction buffer method 
[13C]L-lysine labelling was only observed for cellular proteins and incorporation was 
low (Fig.6.3.A). However, after changing to the Rapigest extraction method and 
increasing initial cell numbers incorporation of [13C]L-lysine into ECM proteins as 
well as cellular proteins was observed (Fig.6.3.B). 
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Figure 6.3. Extracted ion chromatograms of representative proteins from 13C-lysine labelled canine ligament cell 
ECM extracts demonstrating label incorporation. L = light isoform, H = heavy isoform. H/(L+H) = proportion of 
peptide labelled with heavy isoform. 
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6.4.3 Identification and label-free quantification of ECM proteins in the LDSC 
and ligamentocyte niche 
 
ECM samples extracted from LDSC and ligamentocyte cultures using a 
Rapigest extraction buffer were analysed using LC-MS/MS (see Chapter 2, Section 
2.2.3.7). 
A total of 83 extracellular matrix related proteins were identified by PEAKS 
software (Zhang et al., 2012) and the Matrisome Project database (Naba et al., 
2016) as being produced by ligament cells (both LDSCs and ligamentocytes). The list 
of proteins is provided in Table 6.1 and the proportion of proteins belonging to each 
ECM category is shown in Figure 6.4. The Matrisome Project categorises proteins 
into ECM collagens (10 proteins), ECM proteoglycans (6 proteins), ECM 
glycoproteins (17 proteins), ECM affiliated proteins (14 proteins), ECM regulators 
(29 proteins) and secreted factors (7 proteins). A STRING protein interaction map 
shows strong interactions between collagens with weaker clusters forming for some 
regulatory proteins and glycoproteins (Fig.6.5). 
A comparison between ECM proteins produced by LDSCs and 
ligamentocytes identified only small differences with 8 proteins unique to LDSCs 
and 8 proteins unique to ligamentocytes (Fig.6.6). Those were predominately 
glycoproteins and regulatory proteins unique to ligamentocytes and collagens and 
proteoglycans unique to LDSCs (Table 6.2).  
Label-free quantitative analysis was performed using PEAKS software and 
the Matrisome Project database to determine differential abundance of ECM 
proteins between LDSCs and ligamentocytes, however there were no differentially 
abundant ECM proteins between the two cell types. 
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ECM collagens Collagen type I, alpha 1 
Collagen type I, alpha 2 
Collagen type II, alpha 1 
Collagen type III, alpha 1 
Collagen type V, alpha 1 
Collagen type V, alpha 2 
Collagen type VI, alpha 1 
Collagen type VI, alpha 2 
Collagen type VI, alpha 3 
Collagen type XII, alpha 1 
ECM proteoglycans Biglycan 
Decorin 
Lumican 
Mimecan 
Proteoglycan 4 
Versican 
ECM glycoproteins EGF-like repeats and discoidin I-like domains 3 
Elastin 
Elastin microfibril interfacer 1 
Fibulin 1 
Fibrinogen alpha chain 
Fibrinogen beta chain 
Fibrinogen gamma chain 
Fibronectin 
Latent transforming growth factor beta binding protein 2 
Milk fat globule-EGF factor 8 protein 
Periostin 
Transforming growth factor beta I 
Thrombospondin 1 
Thrombospondin 4 
Tenascin C 
Tsukushi small leucine rich proteoglycan homolog 
Vitronectin 
ECM affiliated proteins Annexin A1 
Annexin A2 
Annexin A4 
Annexin A5 
Annexin A6 
Annexin A7 
Annexin A8 
Annexin A11 
Chondroitin sulphate proteoglycan 4 
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Table 6.1. Identification of ECM proteins produced by canine ligament cells. All ECM 
proteins produced by ligament cells as determined by PEAKS software and the 
Matrisome Project database. 
 Hemopexin 
Lectin, galactoside-binding, soluble 1 
Lectin, galactoside-binding, soluble 3 
Lectin, mannose-binding, 1 
Plexin A3 
ECM regulatory 
proteins 
Alpha-2-macroglobulin 
Alpha-1-microglobulin/bikunin precursor 
Cystatin B 
Cathepsin B 
Cathepsin D 
Cathepsin K 
Cathepsin Z 
Coagulation factor II (thrombin) 
Coagulation factor IX 
HtrA serine peptidase 1 
HtrA serine peptidase 3 
Inter-alpha (globulin) inhibitor H1 
Inter-alpha (globulin) inhibitor H2 
Inter-alpha (globulin) inhibitor H3 
Inter-alpha (globulin) inhibitor H4 
Prolyl-hydroxylase, alpha polypeptide I 
Prolyl-hydroxylase, alpha polypeptide II 
Plasminogen 
Procollagen-lysine, 2-oxogluterate 5-dioxygenase 1 
Procollagen-lysine, 2-oxogluterate 5-dioxygenase 3 
Anionic trypsin 
Serpin peptidase inhibitor A7 
Serpin peptidase inhibitor C1 
Serpin peptidase inhibitor D1 
Serpin peptidase inhibitor E1 
Serpin peptidase inhibitor E2 
Serpin peptidase inhibitor F1 
Serpin peptidase inhibitor H1 
TIMP metallopeptidase inhibitor 1 
Secreted factors Cytokine receptor-like factor 1 
S100 calcium binding protein A4 
S100 calcium binding protein A6 
S100 calcium binding protein A10 
S100 calcium binding protein A11 
Wingless-type MMTV integration site family, member 5A 
Wingless-type MMTV integration site family, member 5B 
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ECM collagens
ECM proteoglycans
ECM glycoproteins
ECM affiliated proteins
ECM regulators
Secreted factors
Figure 6.4. Identification of ECM proteins produced by canine ligament cells. All ECM 
proteins produced by ligament cells as determined by PEAKS software and the 
Matrisome Project database. The proportion of protein identifications belonging to 
each ECM category is depicted in a pie chart. 
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Regulatory proteins 
Figure 6.5. Canine ligament ECM protein interactions. All ECM proteins produced by 
ligament cells as determined by PEAKS software were entered into STRING for 
visualisation of ECM protein interactions. 
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Figure 6.6. Comparison of ECM proteins produced by ligamentocytes and 
LDSCs as determined by PEAKS software and the Matrisome Project database. 
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ECM glycoproteins Fibronectin 
Periostin 
Thrombospondin 4 
ECM regulatory proteins Cathepsin K 
Inter-alpha (globulin) inhibitor H1 
Procollagen-lysine, 2-oxogluterate 5-dioxygenase 3 
Serpin peptidase inhibitor D1 
Secreted factors Wingless-type MMTV integration site family, member 5B 
 
ECM collagens Collagen type II, alpha 1 
Collagen type V, alpha 1 
Collagen type V, alpha 2 
Collagen type XII, alpha 1 
ECM proteoglycans Decorin 
Versican 
ECM glycoproteins Latent transforming growth factor beta binding protein 2 
ECM regulatory proteins Cathepsin Z 
 
Table 6.2. Comparison of ECM proteins produced by ligamentocytes and LDSCs as 
determined by PEAKS software and the Matrisome Project database. Proteins 
apparently unique to ligamentocytes and LDSCs are shown in (A) and (B) 
respectively. 
 
 
 
 
 
 
 
 
A 
B 
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6.4.4 Metabolic labelling of ECM proteins in the LDSC and ligamentocyte niche – 
analysis of protein synthesis and turnover 
 
ECM samples extracted from LDSC and ligamentocyte cells using a Rapigest 
extraction buffer were analysed for protein synthesis (heavy peptide content) and 
turnover (total peptide content) using LC-MS/MS after heavy isotope metabolic 
labelling (see Chapter 2, Section 2.2.3.6-2.2.3.7) (Fig.6.7). 
Collagens: There was new synthesis of collagen type I alpha 1 and 2, collagen 
type III alpha 1 and collagen type VI alpha 1, 2 and 3 (Fig.6.7.A-F). The general trend 
for new protein synthesis consisted of an initial increase in collagen synthesis over 
the first 24 hours, with a decrease in synthesis seen at 48 hours. This is consistent 
with the protein turnover data which suggested an increase in total protein quantity 
(new protein synthesis plus pre-existing protein) over the first 24 hours and a 
decline at 48 hours. There were some exceptions to this trend, for example collagen 
type VI alpha 1 and 3 with new protein synthesis continuing to increase over 48 
hours. 
Proteoglycans: New synthesis of decorin, lumican and Tsukushi was 
observed (Fig.6.7.G-I). New protein synthesis for proteoglycans generally increased 
over 48 hours. Consistent with this, total protein quantity also continued to increase 
over 48 hours. 
Glycoproteins: There was new synthesis of transforming growth factor β1 
(TGF β1), tenascin C, fibronectin and elastin (Fig.6.7.J-M). Similar to proteoglycans, 
synthesis of new glycoproteins generally continued to increase over 48 hours. The 
total protein pool varied between glycoproteins, with some proteins demonstrating 
an increase in total protein quantity over time (such as tenascin C and Tsukushi), 
consistent with the synthesis of new protein. In contrast, some proteins showed an 
initial increase in total protein quantity over 24 hours followed by a decrease at 48 
hours (such as fibronectin and elastin), indicative of increased protein degradation 
between 24 and 48 hours. 
ECM regulatory proteins: New synthesis of HtrA serine peptidases 1 and 3, 
cathepsins B and D and serpin peptidase inhibitors E2 and H1 were observed 
(Fig.6.7.N-S). Synthesis of new regulatory proteins generally continued to increase 
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over 48 hours, with some proteins starting to plateau between 24 and 48 hours. The 
total protein content for ECM regulatory proteins increased over 24 hours and then 
started to decrease by 48 hours, indicative of increased protein degradation 
between 24 and 48 hours. The only exception to this was serpin peptidase inhibitor 
E2, which showed a continued increase in total protein content over 48 hours. 
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Peptide 
number 
Protein Peptide 
1 Collagen type I alpha 1 GFSGLDGAK 
2  GLTGSPGSPGPDGK 
3  GFPGADGVAGPK 
4 Collagen type I alpha 2 GFPGAPGNVGPAGK 
5  GYPGNIGPVGAVGAPGPHGPVGPTGK 
6 Collagen type III alpha 1 GEAGSPGIPGPK 
7  GPVGPSGPPGK 
8 Collagen type VI alpha 1 LLLFSDGNSQGATAAAIEK 
9  DTTPLSVLCGPDIQVVSVGIK 
10 Collagen type VI alpha 2 GPQGALGEPGK 
11 Collagen type VI alpha 3 VPQIAFVITGGK 
12  IEDGVPQHLVLFLGGK 
13  SDDEVDDSAAELK 
14 TGFβ1 LTLLAPLNSVFK 
15  DVLATNGVIHFIDELLIPDSAK 
16 Decorin ISPGAFTPLLK 
17 Lumican NNQIDHIDEK 
18  ILGPLSYSK 
19 Tenascin C VATYLPAPEGLK 
20  LSWTADEGVFDSFVLK 
21 Fibronectin DLQFVEVTDVK 
22  YEKPGSPPR 
23 Elastin FPGVGVLPGVPTGTGVK 
24  AGYPTGTGVGTQAAAAAAK 
25 TSKU ELQSLQVLDLSGNPK 
T 
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Figure 6.7. Metabolic labelling of canine ligamentocytes and LDSCs. Cells were 
labelled with 13C lysine for 4, 24 and 48 hours before the ECM was harvested and 
LC-MS/MS performed. ECM proteins labelled with 13C lysine were identified using 
MASCOT and extracted ion chromatograms were analysed using Xcalibur. Heavy (H) 
and light (L) peaks were identified for each labelled peptide and the area under the 
peak recorded. Total peptide content (H+L) was plotted on bar charts along with 
heavy peptide content (H) against time for each peptide (A-S). Purple bars represent 
ligamentocytes and green bars represent LDSCs, light bars represent total peptide 
content and dark bars represent heavy peptide content. A two-way ANOVA with 
repeated measures was used to analyse total peptide content (H+L) and relative 
isotope abundance (H/(L+H)) for differences between time points, cell types and 
peptides. Grey bars represent statistically significant differences in total peptide 
content (H+L) and black bars represent statistically significant differences in relative 
isotope abundance (H/(L+H)) . * represent statistically significant differences 
between time points, † represent statistically significant differences between cell 
types and ‡ represent statistically significant differences between peptides. * = 
p<0.05, ** = p<0.01 and *** = p<0.001. Lig = ligamentocytes, LDSC = ligament-
derived stem cell, pep = peptide. Peptide sequences are provided in the table in 
part T. 
 
 
Peptide 
number 
Protein Peptide 
26 HtrA serine peptidase 1 VTAGISFAIPSDK 
27  VKVELK 
28 HtrA serine peptidase 3 GGIQDGDIIVK 
29  TITPSLVEELK 
30 Cathepsin B HYGCSSYSVSDNEK 
31  EQWPNCPTIK 
32 Cathepsin D VSTLPDVTLK 
33  LSSEDYTLK 
34 Serpin peptidase inhibitor E2 ALGITEMFDPSK 
35  DIVTVANAVFVK 
36 Serpin peptidase inhibitor H1 HLAGLGLTEAIDK 
37  SAGLAFSLYQAMAK 
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6.5 Discussion 
 
6.5.1 Optimisation of cellular and extracellular matrix extraction methods 
 
In order to ensure sufficient protein quantity for mass spectrometry ECM 
protein extraction techniques were optimised (Fig.6.2). Several methods for 
removal of cells prior to ECM extraction were also tested (Fig.6.1). Cellular 
extraction was necessary as the presence of cellular proteins during proteomic 
analysis would have overwhelmed the ECM proteins, which may only be present in 
small quantities. I tested cellular and ECM extraction techniques previously 
published or previously used within my group. 
EDTA and trypsin have been successfully used for the removal of cells prior 
to ECM extraction (Choi et al., 2011), however EDTA was unable to remove cells in 
this study. This may be due to different concentrations used as Choi and others 
(2011) did not state the concentration of EDTA used. Trypsin was used successfully 
to remove cells in this study, consistent with Choi and others (2011), although it 
proved difficult to completely remove all cells using this method. I also tested a 
method published by Soteriou and others (2013) which used a detergent to remove 
cells (Soteriou et al., 2013). This method appeared effective, with the absence of 
cells, however this method also removed a lot of the ECM deposited by the cells 
and so I opted to continue with trypsin for cell removal.  
For the extraction of ECM a urea extraction buffer was tested, which had 
been previously used within my group as well as a sample buffer published by 
Soteriou and others (2013). The sample buffer successfully extracted increased 
numbers of identifiable proteins and a wider complement of proteins compared 
with the urea buffer, however there was similar incorporation of 14C-labelled amino 
acids into proteins using both extraction methods. Due to the potential 
incompatibility of the sample buffer with protein assays and further downstream 
processing I opted to continue with the urea buffer for further validation. 
Unfortunately the combination of trypsin and the urea buffer resulted in low 
protein hits when LC-MS/MS was performed, therefore a Rapigest method, 
213 
 
previously used within my group (Peffers et al., 2015b), replaced the urea buffer for 
all further experiments. 
 
6.5.2 Identification and label-free quantification of ECM proteins in the LDSC 
and ligamentocyte niche 
 
I have demonstrated the production of a number of collagens, proteoglycans 
and glycoproteins, as well as numerous ECM related proteins by canine ligament 
cells as determined by mass spectrometry (Table 6.1, Fig.6.4-5). The ECM related 
proteins produced by ligament cells in this study are consistent with previous 
literature looking at the proteome of whole canine CCL tissue (Kharaz et al., 2016). 
Particularly, Kharaz and others (2016) observed the presence of collagen type I, V, 
VI, decorin, biglycan, lumican, tenascin C, fibulin 1 and thrombospondin 1, 
consistent with this study. Similarly, a study investigating the proteome of human 
spinal ligaments (ligamentum flavum) observed the presence of the proteins 
mentioned above as well as collagen type II, III, mimecan, versican, proteoglycan 4, 
fibrinogen, fibronectin, periostin, thrombospondin 4, vitronectin, latent 
transforming growth factor beta binding protein 2, as well as ECM related proteins 
including annexins and plasminogen, consistent with this study (Sato et al., 2016). 
Similar proteins were observed in human anterior cruciate ligaments (ACL) with all 
of the proteins listed above as well as collagen type XII, elastin, TGFβ1 and the ECM 
related proteins hemopexin and inter-alpha (globulin) inhibitor H1 (Little et al., 
2014). Generally, fewer proteins were observed in this study than the studies 
discussed above, however this is most likely due to the fact that I extracted ECM 
protein from cells grown in culture as opposed to extracting protein from whole 
ligament tissue. Protein assays and gel electrophoresis I have previously conducted 
(data not shown) demonstrate that increased matrisomal protein can be extracted 
from tissue compared with cells in culture. No studies to date have investigated the 
ECM proteome of intra-articular ligament cells or LDSCs. However several studies 
have demonstrated gene expression of certain ECM components by human ACL and 
periodontal LDSCs including collagen type I, III, tenascin C, fibronectin and 
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thrombospondin 4 (Cheng et al., 2010; Huang et al., 2008; Lee et al., 2015b), 
consistent with this study. 
Few differences were observed in this study between ECM proteins 
produced by ligamentocytes and LDSCs (Fig.6.6, Table 6.2) with several 
glycoproteins and regulatory proteins unique to ligamentocytes and a number of 
collagens and proteoglycans unique to LDSCs. I expected to see greater differences 
in ECM production and the niche between the two cell types. The phenotypic 
differences between the two cell types seen in this study (see Chapter 5) are 
suggestive of two distinct cell populations with differing genotypes and phenotypes 
and therefore a difference in the cells’ requirements and environment would be 
expected. In addition, the requirement for a specific niche has been demonstrated 
for multiple stem cell populations (Bi et al., 2007; Calvi et al., 2003; Garcion et al., 
2004), therefore I hypothesised that LDSCs would also require a specific 
environment in which to survive and function, separate to that of native fibroblasts. 
To my knowledge no study has compared the ECM proteome/niche between stem 
cells and fibroblasts from the same tissue, therefore I am unable to compare with 
my own data. It is possible that the small differences in ECM production between 
LDSCs and ligamentocytes observed in this study are instrumental in maintaining 
the cells’ differing phenotypes. For example, collagen type V and decorin (ECM 
proteins I found to be unique to LDSCs) have been shown to be present in the bone 
marrow niche. When bone marrow-derived mesenchymal stromal cells are grown 
on a matrix containing these ECM components their replication and clonogenicity is 
promoted and differentiation potential is regulated (Chen et al., 2007). 
Interestingly, some of the proteins found to be unique to ligamentocytes in this 
study have previously been shown to play key roles in niches for other stem cell 
populations. Fibronectin has been shown to promote expansion of both muscle 
satellite cells (Bentzinger et al., 2013) and HSCs (Malara et al., 2014), and periostin 
indirectly supports HSC survival and growth (Tanaka et al., 2016). It is an 
unexpected finding in this study for ECM components known to influence stem cells 
to be uniquely produced by ligamentocytes. It is possible that there is a certain 
amount of redundancy in stem cell niches, and the absence of specific ECM 
components may have little effect on stem cell survival and function. However the 
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knockdown of fibronectin caused impaired satellite cell replication which was 
restored with over-expression of fibronectin (Bentzinger et al., 2013) suggesting this 
ECM component at least is not redundant. Alternatively, there may be low level 
production of fibronectin, periostin, thrombospondin 4, cathepsin K, inter-alpha 
(globulin) inhibitor H1, procollagen-lysine, 2-oxogluterate 5-dioxygenase 3, serpin 
peptidase inhibitor D1 and wingless-type MMTV integration site family, member 5B 
by LDSCs, however due to the selected parameters for PEAKS software these 
proteins were excluded from the output. It is clear that further investigation into 
the role of these ECM proteins in LDSC survival and function is needed. 
Label-free quantitative analysis of LDSC and ligamentocyte ECM proteins 
resulted in no differentially abundant ECM proteins between the two cell types 
therefore no data is shown. This was unexpected due to the reasons discussed 
previously, however the lack of differentially abundant proteins between cell types 
may be due to high variability between biological replicates within each cell type 
which would reduce peptide significance scores, or possibly that the cell types share 
a similar proteome and niche. 
 
6.5.3 Metabolic labelling of ECM proteins in the LDSC and ligamentocyte niche 
 
The SILAC proteomic method involves culturing cells in the presence of 
amino acids labelled with a light or heavy isotope. Newly synthesised proteins will 
incorporate the light (L) or heavy (H) isotope and this incorporation can be 
measured and quantified, providing a comparison between different samples or 
treatments, as well as analysis of protein dynamics (Chen et al., 2015d; Hoedt et al., 
2014). I have utilised a variation of the SILAC method in this study to investigate 
which proteins are being actively synthesised by LDSCs and ligamentocytes and at 
what rate they are being synthesised. I analysed new protein synthesis by 
measuring the quantity of heavy isotope that had been incorporated into newly 
synthesised ECM proteins. I investigated both total heavy isotope incorporation 
values as well as calculating the proportion of the total protein pool that had been 
labelled with heavy isotope. This technique also provides information on protein 
turnover which is dependent on both protein synthesis and degradation. By 
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analysing the total protein pool over time I was able to investigate protein pool 
expansion and reduction for individual ECM proteins.  
The data has been presented as bar charts demonstrating both total peptide 
content as well as heavy peptide content (new peptide synthesis), however I was 
unable to show relative isotope abundance (RIA) in this format (Fig.6.7). RIA 
represents the proportion of the total protein pool that is labelled with heavy 
isotope (calculated as H/(L+H)). Although RIA is not shown directly it is important to 
keep in mind the proportion of the total protein pool that has been labelled with 
heavy isotope. For many of the proteins the total amount of protein decreased at 
48 hours compared with 24 hours with the quantity of protein labelled with heavy 
isotope also decreasing. However the RIA actually increased for many of these 
proteins: 9 proteins out of a total of 19, with the proportion of the total pool 
labelled with heavy isotope increasing (such as fibronectin) which is indicative of 
continued new protein synthesis, albeit with concurrent degradation of existing 
protein. Therefore, it is important to consider RIA when assessing this data and for 
this reason I have performed statistical analysis on RIA data rather than absolute 
heavy labelled values. The reason for the reduced protein quantities at 48 hours is 
unknown. It could possibly be due to cell death as the cells are cultured in serum-
free media for the labelling period, however there appeared to be little or no loss of 
cells after 48 hours. Alternatively, the media could have been completely depleted 
of lysine prior to 48 hours, which would result in reduced protein synthesis. A 
suggestion for future work would be to measure the quantity of both 12C- and 13C-
labelled lysine in the media extracts from the samples using nuclear magnetic 
resonance (NMR) (Hattori et al., 2013) to determine if lysine had been depleted 
from the media. However, the reasons outlined above are unlikely to be the cause 
of the reduced protein levels at 48 hours as some ECM proteins (as well as some 
intracellular proteins – data not shown) demonstrated increased levels of both total 
protein and protein labelled with heavy isotope at this time point (such as decorin 
and lumican), indicating that the cells had not died or exhausted the supply of 
lysine. 
New synthesis and turnover of a number of ECM proteins was observed in 
this study, including collagens, proteoglycans and glycoproteins (Fig.6.7). The 
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expression of these proteins by ligament tissue has previously been demonstrated 
(see Section 6.5.2). However, little previous research has investigated turnover of 
ECM proteins in any tissue with the exception of collagen, as discussed below. I also 
observed synthesis and turnover of some ECM regulatory proteins. The presence of 
some of these proteins has been demonstrated in periodontal ligament, such as 
HtrA serine peptidase 1, cathepsin B and serpin peptidase inhibitor H1 (Goseki et 
al., 1996; Li and Zhang, 2015; Yoshimatsu et al., 2008), however to date there are 
no reports of HtrA serine peptidase 3, cathepsin D and serpin peptidase inhibitor E2 
expression in any ligament tissue. There is also little research on protein dynamics 
of ECM regulatory proteins. 
I observed a general trend for collagens of an initial increase in new protein 
synthesis up to 24 hours followed by a decrease between 24 and 48 hours. Similarly, 
the total protein content increased up to 24 hours followed by a decrease. At 24 
hours a variable RIA was observed for different collagens with as much as 93% of 
collagen type I alpha 1 being turned over in a 24 hour period and 46% of collagen 
type VI alpha 3. Several previous studies have utilised methods based on the 
incorporation of stable isotope into newly synthesised proteins for analysis of 
protein turnover. Human tendon and ligament demonstrated collagen turnover 
rates of 0.045%/h and 0.04%/h respectively after intravenous infusion of heavy 
labelled proline into subjects prior to surgery (Babraj et al., 2005). The turnover 
levels reported by Babraj and others (2005) are considerably lower than those 
reported here, however they still demonstrate a high turnover of collagen in these 
tissues. The discrepancies between Babraj and others (2005) and this study may be 
due to the use of healthy tissue in this study and the use of ruptured ligament tissue 
by Babraj and others (2005), however a comparison of healthy and ruptured tendon 
showed increased collagen turnover in ruptured tendon (Riley et al., 2002). 
Alternatively, species differences may play a role as smaller mammals have been 
shown to exhibit increased protein turnover (Nagy et al., 1999), or the differences 
in turnover may be due to the use of tissue by Babraj and others (2005) and the use 
of in vitro cultured cells in this study. Another study analysing protein turnover 
using intravenous infusion of heavy labelled proline into subjects found an increase 
in incorporation after strenuous exercise with a peak incorporation of 0.08%/h 
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(Miller et al., 2005). Intraperitoneal infusion of heavy labelled proline enabled 
analysis of collagen turnover in murine periodontal ligament with a half-life of 2.4-
6.5 days depending on the section of ligament (Perera and Tonge, 1981). Other 
methods have been utilised to analyse collagen turnover; one study analysed 
collagen propeptides and collagen degradation products using microdialysis which 
suggested a high turnover of collagen in human tendon (Langberg et al., 1999). 
However, some studies analysing collagen turnover have reported much greater 
half-lives, for example, analysis of aspartic racemization and collagen degradation 
markers in equine tendon revealed a collagen half-life of 34-198 years depending on 
the tendon type (Thorpe et al., 2010). In addition, analysis of human tendon core 
tissue turnover using the 14C bomb-pulse method revealed that the tendon core is 
formed during development and the tissue is not renewed after this time 
(Heinemeier et al., 2013). It is possible that the increased quantity of collagen 
synthesised in this study and others is degraded quickly before incorporation into 
tissue which would account for the discrepancy in collagen turnover observed 
between these studies and Heinemeier and others (2013). This degradation could 
occur extracellularly in the matrix or intracellularly. Although cellular matter was 
removed before extraction of ECM proteins in this study there were still some cells 
remaining and the identification of intracellular proteins by LC-MS/MS confirmed 
this (data not shown). It is possible that the new collagen synthesis observed during 
this study may, in part, be intracellular procollagen. Secretory proteins including 
ECM proteins have been shown to have short cellular half-lives (Schwanhausser et 
al., 2011) and therefore procollagen may be degraded rapidly intracellularly and not 
contribute to new mature collagen synthesis, or procollagen may be secreted from 
the cells but not incorporated into longer-lived collagen fibrils. Alternatively, it is 
possible that turnover occurs in the peripheral region of the tendon and not in the 
core. The decline in total and labelled peptide seen at 48 hours in this study is due 
to both reduced synthesis and increased degradation. The reduction in heavy 
isotope incorporation is suggestive of reduced protein synthesis, and the reduction 
in light isotope labelled protein is indicative of protein degradation. The cause of 
these changes in collagen turnover are unknown, however the reduction in collagen 
synthesis may be due to changes in collagen regulatory enzymes and the increase in 
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collagen degradation is most likely due to upregulation of collagen degrading 
enzymes (discussed further below). 
For proteoglycans there were a limited number of peptides which had been 
labelled with heavy isotope therefore the conclusions I can draw for these proteins 
are with less confidence than the other protein categories such as collagens. The 
trend for proteoglycan turnover generally consisted of a continual increase in both 
total peptide content as well as heavy labelled peptide content. The data for 
proteoglycans was considerably more variable and there were instances for all 
proteoglycans where there were increased light labelled peptides at later time 
points compared with earlier time points. As all available lysine was of the heavy 
isotope during the labelling period cells should not be able to synthesise proteins 
containing the light isotope as lysine is an essential amino acid. Due to the limited 
number of labelled peptides mentioned above and the low quantity of protein in 
general (compared with other protein categories) my confidence in these proteins is 
reduced. Previous reports have demonstrated high turnover of proteoglycans in 
tendon which is comparable with this study, although I did not observe synthesis or 
turnover of biglycan, aggrecan or versican which is in contrast to previous studies in 
bovine tendon and ligament (Ilic et al., 2005; Rees et al., 2000; Samiric et al., 2004a, 
b; Winter et al., 2000). This may be due to tissue or species differences, or 
differences in methodology and analysis of protein turnover. Alternatively this may 
be due to the low quantities of proteoglycans in canine CCL tissue observed here. 
The parameters used for protein identification and quantification may have gated 
out certain proteoglycans which are present in only small quantities, therefore I was 
unable to analyse their turnover. Samiric and others (2004) found a half-life of 
greater than 20 days for small proteoglycans and 2 days for large proteoglycans 
(Samiric et al., 2004b) in bovine tendon. These values are generally lower than 
those observed for collagen turnover in tendon tissue (Thorpe et al., 2010), 
however I observed similar levels of new protein synthesis for collagens and 
proteoglycans, although levels of degradation varied. 
Synthesis of new glycoproteins followed a similar pattern to proteoglycans 
with a continual increase over time, however total protein content was variable 
with a continual increase for some proteins  (such as tenascin C and Tsukushi), and a 
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decrease after 48 hours for other proteins (such as fibronectin and elastin) 
indicative of increased protein degradation. This variability could reflect differences 
in regulation of these proteins and differences in function. Previous studies in 
equine tendon demonstrated a relatively slow rate of turnover for non-collagenous 
proteins (both proteoglycans and glycoproteins) with a half-life of 2-3.5 years 
depending on the tendon type, however these values were still considerably shorter 
than those for collagen (Thorpe et al., 2010). There is very little previous research 
available on the dynamics of glycoprotein turnover and metabolism.  
ECM regulatory protein synthesis continually increased over time, whereas 
total protein content increased until 24 hours and then decreased between 24 and 
48 hours, indicative of increased protein degradation, except for serpin peptidase 
inhibitor E2 which continued to increase over time. Little is known about the 
turnover of these ECM regulatory proteins, however due to their regulatory nature 
and the requirement for fast responsiveness to changing cellular demands it would 
be expected that their turnover would be high (Schwanhausser et al., 2011), as seen 
in this study.  
There are complex interactions between ECM core and regulatory proteins 
which may be reflected in their expression and turnover profiles. Collagen is 
transcriptionally regulated by TGFβ1, with TGFβ1 causing an increase in collagen 
type I, III and VI gene expression (Heckmann et al., 1992; Klein et al., 2002; 
Verrecchia and Mauviel, 2004). I observed an initial increase in collagen synthesis 
followed by a decrease after 24 hours, although I observed a continual steady 
increase in TGFβ1 synthesis the total protein content of TGFβ1 also declined after 
24 hours. This may suggest that the decline in collagen synthesis was due to a 
reduction in TGFβ1 content. The reduction in TGFβ1 may be due to the increased 
production of decorin, tsukushi and/or HtrA serine peptidases which have been 
reported to bind to and inhibit TGFβ1, thereby reducing collagen synthesis (Fullár et 
al., 2016; Niimori et al., 2012; Niimori et al., 2014; Oka et al., 2004; Tocharus et al., 
2004; Wang et al., 2016). In addition, lumican also reduces collagen fibril formation 
(Matheson et al., 2005; Neame et al., 2000; Rada et al., 1993) and a continual 
increase in synthesis of this proteoglycan was observed. Interestingly a decrease in 
total serpin peptidase inhibitor H1 content, also known as heat shock protein 47 
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and collagen binding protein 1, after 24 hours was observed. Serpin peptidase 
inhibitor H1 is vital for collagen maturation and folding and is positively regulated 
by TGFβ1 (Ishida et al., 2006; Ito and Nagata, 2016; Razzaque and Ahmed, 2002). 
The reduction in TGFβ1 may have reduced the production of serpin peptidase 
inhibitor H1, as the synthesis of this protein starts to plateau after 24 hours, thereby 
further reducing collagen synthesis. The decrease in total collagen content seen in 
this study is due to both reduced synthesis and increased degradation of collagen. 
The increase in degradation is likely due to an increase in collagen degrading 
enzymes such as HtrA serine peptidase 1, cathepsins and serpins, which I have 
shown to be produced by canine CCL cells. HtrA serine peptidase 1, the synthesis of 
which I have shown to increase over time, has previously been found to degrade 
collagen type I, III and VI (Murwantoko et al., 2004; Polur et al., 2010). Cathepsins B 
and D are also able to degrade collagen, including types I and III (Creemers et al., 
1998; Li et al., 2016a; Scott and Pearson, 1981; Turk et al., 2012). Despite their 
ability to degrade collagen, it is unlikely that cathepsins played a significant role in 
the degradation of collagen in this study as total protein content of these enzymes 
decreased after 24 hours. Cathepsin B also activates plasmin (Guo et al., 2002) 
which has been shown to activate collagenases (Berman, 1993; Mazzieri et al., 
1997) and may contribute to the degradation of collagen seen here, however no 
matrix metalloproteinase (MMP) collagenases were identified in this study, which 
are the main family of enzymes responsible for collagen degradation. Different 
collagen types also interact with each other and may contribute to regulation of 
collagen synthesis, maturation and stabilisation (Harumiya et al., 2002; Liu et al., 
1997). A continual increase in tenascin C expression was observed over time which 
may have been stimulated by the earlier increase in TGFβ1 as TGFβ1 has been 
shown to increase tenascin C expression (Estany et al., 2014; Islam et al., 2014; 
Mercado-Gómez et al., 2014). Tenascin C has been shown to interfere with 
fibronectin fibrillogenesis (To and Midwood, 2010), which can cause a reduction in 
fibronectin function. As mature fibronectin is required for collagen assembly (Sottile 
and Hocking, 2002), the reduced total protein levels of fibronectin observed here 
may have contributed to the reduction in collagen observed after 24 hours. 
Fibronectin is stimulated by TGFβ1 (Quan et al., 2005), therefore the continual 
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increase in synthesis of TGFβ1 may have contributed to the continual increase in 
synthesis of fibronectin (despite reduced levels of total protein content for both of 
these proteins after 24 hours). The reason for the decrease in total fibronectin 
content after 24 hours despite continued synthesis is due to degradation. 
Fibronectin is degraded by a number of enzymes including HtrA serine peptidase 1 
and cathepsins (Buck et al., 1992; Grau et al., 2006; Jiang et al., 2012; Richter and 
Hörmann, 1983) and these enzymes may contribute to the degradation of 
fibronectin observed here. Continued synthesis of elastin was observed over time 
which may again have been stimulated by TGFβ1 (Oleggini et al., 2007). The total 
protein content of elastin however decreased after 24 hours which was due to 
increased degradation, possibly by HtrA serine peptidase 1 and/or cathepsins as 
these enzymes have previously been shown to degrade elastin (Jones et al., 2011; 
Turk et al., 2012). Serpin peptidase inhibitor E2, also known as protease nexin, 
inhibits collagenases both directly and indirectly thereby preventing degradation of 
collagen as well as fibronectin (Bouton et al., 2012; Francois et al., 2014; Santoro et 
al., 2015). Serpin peptidase inhibitor E2 also increases collagen synthesis via TGFβ1 
signalling (Li et al., 2016b). Therefore, the continued increase in synthesis and total 
protein content of serpin peptidase inhibitor E2 over time would be expected to 
correlate to an increase in collagen content over time (through both increased 
synthesis and reduced degradation), however this was not the case. It is possible 
that other proteins and factors are required for serpin peptidase inhibitor E2 to 
function that were not present here, or alternatively that other proteins and factors 
required for collagen synthesis were not present, and/or other degradative 
enzymes unaffected by serpin peptidase inhibitor E2 were present. The total 
protein content of serpin peptidase inhibitor E2 was relatively high therefore it is 
unlikely that this protein was not present in a high enough quantity to affect 
function, however this is a possibility. A summary of the potential interactions 
between the metabolically labelled ECM core and regulatory proteins in this study is 
shown in Figure 6.8. 
 Very few differences in protein turnover were observed between 
ligamentocytes and LDSCs. There were no differences in total protein content 
between cell types however there were a few statistically significant differences 
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Figure 6.8. Protein interaction map highlighting the potential positive and negative interactions/effects between the core and regulatory ECM 
proteins metabolically labelled in this study. The map was produced using Ingenuity Pathway Analysis (IPA) (Ingenuity systems. 
www.ingenuity.com).
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between RIA with all differences being an increase in RIA in ligamentocytes. This 
indicates that there was an increase in new protein synthesis and turnover in the 
niche of ligamentocytes compared with LDSCs. This would suggest that LDSCs 
require a more stable environment than ligamentocytes, however it would be 
expected that due to the dynamic needs of stem cells and the requirement for 
proliferation and differentiation at times of need that stem cell niches would be 
dynamic with increased turnover of niche components (Gattazzo et al., 2014). In 
contrast, in the absence of injury or challenge many stem cell populations tend to 
be dormant and quiescent and are only activated during times of repair (Foudi et 
al., 2009; Sottocornola and Lo Celso, 2012; Wilson et al., 2008). This may be the 
case in healthy canine CCL with LDSCs in a state of quiescence. It would be valuable 
to compare the expression and turnover of the LDSC niche for LDSCs isolated from 
ruptured or diseased ligament. 
 
6.5.4 Conclusion 
 
I have characterised the ECM composition of the canine CCL cell niche in 
terms of protein expression and turnover. The expression of ECM proteins by canine 
CCL cells was, as expected, similar to that described in previous reports in a variety 
of ligaments from a number of difference species. The identification of ECM 
proteins using PEAKS software yielded a number of proteins unique to either 
ligamentocytes or LDSCs. For example, fibronectin was found by PEAKS to be unique 
to ligamentocytes, however as can be seen from the metabolic labelling data, 
fibronectin has been metabolically labelled with heavy isotope in both cell types. It 
is clear that there are many differences between different software and databases 
in terms of sensitivity. It is possible that fibronectin is produced by both cell types, 
however it is produced in a lower quantity by LDSCs which was not detected by 
PEAKS (based on the parameters used) but was detected by MASCOT which may 
have an increased sensitivity and decreased threshold. However, this is inconsistent 
with the metabolic labelling data, which found no significant difference in 
fibronectin expression between cell types, although fibronectin expression was 
slightly reduced for LDSCs compared with ligamentocytes at three out of four time 
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points. This highlights the potential unreliability of using PEAKS software for such 
analysis and enforces the necessity of validating any data produced using mass 
spectrometry. This is often achieved using Western blotting, unfortunately due to 
time and cost restraints as well as the lack of available validated canine antibodies I 
was unable to confirm the unique protein identifications observed in this study. 
I have, for the first time, developed a proteomics-based method enabling 
analysis of the dynamics of newly synthesised ECM proteins in vitro, including 
collagens, proteoglycans and glycoproteins. Using this method I observed new 
synthesis of a number of different ECM proteins by canine CCL cells with varying 
synthesis and turnover profiles. My data demonstrated a decline in collagen 
synthesis after 24 hours and a continual increase in non-collagenous synthesis over 
time, although there was variability between proteins. This may suggest an 
important role for non-collagenous proteins in the ligament cell niche and further 
investigation of the role of such proteins in the ligament cell niche is required. It is 
clear that the study of protein dynamics is of vital importance for a number of 
reasons. Firstly for protein identification, for example, if only proteins present at 48 
hours had been investigated then this would not have given an accurate 
representation of the ECM niche of ligament cells. Several proteins were produced 
early on and had been degraded by 48 hours with very low or no protein present at 
this time, such as collagen type III alpha 1 and serpin peptidase inhibitor H1. As well 
as the role of protein dynamics in protein identification, the study of protein 
turnover is necessary to fully understand the function and regulation of proteins. It 
also enables a comparison of the dynamics of different proteins and highlights 
potential protein interactions and roles based on protein synthesis and degradation 
profiles. The study of protein dynamics is of great importance for future research 
not only in ligament but for many different fields. 
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General Discussion 
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7.1 General discussion 
 
Tendon and ligament are prone to age- and injury-related degeneration 
(Cimino et al., 2010; Maffulli et al., 2003). Tendon and ligament are unable to heal 
effectively after injury (Frank, 2004; Maffulli et al., 2003) and current treatment 
strategies have variable success rates (Dawson et al., 2016; Mayor, 2012; Murawski 
et al., 2014). The identification of stem cell populations in tendon and ligament (Bi 
et al., 2007; Seo et al., 2004) holds potential for new therapeutic strategies to treat 
tendon and ligament injuries. 
The aim of this study was to characterise stem cell populations in equine 
superficial digital flexor tendon (SDFT) and canine cranial cruciate ligament (CCL), as 
well as to characterise the stem cell niche of these stem cell populations. Equine 
SDFT and canine CCL are both prone to injury and degeneration (Ely et al., 2009; 
Wilke et al., 2006; Witsberger et al., 2008) and therefore effective treatment 
options are currently being sought. The study of tendon and ligament in these 
species also provides a suitable translatable model for human research due to the 
similarities in these tissues between species (Innes and Clegg, 2010). There is 
limited data available on tendon-derived stem cell (TDSC) populations in equine 
SDFT (Lovati et al., 2011), however, to date, there is no data available on ligament-
derived stem cells (LDSCs) isolated from canine CCL. Therefore characterisation of 
these cell populations is vital in order to assess their suitability for tendon and 
ligament repair strategies. Characterisation of stem cell populations in tendon and 
ligament involved the use of a number of assays to analyse the stemness of the cells 
based on the criteria outlined by the International Society for Cellular Therapy 
(ISCT) (Dominici et al., 2006). These included clonogenic assays, gene expression 
analysis and tri-lineage differentiation assays. The stem cell niche has been shown 
to be vital for survival and function of a number of stem cell populations, including 
tendon (Bi et al., 2007; Calvi et al., 2003; Garcion et al., 2004). Therefore 
characterisation of the stem cell niche is also necessary to understand the 
regulation of stem cell populations. In addition, modulation of the stem cell niche 
can induce changes in both stem cell phenotype and function and holds therapeutic 
potential (Lane et al., 2014). 
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TDSC populations from equine SDFT were isolated along with tenocytes 
(tendon fibroblasts) as a comparative cell type (see Chapter 3). The TDSC population 
isolated in this study demonstrated clonogenicity, stem cell marker expression and 
multipotency, all hallmarks of mesenchymal stromal cells (MSCs) (Dominici et al., 
2006). However, limited multipotency of TDSC populations was observed, with an 
inability of these cells to differentiate down the adipogenic lineage. In addition, I 
observed very few differences between TDSCs and tenocytes. There were also no 
differences in extracellular matrix (ECM) composition and production between cell 
types. These results were not consistent with previous reports in equine SDFT 
(Lovati et al., 2011) and suggested a heterogeneous population of cells at different 
stages of differentiation. Optimisation of TDSC isolation procedures are required to 
ensure a purer population of TDSCs. The reduced multipotency of the TDSCs 
isolated in this study may provide a therapeutic benefit during injury and with 
further characterisation may form the basis for future treatment strategies. The use 
of TDSCs isolated from tendons of various species have successfully aided tendon 
repair after injury (Ni et al., 2012; Yin et al., 2010; Zhang et al., 2011a), indicating 
that TDSCs present in equine SDFT may be targets for future tendon repair 
strategies. 
  In order to ensure the reduced multipotency observed in equine TDSCs was 
not due to experimental or technical differences, TDSCs from murine tail tendons 
were also isolated, along with tenocytes as a comparative cell type (see Chapter 4). I 
observed clonogenicity, the expression of stem cell markers and multipotency of 
murine TDSC populations. Interestingly, I observed increased multipotency of 
murine TDSCs compared with equine TDSCs, with murine TDSCs able to 
differentiate down the adipogenic lineage as well as osteogenic and chondrogenic 
lineages. These results are consistent with the literature (Alberton et al., 2014; Bi et 
al., 2007; Salingcarnboriboon et al., 2003). In addition, several differences between 
murine TDSCs and tenocytes were observed, including clonogenicity, stem cell 
marker expression and multipotency, suggestive of two distinct cell populations 
within murine tail tendon. These results indicated that the restricted multipotency 
of equine TDSCs is a feature of this cell population rather than due to experimental 
differences. 
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LDSCs from canine CCL were isolated as well as ligamentocytes (ligament 
fibroblasts) as a comparative cell type (see Chapter 5). LDSCs demonstrated 
clonogenicity, stem cell marker expression and multipotency, consistent with 
previous reports in other species (Fu et al., 2015; Steinert et al., 2011). Differences 
in clonogenicity, stem cell marker expression and multipotency were observed 
between LDSCs and ligamentocytes, suggestive of two distinct cell populations 
within canine CCL. LDSCs isolated from canine CCL may provide a basis for future 
treatment strategies for CCL injuries. Studies conducted using LDSCs isolated from 
rabbit medial collateral ligament have shown promising results in terms of ligament 
repair (Jiang et al., 2015), suggestive of the therapeutic potential of canine LDSCs.  
The canine CCL niche was also characterised for LDSCs and ligamentocytes in 
terms of ECM composition (see Chapter 6). Mass spectrometry was used to identify 
the complement of ECM proteins present in the LDSC niche as well as analysing 
protein synthesis and turnover using a label-based proteomics method. Many ECM 
proteins were identified in the niche of LDSCs and ligamentocytes including 
collagens, glycoproteins, proteoglycans, ECM affiliated proteins, ECM regulatory 
proteins as well as secreted proteins. The proteins identified within canine CCL were 
consistent with the literature (Kharaz et al., 2016; Little et al., 2014; Sato et al., 
2016). There were a small number of proteins which were apparently unique to 
either LDSCs or ligamentocytes, with several glycoproteins and regulatory proteins 
unique to ligamentocytes and a number of collagens and proteoglycans unique to 
LDSCs. Confirmation of the role of these proteins in the LDSC and ligamentocyte 
niche is necessary to understand the regulation and maintenance of these cell 
populations. Analysis of protein synthesis and turnover yielded some interesting 
data with characteristic patterns emerging for different ECM protein categories, for 
example collagens showed an initial increase in content and synthesis which 
declined with time, however the content and synthesis of proteoglycans and some 
glycoproteins continued to increase over time. These results may suggest that non-
collagenous proteins play an important role in the maintenance of canine CCL cell 
populations. There were very few differences in protein synthesis and turnover 
between cell types, however these differences all reflected increased synthesis of 
proteins by ligamentocytes. This suggests that ligamentocytes require a more 
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dynamic niche compared with LDSCs which require an environment which is more 
stable. Although initially this seems counter-intuitive, it is possible that LDSCs are in 
a state of dormancy in healthy tissue and are only activated during times of 
homeostasis and repair, as seen in other stem cell populations (Foudi et al., 2009; 
Sottocornola and Lo Celso, 2012; Wilson et al., 2008). The role of these newly 
synthesised proteins in the maintenance and regulation of CCL cell populations 
needs to be elucidated. Their active synthesis is suggestive of their importance in 
the CCL niche, however the exact role and function of these proteins is an area for 
future research. The modulation of some of these proteins may improve LDSC and 
ligamentocyte survival and function and thereby be of potential therapeutic benefit. 
 
7.2 Suggestions for future work 
 
Suggestions for future work on tendon-derived stem cells include: 
optimisation of equine TDSC isolation methods; identification of TDSC-specific 
markers; characterisation of pure cell populations; tissue engineering/stem cell 
therapy approaches to tendon injury utilising equine TDSCs; comparison of TDSC 
phenotype between healthy and injured tissue. 
 Suggestions for future work on ligament-derived stem cells include: 
identification of LDSC-specific markers; tissue engineering/stem cell therapy 
approaches to ligament injury utilising canine LDSCs; comparison of LDSC 
phenotype between healthy and injured tissue; investigation of the regulation of 
different LDSC subpopulations, including the role of epigenetics. 
Suggestions for future work on the ligament-derived stem cell niche include: 
validation of protein identifications; investigation of the role of proteins unique to 
either cell type; investigation of the role of proteins with significantly different 
synthesis or turnover rates between cell types; determination of candidates for 
ligament cell niche modulation therapies; comparison of ligament cell niche 
between healthy and injured tissue. 
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8.1 Appendix A – Joint-first author paper published in Journal of Orthopaedic 
Research 
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8.2 Appendix B – Selection of best housekeeping genes for qPCR and analysis of 
primer efficiencies  
 
All equine primers used in this study were kindly donated by Dr. Kate 
Williamson (University of Liverpool), who had previously designed the primers using 
the same software described in Chapter 2, Section 2.2.2.5. All primers were tested 
for efficiency and the best housekeeping genes had also previously been 
determined, therefore this data is not included. 
 
8.2.1 Determination of best housekeeping genes 
 
Analysis of murine housekeeping genes using the geNorm gene stability 
algorithm (Vandesompele et al., 2002) revealed that GAPDH and B2M possessed 
equal stability (Fig.8.1-8.2), therefore GAPDH was selected for use in future 
experiments. 
Analysis of caninehousekeeping genes using the geNorm gene stability 
algorithm (Vandesompele et al., 2002) revealed that GAPDH and RPS13 possessed 
equal stability (Fig.8.3-8.4), therefore GAPDH was selected for use in future 
experiments. 
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Step 1: 
  
stability values M: 
  
   RPS13     ACTB   RPL13a    GAPDH      B2M     X18S  
1.489960 1.754691 1.823530 1.855685 1.972452 2.824383  
average stability M: 1.95345017415506 
  
variable with lowest stability (largest M value): X18S 
  
Pairwise variation, (5/6): 0.449623653312269 
  
############################################################### 
  
Step 2: 
  
stability values M: 
  
   RPS13     ACTB    GAPDH      B2M   RPL13a  
1.314197 1.422728 1.518825 1.601194 1.732975  
average stability M: 1.51798388199079 
  
variable with lowest stability (largest M value): RPL13a 
  
Pairwise variation, (4/5): 0.319142565151587 
  
############################################################### 
  
Step 3: 
  
stability values M: 
  
   GAPDH      B2M     ACTB    RPS13  
1.342864 1.347084 1.399408 1.409270  
average stability M: 1.37465640743623 
  
variable with lowest stability (largest M value): RPS13 
  
Pairwise variation, (3/4): 0.295359097556527 
  
############################################################### 
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 Step 4: 
  
stability values M: 
  
     B2M    GAPDH     ACTB  
1.216605 1.363272 1.440251  
average stability M: 1.3400426868367 
  
variable with lowest stability (largest M value): ACTB 
  
Pairwise variation, (2/3): 0.443614637219158 
  
############################################################### 
  
Step 5: 
  
stability values M: 
  
     B2M    GAPDH  
1.139627 1.139627  
average stability M: 1.13962697647197 
  
>  
> ranks <- HK$ranking 
>  
> ranks 
       1        1        3        4        5        6  
   "B2M"  "GAPDH"   "ACTB"  "RPS13" "RPL13a"   "X18S"  
  
Figure 8.1. R script used to determine most stable murine housekeeping gene. 
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Figure 8.2. Graphical representation of R script highlighting the most stable murine 
housekeeping gene. 
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Step 1: 
  
stability values M: 
  
   RPS13    GAPDH      B2M     ACTB  
1.736057 2.044986 2.630631 2.650524  
average stability M: 2.26554970320895 
  
variable with lowest stability (largest M value): ACTB 
  
Pairwise variation, (3/4): 0.607435751668605 
  
############################################################### 
  
Step 2: 
  
stability values M: 
  
   RPS13    GAPDH      B2M  
1.507763 1.820493 2.313470  
average stability M: 1.88057551391956 
  
variable with lowest stability (largest M value): B2M 
  
Pairwise variation, (2/3): 0.759568484198066 
  
############################################################### 
  
Step 3: 
  
stability values M: 
  
   GAPDH    RPS13  
1.014786 1.014786  
average stability M: 1.01478555088537 
  
>  
> ranks <- HK$ranking 
>  
> ranks 
      1       1       3       4  
"GAPDH" "RPS13"   "B2M"  "ACTB" 
Figure 8.3. R script used to determine most stable canine housekeeping gene. 
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Figure 8.4. Graphical representation of R script highlighting the most stable canine 
housekeeping gene.
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8.2.2 Assessment of primer efficiencies 
 
All primers were tested for efficiency before use in experiments, including all 
housekeeping primers used. Serial dilution of cDNA was performed ranging from 
0.3-40 ng, which encompassed the cDNA concentration normally used: 10 ng. qPCR 
was then conducted as described in Chapter 2, Section 2.2.2.5. Primer efficiencies 
were then plotted and calculated and dissociation curves assessed. Representative 
images are shown below (Fig.8.5). Primers with efficiencies between 90-110% were 
deemed to be acceptable and were used for future experiments. 
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A 
y = -3.3187x + 21.02 
R² = 0.9947 
0
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Figure 8.5. Determination of murine GAPDH primer quality and efficiency. 2^ΔCT values were 
determined for a range of murine cDNA concentrations (A), and then plotted on a scatter 
graph to determine the linear equation (B), and the overall primer efficiency (A). Dissociation 
curves for all primers were also analysed to ensure amplification of a single PCR product (C). 
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